Search
 CELL BANK Website

Back Back
Total:2615cells
Cell No. Cell Name
RCB0002
ARM193
CommentAnti-recA protein mAb.
Comment from the depositor
RCB0005
BALB/3T3 clone A31
CommentA subline of BALB/3T3 cell line. Contact inhibition is well observed.
Comment from the depositor
RCB0007
HeLa
CommentHuman cell line derived from cervical cancer.
Comment from the depositor
RCB0008
V79
CommentChinese hamster lung fibroblast
Comment from the depositor
RCB0009
PC-12
CommentPheochromocytoma, differentiate by NGF stimulation
Comment from the depositor
RCB0012
M227
CommentInfected with ts mutant of Kirsten sarcoma virus
Comment from the depositor
RCB0016
CCRF-HSB-2
CommentT cell leukemia
Comment from the depositor
RCB0026
PAb1400
CommentAnti-SV40 large T antigen mAb.
Comment from the depositor
RCB0027
K562
CommentHuman cell line derived from chronic myelogenous leukemia. Sensitive to NK cells. Differentiate to erythroid cells.
Comment from the depositor
RCB0032
FM3A FT-101
CommentTemperature-sensitive, forms multiple nuclei
Comment from the depositor
RCB0033
FM3A tscl.T85 Tsai
CommentTemperature-sensitive at chromosome condensation
Comment from the depositor
RCB0034
FM3A ts T244
CommentTemperature-sensitive at DNA polymerase
Comment from the depositor
RCB0035
WEHI-3
CommentMouse cell line derived from leukemia. Secretes cytokines for hematopoietic cells.
Comment from the depositor
RCB0036
C127
CommentHost for bovine papiloma virus
Comment from the depositor
RCB0041
HL60
CommentHuman cell line derived from promyelocytic leukemia. Differentiates to granulocytes and macrophages.
Comment from the depositor
RCB0043
NRK
CommentContact-inhibited semi-normal, original of NRK49F
Comment from the depositor
RCB0056
NIH3T3/14-1
CommentSpontaneous transformant of NIH3T3
Comment from the depositor
RCB0057
NIH3T3/13C7
CommentSV40 large T (tsA58)-pBR322 transformed NIH3T3.
Comment from the depositor
RCB0063
JTC-15
CommentSubclone of AH-66, lost transplantability in rats.
Comment from the depositor
RCB0065
JTC-27
CommentAscites hepatoma.
Comment from the depositor
RCB0067
M
CommentCapable to form collagen network
Comment from the depositor
RCB0069
RLC-16
CommentEpithelial cell from rat liver
Comment from the depositor
RCB0070
RLC-18
CommentNon tumorigenic in nude mice
Comment from the depositor
RCB0072
RLC-27
CommentLiver-derived cell, tumorigenic in nude mice
Comment from the depositor
RCB0074
JTC-19
CommentRat lung fibroblast once said interferon-producing. Serum-& protein-free culturable.
Comment from the depositor
RCB0075
RCR-1
CommentAstroglia cell line
Comment from the depositor
RCB0076
LYM-1
CommentSticky cell from lymph node.
Comment from the depositor
RCB0083
HLC-1
CommentLung adenocarcinoma
Comment from the depositor
RCB0086
FM3A
CommentMammary carcinoma, grow in vitro and in vivo
Comment from the depositor
RCB0095
P3/NSI/1-AG4-1
CommentMouse myeloma cell line. Utilized for genration of hybridoma. Reported in the literature to synthesize kappa chain, but do not secrete free light chain.
Comment from the depositor
RCB0096
Don(D-6)
CommentPseudodiploid, two marker chromosomes
Comment from the depositor
RCB0097
CHL
CommentWidely used in chromosome aberration test
Comment from the depositor
RCB0098
A549
CommentHuman cell line derived from lung cancer.
Comment from the depositor
RCB0101
L·P3
CommentProtein- & lipid-free medium growing
Comment from the depositor
RCB0102
IC-2
CommentMast cell precursor, respond to IL-3. Conditioned medium.
Comment from the depositor
RCB0112
NRK49F
CommentContact-inhibited semi-normal cell line
Comment from the depositor
RCB0115
ARM321
CommentAnti-recA protein mAb.
Comment from the depositor
RCB0116
7501
CommentS. cerevisiae Endo.Sce I large subunit mAb.
Comment from the depositor
RCB0120
LT4Tr
CommentSpontaneous transformant of LT4
Comment from the depositor
RCB0135
L5178Y
CommentRapidly growing lymphoma
Comment from the depositor
RCB0136
M10
CommentHighly sensitive to X-ray irradiation
Comment from the depositor
RCB0137
M10^(-)
CommentResistant to 6TG, isolated from M10
Comment from the depositor
RCB0138
LX830
CommentHighly sensitive to X-ray irradiation
Comment from the depositor
RCB0142
Ehrlich
CommentEhrlich's ascite tumor
Comment from the depositor
RCB0153
HUC-F
CommentNormal umbilical cord fibroblast, female
Comment from the depositor
RCB0156
305M
CommentNormal human skin fibroblast
Comment from the depositor
RCB0159
HS-K
CommentNormal diploid fibroblast from Japanese
Comment from the depositor
RCB0162
NHSF46
CommentDiploid fibroblast from normal Japanese skin.
Comment from the depositor
RCB0163
RGB3T3-1
CommentOriginal cloned line from RCB, just like BALB/3T3
Comment from the depositor
RCB0164
RGB3T3-5
CommentSiblings of RGB3T3-1, contact-inhibited
Comment from the depositor
RCB0165
REF-RGB
CommentSuitable as feeders for hybridoma cloning
Comment from the depositor
RCB0169
M1
CommentDifferentiate to macrophage and granulocyte
Comment from the depositor
RCB0171
7T1
CommentContact inhibited, may transform spontaneously
Comment from the depositor
RCB0174
SUSM-1
CommentTransformed in vitro with carcinogen
Comment from the depositor
RCB0180
MDBK
CommentA cell line derived from kidney of bovine.
Comment from the depositor
RCB0183
RK13
CommentA cell line derived from kidney of rabbit. Susceptible to viruses such as rubella virus.
Comment from the depositor
RCB0184
OLF-136
CommentFish (medaka) fin fibroblast. Application consideration
Comment from the depositor
RCB0185
CAEP
CommentGold fish erythrophoroma with 4n chromosomal mode
Comment from the depositor
RCB0186
CAF
CommentPinna fibroblast
Comment from the depositor
RCB0187
OLHE-131
CommentH04C medaka hepatoma pretreated with MAM-acetate. Application consideration
Comment from the depositor
RCB0188
OLME-104
CommentHB32C medaka treated with MNNG. From peritoneum. Amelanotic. Application consideration
Comment from the depositor
RCB0191
HeLa.S3
CommentMost famous cultured human cell line
Comment from the depositor
RCB0193
KMM-1
CommentHuman myeloma. Lambda- chain producing.
Comment from the depositor
RCB0195
PAb419
CommentAnti-SV40 large T antigen mAb.
Comment from the depositor
RCB0197
HUC-Fm
CommentNormal umbilical cord fibroblast, male
Comment from the depositor
RCB0202
A431
CommentHuman cell line derived from epidermoid carcinoma. Expressing EGF receptor.
Comment from the depositor
RCB0205
BU25 TK-
CommentThymidine kinase defective HeLa. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA85022104 prior to order.
Comment from the depositor
RCB0206
MOLT-4
CommentT cell leukemia, the same patient as RCB1164 MOLT-3. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA 85011413 prior to order.
Comment from the depositor
RCB0207
MRC-5 SV1 TG1
CommentSV40-transformed, 6TG-resistant and HAT-sensitive. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA85042501 prior to order.
Comment from the depositor
RCB0208
LTK-
CommentThymidine kinase defective L cell. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA85011432 prior to order.
Comment from the depositor
RCB0209
SP2/0-Ag14
CommentMouse myeloma cell line. Utilized for generation of hybridoma. This is a non-Ig-secreting or synthesising line. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to the ECA 85072401 prior to order.
Comment from the depositor
RCB0210
HF19
CommentNormal human lung fibroblast. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA 85011418 prior to order.
Comment from the depositor
RCB0218
MRC-5
CommentNormal embryonic lung fibroblast with accurate PDL
Comment from the depositor
RCB0222
NB1RGB
CommentNormal human skin fibroblast, RCB original
Comment from the depositor
RCB0224
ST2
CommentBone marrow stroma cell-derived
Comment from the depositor
RCB0243
Nil2C2
CommentA fibroblastic cell line derived from a fetus of Syrian hamster. Transformed cells. Tumor formation and metastasis can be observed after transplantation.
Comment from the depositor
RCB0244
Nil2C1
CommentA fibroblastic cell line derived from a fetus of Syrian hamster. Transformed cells. Tumor formation and metastasis can be observed after transplantation, but these abilities are lower than Nil2C2.
Comment from the depositor
RCB0245
Nil1C1
CommentA fibroblastic cell line derived from a fetus of Syrian hamster. Transformed cells. Tumor formation and metastasis can be observed after transplantation, but these abilities are much lower than Nil2C2.
Comment from the depositor
RCB0247
10T1/2
CommentFibroblast-like cells derived from mouse embryo. Can be used for experiments regarding cell transformation.
Comment from the depositor
RCB0248
3T6
CommentNon-contact inhibited
Comment from the depositor
RCB0249
CKT-1
CommentVery flat and thin kidney epithelial cell
Comment from the depositor
RCB0251
VA-13
CommentSV40-transformed WI-38.
Comment from the depositor
RCB0252
W-V
CommentSV40-transformed Werner's syndrome fibroblast
Comment from the depositor
RCB0256
BALL-1
CommentHuman cell line derived from B cell leukemia.
Comment from the depositor
RCB0266
CLA1RGB
CommentPseudo congenital lactic acidosis.
Comment from the depositor
RCB0270
KG-1-C
CommentGlioma, S-100 Protein producing.
Comment from the depositor
RCB0271
HeLa S3 (SC)
CommentSuspension culturable. Useful for JIS medium inspection
Comment from the depositor
RCB0273
BRL
CommentES cell differentiation inhibitory activity (DIA)
Comment from the depositor
RCB0275
SES-MaBr-1
CommentCabbage armyworm cell line applicable to large scale insect virus production.
Comment from the depositor
RCB0276
SES-MaBr-3
CommentCabbage armyworm cell line applicable to large scale production of insect virus.
Comment from the depositor
RCB0278
NIAS-MB-25
CommentShow finely branched cytoplasmic processes
Comment from the depositor
RCB0279
NIAS-MaBr-92
CommentSusceptible to nuclear polyhedrosis virus
Comment from the depositor
RCB0282
NFSa Y83
Comment A subline of NFSa which is a mouse cell line derived from fibrosarcoma. Transplantable.
Comment from the depositor
RCB0283
C-1300
CommentHighly metastatic neuroblastoma
Comment from the depositor
RCB0284
Sq-1979
CommentMetastatic epithelial cell
Comment from the depositor
RCB0285
CHO-K1
CommentA cell line derived from ovary of Chinese hamster. Frequently used for production of recombinant proteins etc.
Comment from the depositor
RCB0286
tk^(-)ts13
CommentThymidine kinase-defective mutant of ts13
Comment from the depositor
RCB0288
3Y1-B clone 1-6-2
CommentSubclone of 3Y1-B clone 1.
Comment from the depositor
RCB0289
3Y1-B cl 1-6-K5-4-2
CommentSubclone of 3Y1-B clone 1-6.
Comment from the depositor
RCB0290
3Y1-B clone 1
CommentMother clone of 3Y1 series.
Comment from the depositor
RCB0291
3Y1ts-101
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0292
3Y1tsC102
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0293
3Y1ts-103
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0294
3Y1ts-104
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0295
3Y1ts-105
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0296
3Y1tsA106
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0297
3Y1tsB107
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0298
3Y1ts-108
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0299
3Y1ts-109
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0301
3Y1ts-111
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0302
3Y1tsC112
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0303
3Y1tsC113
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0304
3Y1ts-114
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0305
3Y1ts-115
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0306
3Y1tsC116
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0307
3Y1ts-117
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0308
3Y1ts-118
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0309
3Y1tsC119
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0310
3Y1ts-120
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0311
3Y1tsF121
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0312
3Y1ts-122
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0313
3Y1tsD123
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0314
3Y1tsD124
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0315
3Y1tsG125
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0316
3Y1tsF126
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0317
3Y1ts-201
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0318
3Y1ts-202
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0319
3Y1tsH203
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0320
3Y1tsE204
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0321
3Y1tsC205
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0322
3Y1tsD206
CommentA subline of 3Y1 cell line. Temperature-sensitive mutant.
Comment from the depositor
RCB0323
3Y1-SB-15
CommentA subline of 3Y1 cell line. Tetraploid clone.
Comment from the depositor
RCB0324
3Y1-SB-16
CommentA subline of 3Y1 cell line. Tetraploid clone.
Comment from the depositor
RCB0325
3Y1BU^(r-1)
CommentA subline of 3Y1 cell line. Thymidine kinase-defective.
Comment from the depositor
RCB0326
3Y1BU^(r-2)
CommentA subline of 3Y1 cell line. Thymidine kinase-defective.
Comment from the depositor
RCB0327
3Y1BU^(r-3)
CommentA subline of 3Y1 cell line. Thymidine kinase-defective.
Comment from the depositor
RCB0328
Ad12-3Y1-Z11
CommentA subline of 3Y1 cell line. Transformed by adenovirus type 12.
Comment from the depositor
RCB0329
Ad12-3Y1-Z13
CommentA subline of 3Y1 cell line. Transformed by adenovirus type 12.
Comment from the depositor
RCB0330
Ad12-3Y1-Z19
CommentA subline of 3Y1 cell line. Transformed by adenovirus type 12.
Comment from the depositor
RCB0331
Ad12-3Y1-W5
CommentA subline of 3Y1 cell line. Transformed by adenovirus type 12.
Comment from the depositor
RCB0332
E1A-3Y1-1
CommentA subline of 3Y1 cell line. Transformed by adenovirus type 12 E1A gene.
Comment from the depositor
RCB0333
E1A-3Y1-2
CommentA subline of 3Y1 cell line. Transformed by adenovirus type 12 E1A gene.
Comment from the depositor
RCB0334
E1A-3Y1-3
CommentA subline of 3Y1 cell line. Transformed by adenovirus type 12 E1A gene.
Comment from the depositor
RCB0335
in203-3Y1-7
CommentA subline of 3Y1 cell line. Transformed by adenovirus in203.
Comment from the depositor
RCB0336
in203-3Y1-19
CommentA subline of 3Y1 cell line. Transformed by adenovirus in203.
Comment from the depositor
RCB0337
in203-3Y1-23
CommentA subline of 3Y1 cell line. Transformed by adenovirus in203.
Comment from the depositor
RCB0338
Ad2-3Y1-1
CommentA subline of 3Y1 cell line. Transformed by adenovirus type 2.
Comment from the depositor
RCB0339
Ad2-3Y1-2
CommentA subline of 3Y1 cell line. Transformed by adenovirus type 2.
Comment from the depositor
RCB0340
Ad2-3Y1-3
CommentA subline of 3Y1 cell line. Transformed by adenovirus type 2.
Comment from the depositor
RCB0343
SV-3Y1-C66
CommentA subline of 3Y1 cell line. Transformed by SV40 virion.
Comment from the depositor
RCB0344
A640-3Y1-1
CommentA subline of 3Y1 cell line. Transformed by SV40 tsA640.
Comment from the depositor
RCB0347
dl-884-3Y1-KO1
CommentA subline of 3Y1 cell line. Transformed by SV40 dl-884.
Comment from the depositor
RCB0350
Py-3Y1-S2
CommentA subline of 3Y1 cell line. Transformed by mouse polyoma virus.
Comment from the depositor
RCB0353
SR-3Y1-1
CommentA subline of 3Y1 cell line. Transformed by Rous sarcoma virus.
Comment from the depositor
RCB0354
SR-3Y1-2
CommentA subline of 3Y1 cell line. Transformed by Rous sarcoma virus.
Comment from the depositor
RCB0356
HR-3Y1-1
CommentA subline of 3Y1 cell line. Transformed by v-Ha-ras oncogene.
Comment from the depositor
RCB0357
HR-3Y1-2
CommentA subline of 3Y1 cell line. Transformed by v-Ha-ras oncogene.
Comment from the depositor
RCB0359
NG-3Y1-D303
CommentA subline of 3Y1 cell line. Transformed by nitrosoguanidine.
Comment from the depositor
RCB0371
NG-3Y1-T18D
CommentA subline of 3Y1 cell line. Transformed by nitrosoguanidine.
Comment from the depositor
RCB0379
mos-3Y1-10
CommentA subline of 3Y1 cell line. Transformed by v-mos oncogene.
Comment from the depositor
RCB0380
mos-3Y1-16
CommentA subline of 3Y1 cell line. Transformed by v-mos oncogene.
Comment from the depositor
RCB0381
V12S-3Y1-2
CommentA subline of 3Y1 cell line. Transformed by adenovirus type 12 12S-E1A.
Comment from the depositor
RCB0384
V13S-3Y1-4
CommentA subline of 3Y1 cell line. Transformed by adenovirus type 12 12S-E1A.
Comment from the depositor
RCB0388
NCU-F1
CommentEhlers-Danlos syndrome
Comment from the depositor
RCB0389
NCU-F2
CommentMorquio syndrome
Comment from the depositor
RCB0390
NCU-F3
CommentWilson's disease
Comment from the depositor
RCB0391
NCU-F4
CommentWilson's disease
Comment from the depositor
RCB0393
NCU-F6
CommentCitrullinemia
Comment from the depositor
RCB0394
NCU-F7
CommentCitrullinemia
Comment from the depositor
RCB0395
NCU-F8
CommentWilson's disease
Comment from the depositor
RCB0397
NCU-F10
CommentCockayne's syndrome
Comment from the depositor
RCB0402
HeLa·P3
CommentProtein- free, serm- free, lipid-free medium growing
Comment from the depositor
RCB0403
CHO-K1 (SC)
CommentA subline of CHO-K1 (RCB0285). Suspension culture is possible.
Comment from the depositor
RCB0404
SES-MaBr-4
CommentSensitive to nuclear polyhedrosis virus. Possible to grow in sea-water based low-cost medium.
Comment from the depositor
RCB0405
NIAS-LeSe-11
CommentSusceptible to insect viruses.
Comment from the depositor
RCB0407
WS2TKB
CommentWerner's syndrome
Comment from the depositor
RCB0409
WS1TKB
CommentWerner's syndrome, the same patient as RCB0433 WS1TKB2.
Comment from the depositor
RCB0410
MEN1RGB
CommentFibroblasts from multiple endocrine neoplasia
Comment from the depositor
RCB0411
HaP-T1
CommentMucin producing, BHP-induced pancreatic tumor
Comment from the depositor
RCB0412
NIAS-PX-64
CommentPupal ovary.
Comment from the depositor
RCB0413
NIAS-MB-32
CommentShow finely branched cytoplasmic processes. Application consideration
Comment from the depositor
RCB0414
NIAS-MaBr-93
Commentlarval hemocyte
Comment from the depositor
RCB0417
KU-1
CommentBovine B cell leukemia cell line. It is described in the paper that bovine leukaemia virus (BLV) particles and BLV antigen are both negative. In relation to the production of virus, RIKEN Cell Bank has not confirmed it.
Comment from the depositor
RCB0418
KU-17
CommentBovine leukemia cell line. It is described in the paper that this cell line produces bovine leukosis virus (BLV). In relation to the production of virus, RIKEN Cell Bank has not confirmed it. Application consideration
Comment from the depositor
RCB0420
BHK-21C13-2P
CommentCulturable in suspension, cf. ECACC ( BHK-21C13-3P). Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA 84111301 prior to order.
Comment from the depositor
RCB0421
MEN2RGB
CommentFibroblasts from multiple endocrine neoplasia
Comment from the depositor
RCB0423
BL312
CommentBovine derived lymphocyte. It is described in the paper that this cell line produces bovine leukemia virus (BLV). In relation to the production of virus, RIKEN Cell Bank has not confirmed it.
Comment from the depositor
RCB0429
SES-MaBr-5
CommentLarval fat body hemocyte.
Comment from the depositor
RCB0431
T24
CommentBladder transitional-cell carcinoma
Comment from the depositor
RCB0432
MT-5
CommentMNNG-initiated clone of BALB/c 3T3 clone A31
Comment from the depositor
RCB0433
WS1TKB2
CommentWerner's syndrome, the same patient as RCB0409 WS1TKB.
Comment from the depositor
RCB0434
J774.1
CommentMacrophage-like cell
Comment from the depositor
RCB0435
U-937 DE-4
CommentCloned U-937, differentiate with TNF
Comment from the depositor
RCB0436
HUC-F2
CommentNormal umbilical cord fibroblast, female
Comment from the depositor
RCB0437
HUC-Fm2
CommentNormal umbilical cord fibroblast, male
Comment from the depositor
RCB0438
LC-1/sq-SF
CommentLung Cancer-1/squamous (RCB0455 LC-1/sq), serum-free cultured. Application consideration
Comment from the depositor
RCB0439
LC-1F
CommentLung Cancer-1/squamous, floating variant, the same patient as RCB0455 LC-1/sq.
Comment from the depositor
RCB0440
LC-2/ad
CommentAdenocarcinoma, moderately differentiated. Application consideration
Comment from the depositor
RCB0441
SCCKN
CommentHighly sensitive to bleomycin
Comment from the depositor
RCB0443
TC-YIK
CommentIntegrating HPV16, neurosecretory granules(+)
Comment from the depositor
RCB0444
RERF-LC-AI
CommentJapanese lung squamous carcinoma.
Comment from the depositor
RCB0447
ARLJ301-3
CommentDiploid rat liver epithelial cell line
Comment from the depositor
RCB0448
ARLJ301-3TR1
CommentSpontaneous transformant of ARLJ301-3
Comment from the depositor
RCB0449
Anr4
CommentEJ-ras oncogene transformed ARLJ301-3
Comment from the depositor
RCB0450
Anr9-1
CommentEJ-ras oncogene transformed ARLJ301-3
Comment from the depositor
RCB0451
Anr13-1
CommentEJ-ras oncogene transformed ARLJ301-3
Comment from the depositor
RCB0452
HTC/C3
CommentSecretes IL-1,TGFα,GM-CSF but not thyroglobulin
Comment from the depositor
RCB0453
SHOK
CommentContact-inhibited hamster embryonal cell line
Comment from the depositor
RCB0455
LC-1/sq
CommentLung Cancer-1/squamous. Parent cell line of RCB0438 LC-1/sq-SF, the same patient as RCB0439 LC-F.
Comment from the depositor
RCB0457
BM-N
CommentUseful for recombinant BmNPV expression. Application consideration
Comment from the depositor
RCB0466
Lu-134-A
CommentSmall cell carcinoma, classic type. See Lu-134-B. Application consideration
Comment from the depositor
RCB0467
Lu-134-B
CommentSmall cell carcinoma, classic type. See Lu-134-A. Application consideration
Comment from the depositor
RCB0468
Lu-135
CommentSmall cell carcinoma, variant type. Application consideration
Comment from the depositor
RCB0469
Lu-139
CommentSmall cell carcinoma, classic type. Application consideration
Comment from the depositor
RCB0470
Lu-140
CommentSmall cell carcimoma, classic type. Application consideration
Comment from the depositor
RCB0471
CYNOM-K1
CommentCynomolgus monkey embryo skin, early passage.Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
Comment from the depositor
RCB0473
DD762
CommentMammary tumor cell line without C-type virus
Comment from the depositor
RCB0474
K562/MTX-2
CommentMethotrexate(MTX)-resistant K562 cell line
Comment from the depositor
RCB0475
ILT-Mat
CommentIL-2 dependent ATL cell line. HTLV-1 pro-virus DNA(+).
Comment from the depositor
RCB0476
Had-1
CommentA subline of FM3A (mouse breast cancer cell line). Resistant to Newcastle virus and Sendai virus. Dye by GS-II lectin. The revertant cells (parent cell-like cells) dye by WGA lectin.
Comment from the depositor
RCB0477
NB9
CommentHuman cell line derived from Neuroblastoma. N-myc gene is amplified. Another name is CHP-212 (PMID: 6871857). Application consideration
Comment from the depositor
RCB0478
NB16
CommentHuman cell line derived from Neuroblastoma. N-myc gene is amplified.
Comment from the depositor
RCB0480
NB69
CommentHuman cell line derived from Neuroblastoma. N-myc gene is not amplified. Application consideration
Comment from the depositor
RCB0481
TNB1
CommentHuman cell line derived from Neuroblastoma. N-myc gene is amplified. Another name is TGW (PMID: 2335222). Application consideration
Comment from the depositor
RCB0482
MC-NB-1
CommentHuman cell line derived from Neuroblastoma. Possess N-myc gene amplicon. Application consideration
Comment from the depositor
RCB0483
LA-N-1
CommentHuman cell line derived from Neuroblastoma. N-myc gene is amplified. Derived from metastatic tumor in bone marrow.
Comment from the depositor
RCB0484
LA-N-2
CommentHuman cell line derived from Neuroblastoma. N-myc gene is amplified.
Comment from the depositor
RCB0485
LA-N-5
CommentHuman cell line derived from Neuroblastoma. N-myc gene is amplified.
Comment from the depositor
RCB0486
CHP-126
CommentHuman cell line derived from Neuroblastoma. N-myc gene is amplified. Application consideration
Comment from the depositor
RCB0487
CHP-134
CommentHuman cell line derived from Neuroblastoma. N-myc gene is amplified. Application consideration
Comment from the depositor
RCB0488
3Y1-B clone 1-6
CommentStandard clone of 3Y1 series. So called 3Y1
Comment from the depositor
RCB0489
NEC8
CommentEmbryonal carcinoma, testis.
Comment from the depositor
RCB0490
NEC14
CommentEmbryonal carcinoma, testis. Application consideration
Comment from the depositor
RCB0492
OTCD1TKB
CommentHuman adherent cells derived from skin of a patient suffering from ornithine transcarbamylase deficiency.
Comment from the depositor
RCB0494
NEC15
CommentEmbryonal carcinoma, testis. Application consideration
Comment from the depositor
RCB0495
KU812
CommentChronic myelogeneous leukemia, Ph1 chromosome (+), basophil-like cells.
Comment from the depositor
RCB0496
KU812E
CommentChronic myelogenous leukemia , subclone of RCB0495 KU812.
Comment from the depositor
RCB0497
KU812F
CommentChronic myelogeneous leukemia, subclone of RCB0495 KU812.
Comment from the depositor
RCB0500
HGC-27
CommentHuman cell line derived from metastatic lymph node of gastric cancer (undifferentiated carcinoma).
Comment from the depositor
RCB0503
HeLa.S3(Mer^(-))
CommentRepair deficient (mer-)
Comment from the depositor
RCB0504
MR1-3
CommentMNNG-reistant HeLa.S3(Mer-) cells
Comment from the depositor
RCB0505
MR6
CommentMNNG-resistant HeLa.S3(Mer-) cells
Comment from the depositor
RCB0507
MR10-1
CommentMNNG-resistant HeLa.S3(Mer-) cells
Comment from the depositor
RCB0508
H-EMC-SS
CommentExtraskeletal myxoid chondrosarcoma
Comment from the depositor
RCB0510
ACL-15
CommentMetastasis to liver, lung
Comment from the depositor
RCB0511
RCN-9
CommentMetastasis to liver, lung
Comment from the depositor
RCB0512
RCN-H-4
CommentMetastasis to liver
Comment from the depositor
RCB0513
SKN
CommentHuman cell line derived from uterine leiomyosarcoma. Sensitive to estradiol-17 beta. Metastasis to kidney was observed in the clinic.
Comment from the depositor
RCB0515
HSKTC
CommentHuman cell line derived from Krukenberg tumor. Metastasis to ovary of gastric signet ring cell carcinoma. Producing mucin. Expressing CA19-9, CEA, and TPA.
Comment from the depositor
RCB0520
WR216
CommentAPRT(-) EB transformed B cell line
Comment from the depositor
RCB0521
HFL-I
CommentHuman fibroblasts derived from fetal lung (11 weekly age).
Comment from the depositor
RCB0522
HFL-II
CommentHuman fibroblasts derived from fetal lung (14 weekly age).
Comment from the depositor
RCB0523
HFL-III
CommentHuman fibroblasts derived from fetal lung (11 weekly age).
Comment from the depositor
RCB0524
HFL-AE-I
CommentHuman fibroblasts derived from lung of anencephalic fetus. 46XY,17p+ or 17ph+
Comment from the depositor
RCB0525
HFL-AE-II
CommentHuman fibroblasts derived from lung of anencephalic fetus. 46XX, inv(9p+,q-)
Comment from the depositor
RCB0526
Jyg-MC(A)
Commentmurine mammary tumor cell lines. High level MMTV producer line.
Comment from the depositor
RCB0527
Jyg-MC(B)
CommentMurine mammary tumor cell lines. Higher incidence in lung metastasis.
Comment from the depositor
RCB0528
MtT/S
CommentRat cell line derived from pituitary tumor. Estrogen-induced tumor. Producing growth hormone. Able to induce the cells producing prolactin. Four cell lines (MtT/E, MtT/S, MtT/SM, MtT/Se) were established simultaneously.Application consideration.
Comment from the depositor
RCB0529
MtT/Se
CommentRat cell line derived from pituitary tumor. Estrogen-induced tumor. Estrogen-dependent cell line. Producing a small amount of growth hormone. Four cell lines (MtT/E, MtT/S, MtT/SM, MtT/Se) were established simultaneously.Application consideration.
Comment from the depositor
RCB0530
MtT/SM
CommentRat cell line derived from pituitary tumor. Estrogen-induced tumor. Producing prolactin and growth hormone. Four cell lines (MtT/E, MtT/S, MtT/SM, MtT/Se) were established simultaneously. Application consideration.
Comment from the depositor
RCB0531
TtT/M-87
CommentMouse cell line derived from pituitary tumor (thyrotropin-producing tumor). Macrophage-like cells. Dependent on conditioned medium of L929 cells. Conditioned medium.
Comment from the depositor
RCB0533
Y1
CommentMouse steroid hormone secreting adrenal cortex cell line. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA 85062807 prior to order.
Comment from the depositor
RCB0535
RAW 264
CommentMouse leukemic monocyte. Abelson leukemia virus induced. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA85062803 prior to order. Application consideration(PDF 580KB)
Comment from the depositor
RCB0536
STO
CommentTioguanine- and ouabain-resistant and HAT-sensitive fibroblasts. Suitable for ES cell feeder layer. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA 86032003 prior to order.
Comment from the depositor
RCB0537
JM
CommentHuman cell line derived from T-cell leukemia. Isolated from the same patient as “Jurkat”. Has the ability to grow HIV. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA86010201 prior to order.
Comment from the depositor
RCB0538
PU5-18
CommentMouse lymphoid tumor, macrophage like. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA85051501 prior to order.
Comment from the depositor
RCB0540
HAL-01
CommentAcute lymphatic leukemia
Comment from the depositor
RCB0544
MBT-2
CommentA mouse cell line derived from bladder cancer.
Comment from the depositor
RCB0545
OHTA
CommentMouse embryonic carcinoma
Comment from the depositor
RCB0546
AT-PDH1TKB
CommentPyruvate dehydrogenase deficiency fibroblasts.
Comment from the depositor
RCB0548
IA-5
CommentHuman cell line derived from lung cancer. Large cell carcinoma. Derived from skin metastasis. Transplantable in immuno-deficient mouse, but metastasis to lymph nodes is rarely observed. IA-5 (RCB0548) and IA-LM (RCB0554) were derived from the same patient.
Comment from the depositor
RCB0549
Cle-H3
CommentNIH3T3 transformant expressing human activated k-ras-2.
Comment from the depositor
RCB0550
Cle-H3^(neo+)
CommentpSV2neo-introduced G418-resistant Cle-H3 mutant.
Comment from the depositor
RCB0554
IA-LM
CommentHuman cell line derived from lung cancer. Large cell carcinoma. Derived from skin metastasis. Transplantable in immuno-deficient mouse, and metastasis to lymph nodes can be observed. IA-5 (RCB0548) and IA-LM (RCB0554) were derived from the same patient.
Comment from the depositor
RCB0555
GCIY
CommentStomach cancer (Borrmann IV). Mucin, CA19-9, CEA, alphafetoprotein positive.
Comment from the depositor
RCB0556
NIAS-PX-58
CommentPupal ovary hemocyte-like.
Comment from the depositor
RCB0557
B16 melanoma 4A5
CommentMelanin pigment producing mouse melanoma. Application consideration
Comment from the depositor
RCB0558
LLC
CommentHighly metastatic and drug-resistant mouse tumor. Application consideration
Comment from the depositor
RCB0559
K-1.fl
CommentSFFV producing Friend leukemia cell line. Non-differentiating.
Comment from the depositor
RCB0560
F5-5.fl
CommentFriend leukemia. Differentiate to erythroblastoid cells with benzidine etc.
Comment from the depositor
RCB0561
T-3-Cl-2-0.fl
CommentFriend leukemia. Differentiate to erythroblastoid cells with 1.5% DMSO etc. A clone of TSFAT-3.fl
Comment from the depositor
RCB0562
TSFAT-3.fl
CommentFriend leukemia. Differentiate to erythroblastoid cells.
Comment from the depositor
RCB0565
ATDC5
CommentDifferentiate to chondrocytes, unidentifiable pigment cells. Teratocarcinoma AT805 derived.
Comment from the depositor
RCB0566
CGM1
CommentEB transformed B cell line
Comment from the depositor
RCB0568
ULF-23
CommentCold water fish cell line. Cultured at 25 C. Relatively large chromosomes (Mode 23).
Comment from the depositor
RCB0569
707.fl
CommentFriend leukemia cell line. High ability to differentiate to erythroblastoid cells.
Comment from the depositor
RCB0570
GM86.fl
CommentFriend leukemia cell line from DBA/2 mouse.
Comment from the depositor
RCB0571
FVTCT.fl
CommentFriend leukemia cell line from BALB/c mouse. Virusnon-producing.
Comment from the depositor
RCB0580
SF8402
CommentControl from a nonexposed individual with breast cancer, different specimen from RCB0635
Comment from the depositor
RCB0582
SF8404
CommentControl from a nonexposed individual without cancer
Comment from the depositor
RCB0583
SF8405
CommentControl from a nonexposed individual without cancer.
Comment from the depositor
RCB0584
SF8406
CommentControl from a nonexposed individual without cancer.
Comment from the depositor
RCB0585
SF8657
CommentControl from a nonexposed individual with stomach cancer
Comment from the depositor
RCB0587
SF8759
CommentAtomic bomb survivor with breast cancer
Comment from the depositor
RCB0588
SF8760
CommentAtomic bomb survivor with breast cancer.
Comment from the depositor
RCB0589
SF8761
CommentControl from a nonexposed individual without cancer.
Comment from the depositor
RCB0590
SF8762
CommentAtomic bomb survivor with breast cancer.
Comment from the depositor
RCB0591
HNS1A
CommentSalamander cell line with large chromosomes.
Comment from the depositor
RCB0592
HNS2
CommentLarger epithelial cells than HNS1A.
Comment from the depositor
RCB0593
HNS3
CommentSalamander cell line. Fibroblast-like cells.
Comment from the depositor
RCB0594
HNS4
CommentSalamander cell line. Epithelial-like cells.
Comment from the depositor
RCB0595
HNS5
CommentSalamander cell line. Fibroblast-like cells.
Comment from the depositor
RCB0596
SF8758
CommentAtomic bomb survivor with breast cancer
Comment from the depositor
RCB0597
SF8656
CommentControl from a non-exposed individual without breast cancer but with thyroid & colon cancer.
Comment from the depositor
RCB0598
SF8655
CommentAtomic bomb survivor without cancer.
Comment from the depositor
RCB0600
SF8653
CommentAtomic bomb survivor without breast cancer but with thyroid cancer.
Comment from the depositor
RCB0602
SF8650
CommentAtomic bomb survivor with breast cancer
Comment from the depositor
RCB0603
SF8649
CommentAtomic bomb survivor with breast cancer
Comment from the depositor
RCB0604
SF8647
CommentAtomic bomb survivor with breast cancer.
Comment from the depositor
RCB0605
SF8546
CommentControl from a nonexposed individual without cancer.
Comment from the depositor
RCB0608
SF8543
CommentControl from a nonexposed individual with breast cancer
Comment from the depositor
RCB0610
SF8541
CommentControl from a nonexposed individual with uterus cancer
Comment from the depositor
RCB0614
SF8536
CommentAtomic bomb survivor without cancer
Comment from the depositor
RCB0617
SF8433
CommentAtomic bomb survivor with breast cancer
Comment from the depositor
RCB0620
SF8429
CommentAtomic bomb survivor with breast cancer
Comment from the depositor
RCB0621
SF8428
CommentAtomic bomb survivor with breast cancer, different specimen from RCB0624
Comment from the depositor
RCB0624
SF8425
CommentAtomic bomb survivor with breast cancer, different specimen from RCB0621.
Comment from the depositor
RCB0631
SF8416
CommentAtomic bomb survivor with breast cancer
Comment from the depositor
RCB0633
SF8414
CommentControl from a nonexposed individual with breast cancer
Comment from the depositor
RCB0634
SF8413
CommentControl from a nonexposed individual with chest cancer
Comment from the depositor
RCB0635
SF8410
CommentControl from a nonexposed individual with breast cancer, different specimen from RCB0580.
Comment from the depositor
RCB0637
CTLL-2
CommentCytotoxic T-cell line. IL-2 dependent.
Comment from the depositor
RCB0638
TCS
CommentHuman cell line derived from uterine cervix cancer. Keratinizing squamous carcinoma. Said producing CEA.
Comment from the depositor
RCB0641
EoL-1 cell
CommentEosinophilic leukemia. Differenciate by n-butylate treatment.
Comment from the depositor
RCB0644
D134
CommentMoAb IgM to sea urchin sperm dynein alpha-heavy chain.
Comment from the depositor
RCB0646
D264
CommentMoAb IgM to sea urchin sperm dynein beta-heavy chain.
Comment from the depositor
RCB0648
D308
CommentMoAb IgM to sea urchin sperm dynein beta-heavy chain.
Comment from the depositor
RCB0649
D52
CommentMoAb IgM to sea urchin sperm dynein IC1.
Comment from the depositor
RCB0650
D9
CommentMoAb IgM to sea urchin sperm dynein IC2.
Comment from the depositor
RCB0651
D58
CommentMoAb IgG1 to sea urchin sperm dynein IC2.
Comment from the depositor
RCB0654
D16
CommentMoAb IgG1 to sea urchin sperm dynein IC3.
Comment from the depositor
RCB0657
HOKUG
CommentHuman cell line derived from uterine cervix cancer. Glassy cell carcinoma.
Comment from the depositor
RCB0658
HHUA
CommentHuman cell line derived from endometrial cancer. Expressing receptor of estradiol-17beta and progesterone.
Comment from the depositor
RCB0659
HOUA-I
CommentHuman cell line derived from uterine cancer (endometrial cancer).
Comment from the depositor
RCB0660
HTMMT
CommentHuman cell line derived from malignant mixed mesodermal tumor found in uterus (malignant mixed Müllerian tumor).
Comment from the depositor
RCB0662
HOTHC
CommentHuman cell line derived from undifferentiated carcinoma of thyroid (pleomorphous). Expressing tumor angiogenesis factor (TAF) and G-CSF.
Comment from the depositor
RCB0665
HFWT
CommentHuman cell line derived from Wilms' tumor. Expressing CA125 and TPA.
Comment from the depositor
RCB0666
HSNB
CommentHuman cell line derived from Neuroblastoma. N-myc gene is amplified. Producing neuron specific enolase.Application consideration
Comment from the depositor
RCB0669
PCH42-63
CommentHybridoma against differentiated PC-12 cell surface
Comment from the depositor
RCB0673
PCH41-43
CommentHybridoma against differentiated PC-12 cell surface
Comment from the depositor
RCB0674
PCH41-44
CommentHybridoma producing monoclonal antibody against differentiated PC-12 cell surface molecules.
Comment from the depositor
RCB0676
PCH42-58
CommentHybridoma producing monoclonal antibody against differentiated PC-12 cell surface molecules.
Comment from the depositor
RCB0678
PCH54-37
CommentHybridoma against differentiated PC-12 cell surface
Comment from the depositor
RCB0679
HDC
CommentHuman fibroblasts derived from uterine. 46XX,t(2/q2/q). The first child of this donor suffers from Down's syndrome, 46XX,t(2/q2/q).
Comment from the depositor
RCB0680
HKBMM
CommentHuman cell line derived from malignant meningioma.
Comment from the depositor
RCB0684
HFL-AE-III
CommentHuman fibroblasts derived from lung of anencephalic fetus (15 weekly age).
Comment from the depositor
RCB0685
SKG-II-SF
CommentA subline of SKG-II (human cell line derived from uterine cervix cancer, large cell non-keratinizing squamous cell carcinoma). Serum-free culture is possible. HPV type 18 integrated.
Comment from the depositor
RCB0687
KP-N-NS
CommentAdrenal neuroblastoma derived from brain metastasis
Comment from the depositor
RCB0688
QG-U
CommentJapanese cervix carcinoma.
Comment from the depositor
RCB0689
TCO-2
CommentHuman cell line derived from uterine cervix cancer. Adenocarcinoma. Said producing CEA, CA125, TPA.
Comment from the depositor
RCB0690
HOTHC-SF
CommentA subline of HOTHC. Serum-free and protein-free culture is possible.
Comment from the depositor
RCB0697
GM2-1TKB
CommentTay-Sachs' disease
Comment from the depositor
RCB0698
HFSKF-II
CommentHuman fibroblasts derived from fetal skin (11 weekly age).
Comment from the depositor
RCB0700
HTMM
CommentHuman cell line derived from malignant melanoma. Established from a metastasis to a lymph node. The origin is unknown.
Comment from the depositor
RCB0701
143B/TK^(-)neo^(R)
Commentv-Ki-ras transformant TE85 cell line. HAT sensitive, neo resistant.
Comment from the depositor
RCB0702
WI-38
CommentThe most famous normal human fibroblast. Obtained directly from L. Hayflick. Younger PDL than RCB704 at time of deposit.
Comment from the depositor
RCB0704
WI-38
CommentThe most famous normal human fibroblast. Obtained directly from L. Hayflick.
Comment from the depositor
RCB0705
10H
CommentAnti poly(ADP-ribose) IgG3 kappa producing.
Comment from the depositor
RCB0708
HF10B4
CommentAnti-human lung carcinoma mAb (IgM). Possible to culture in serum-free medium.
Comment from the depositor
RCB0709
HyLDH·YK-1
CommentAnti-rabbit muscle lactate dehydrogenase (LDH) mAb (IgG1). Possible to culture in serum-free medium.
Comment from the depositor
RCB0710
HyLDH·YK-2
CommentAnti-rabbit muscle lactate dehydrogenase (LDH) mAb (IgG2b). Possible to culture in serum-free medium
Comment from the depositor
RCB0711
HyGPD·YK-1-1
CommentAnti-rabbit muscle glyceraldehyde-3-phosphate dehydrogenase mAb (IgG). Serum-free culturable.
Comment from the depositor
RCB0713
HTUD1
CommentLarge cells with large chromosomes.
Comment from the depositor
RCB0715
CHAUT-G
CommentSmooth muscle cell sarcoma from Chinese hamster.
Comment from the depositor
RCB0721
GOTO·P3
CommentSubline of GOTO. Protein-free medium adapted.
Comment from the depositor
RCB0725
MS-1
CommentSmall lung carcinoma. PTHrP producing.
Comment from the depositor
RCB0733
NLS-6-5
CommentNalidixic acid sensitive mutant. Also sensitive toVP-16 and VM-26 Topo II inhibitors.
Comment from the depositor
RCB0735
OS-RC-2
CommentRenal tumor cell from a Japanese. Transplantable to nude mice.
Comment from the depositor
RCB0736
DJM-1
CommentMalignant trichilemmal cyst cells. Strongly laminin positive on cell surface. Serum-free culturable.
Comment from the depositor
RCB0738
MTHC-1
CommentRat thymoma cell line without mouse chromosome contamination. Compare to MTHC-2 and -3.
Comment from the depositor
RCB0739
MTHC-2
CommentRat thymoma cell line fused to mouse cells during nude-mouse transplantation. Mouse chr. 5, 15, 17.
Comment from the depositor
RCB0740
MTHC-3
CommentRat thymoma cell line fused to mouse cells during nude-mouse transplantation. Mouse chr. 5,7,15,17.
Comment from the depositor
RCB0748
Mm1
CommentSpontaneouly differentiated cell line derived from M1. Non-tumorigenic.
Comment from the depositor
RCB0749
MFH-ino
CommentHuman fibrous histiocytoma. Showing fibroblastic- and histiocytic features.
Comment from the depositor
RCB0750
TLR2
CommentHepatocytes containing temperature sensitive SV40 large T antigen. P450IA1 inducible.
Comment from the depositor
RCB0752
TKD2
CommentMouse kidney cell line. Derived from a transgenic mouse expressing temperature sensitive SV40 large T antigen (SV40tsA58).
Comment from the depositor
RCB0753
OMC-1
CommentJapanese cervix squamous cell carcinoma. Once said TA-4 positive.
Comment from the depositor
RCB0755
OMC-3
CommentMucinous cystadenocarcinoma. Said CA125,CA19-9 (+).
Comment from the depositor
RCB0760
MT-8
CommentRat cell line derived from malignant fibrous histiocytoma. Characteristics of histiocytes are lacking. The tumor formed by this cell line consists of immature cells.
Comment from the depositor
RCB0761
505-05-01
CommentMethylcholanthrene-induced fibrosarcoma. Metastatic to lung.
Comment from the depositor
RCB0762
MT-9
CommentRat cell line derived from malignant fibrous histiocytoma. Possessing characteristics of histiocytes.
Comment from the depositor
RCB0763
GI-1
CommentHuman glioma separated from gliosarcoma.
Comment from the depositor
RCB0764
Fvp^(r)B350
CommentTopoisomerase II inhibitor VP-16 resistant FM3A mutant.
Comment from the depositor
RCB0768
HP50-2
CommentHydrogen peroxide resistant HL60-derived clone.
Comment from the depositor
RCB0769
HP100-1
CommentHydrogen peroxide resistant HL60-derived clone. More resistant than HP50-2.
Comment from the depositor
RCB0770
XTY
CommentFrog (Xenopus laevis) cell line derived from subcutaneous tumor.
Comment from the depositor
RCB0771
XTC-YF
CommentFrog (Xenopus laevis) cell line derived from tadpole.
Comment from the depositor
RCB0772
A6
CommentFrog (Xenopus laevis) cell line derived from kidney.
Comment from the depositor
RCB0773
A8
CommentFrog (Xenopus laevis) cell line derived from liver.
Comment from the depositor
RCB0774
EC-GI-10
CommentProduce hypercalcemia in nude mice. PTH-related protein, IL-1alpha producing.
Comment from the depositor
RCB0775
F-36P
CommentGM-CSF- or IL-3-dependent cell line. Differentiate to erythoid cells with erythropoietin.
Comment from the depositor
RCB0776
F-36E
CommentSubline of F-36P. Erythropoietin-dependent
Comment from the depositor
RCB0777
HMV-II
CommentMelanin producing. Originated from the same site of HMV-I.
Comment from the depositor
RCB0778
CW-2
CommentColon carcinoma. CEA-positive, nude mouse-transplantable.
Comment from the depositor
RCB0782
RC4
CommentNormal rabbit cornea cells. Usually transform spontaneously during serial culture.
Comment from the depositor
RCB0783
FCP-S1M
CommentSkin fibroblasts from a familial colon polyposis patient.
Comment from the depositor
RCB0784
FCP-S2H
CommentSkin fibroblasts from a familial colon polyposis patient at Hiroshima.
Comment from the depositor
RCB0785
FCP-S3H
CommentSkin fibroblasts from a familial colon polyposis patient at Hiroshima.
Comment from the depositor
RCB0786
FCP-S4H
CommentSkin fibroblasts from a familial colon polyposis patient at Hiroshima.
Comment from the depositor
RCB0787
FCP-S5H
CommentSkin fibroblasts from a familial colon polyposis patient at Hiroshima.
Comment from the depositor
RCB0788
FCP-S6H
CommentSkin fibroblasts from a familial colon polyposis patient at Hiroshima.
Comment from the depositor
RCB0789
HSQ-89
CommentJapanese maxillary simus squamous carcinoma
Comment from the depositor
RCB0792
T88-M
CommentIL-5 dependent early B-cell line. Also grows on IL-3. The population contain non-IL-5-dependent cell
Comment from the depositor
RCB0793
B151K12
CommentIL-5 producing T-cell hybridoma. Culture sup is useful for T88-M cell culture.
Comment from the depositor
RCB0794
2C6
CommentHuman cell line derived from embryonic pancreas. Four cell lines (RCB0794,RCB0795,RCB0796,RCB0797) were derived from the same individual.
Comment from the depositor
RCB0795
1B2C6
CommentHuman cell line derived from embryonic pancreas. Four cell lines (RCB0794,RCB0795,RCB0796,RCB0797) were derived from the same individual.
Comment from the depositor
RCB0796
1C3D3
CommentHuman cell line derived from embryonic pancreas. Four cell lines (RCB0794,RCB0795,RCB0796,RCB0797) were derived from the same individual.
Comment from the depositor
RCB0797
1C3IKEI
CommentHuman cell line derived from embryonic pancreas. Four cell lines (RCB0794,RCB0795,RCB0796,RCB0797) were derived from the same individual.
Comment from the depositor
RCB0803
NBsusSR
CommentIsolated from a patient with hiper dopaminemia andnorepinephrinemia.
Comment from the depositor
RCB0804
BRF41
CommentZebrafish fin fibroblast.
Comment from the depositor
RCB0805
Ba/F3
CommentIL-3 dependent pro B cell line. Conditioned medium. Information.
Comment from the depositor
RCB0806
Jurkat
CommentHuman T cell line, the same patient as JM. IL-2 productivity of this line was undetermined.
Comment from the depositor
RCB0808
MMAc
CommentHuman melanoma, spindle-shaped. Said DOPA (+).
Comment from the depositor
RCB0819
HMMME
CommentHuman cell line derived from malignant mesothelioma.
Comment from the depositor
RCB0820
HKBML
CommentHuman cell line derived from malignant lymphoma occurred in brain. Epstein-Barr virus positive.
Comment from the depositor
RCB0844
8C9
CommentProducing anti-human CD36 MoAb.
Comment from the depositor
RCB0867
3-2H3
CommentAnti-human-myeloperoxidase MoAb producing.
Comment from the depositor
RCB0868
4-2C11
CommentAnti-human-myeloperoxidase MoAb producing.
Comment from the depositor
RCB0869
9-1A11
CommentAnti-human-myeloperoxidase MoAb producing.
Comment from the depositor
RCB0870
12-1B6
CommentAnti-human-myeloperoxidase MoAb producing.
Comment from the depositor
RCB0871
LLC-GA5-CoL150
CommentPig kidney (LLC-PK1) cells expressing human P-glycoproteins.
Comment from the depositor
RCB0872
LLC-GA5-CoL300
CommentPig kidney (LLC-PK1) cells expressing human P-glycoproteins.
Comment from the depositor
RCB0875
Chab1KMM
CommentChromosomal aberration; 46XX + (11;12)(q23.3, q15). Need confirmation.
Comment from the depositor
RCB0876
RGM1
CommentSo called clear cells from rat stomach mucosa.
Comment from the depositor
RCB0881
OCUB-M
CommentSame as OCUB-1, OCUB-F.
Comment from the depositorChromosome = pseudotetraploid.
RCB0882
OCUB-F
CommentSame as OCUB-1, OCUB-M.
Comment from the depositorChromosome = pseudodiploid
RCB0959
HH13-1
CommentProducing IgG MoAb against human 29 kDa lectin detectable in many human tumors. Also see HH17-4.
Comment from the depositor
RCB0960
HH17-4
CommentProducing IgG MoAb against human 29 kDa lectin detectable in many human tumors. Also see HH13-1.
Comment from the depositor
RCB0966
HGRT
CommentHuman cell line derived from retroperitoneal teratoma.
Comment from the depositor
RCB0967
HTST
CommentHuman cell line derived from sacrococcygeal teratoma.
Comment from the depositor
RCB0978
HIRS-BM
CommentHuman cell line derived from malignant mixed mesodermal tumor found in uterus (malignant mixed Müllerian tumor). Established from metastasis in bone marrow.
Comment from the depositor
RCB0980
Sa3
CommentSquamous carcinoma cells derived from human oral cancer.
Comment from the depositor
RCB0982
ECC4
CommentHuman cell line derived from rectum cancer (small cell cancer). Expressing creatinine kinase of brain isoenzyme etc. ( PubMed ID: 8392984).
Comment from the depositor
RCB0983
ECC10
CommentHuman cell line derived from stomach cancer (small cell cancer). Expressing creatinine kinase of brain isoenzyme etc. ( PubMed ID: 8392984).
Comment from the depositor
RCB0985
Ae
CommentWorm cell line established by Grace. Culturable in MGM-450-10%FBS.
Comment from the depositor
RCB0987
C2C12
CommentSaid differentiate to myotubes, but need confirmation. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA91031101 prior to order.
Comment from the depositor
RCB0988
CACO-2
CommentHuman colon carcinoma. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA86010202 prior to order. Application consideration
Comment from the depositor
RCB0989
COLO 679
CommentMelanoma from a 47 year old female. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA87061210 prior to order.
Comment from the depositor
RCB0990
CPAE
CommentBovine pulmonary artery endothelial cells producing angiotensin-converting enzyme. Bovine Viral Diarrhea Virus (BVDV) positive. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA86111401 prior to order.
Comment from the depositor
RCB0991
G-361
CommentHuman melanoma producing melanin up to 50 PDL. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA88030401 prior to order.
Comment from the depositor
RCB0992
HOS
CommentSensitive to further transformation with both virus and chemicals. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA87070202 prior to order.
Comment from the depositor
RCB0993
IEC 6
CommentRat small intestine epithelial cells. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA88071401 prior to order.
Comment from the depositor
RCB0995
MDCK
CommentCanine kidney epithelial. Sensitive to wide range of viruses. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA84121903 prior to order.
Comment from the depositor
RCB0996
Mv.1.Lu(NBL-7)
CommentAleutian mink cells. Used for focus forming assays for murine and ferine sarcoma viruses. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA88050503 prior to order.
Comment from the depositor
RCB0998
117-13
CommentAnti-lactotetraosylceramide antibody producing. Discriminates metastatic cells from mesothelial cell
Comment from the depositor
RCB0999
MKN7
Commentc-erbB-2 expressing gastric adenocarcinoma. Differentiated type.
Comment from the depositor
RCB1001
MKN45
CommentPoorly differentiated gastric adenocarcinoma. Producing high level of CEA.
Comment from the depositor
RCB1002
MKN74
CommentModerately differentiated adenocarcinoma. Once they were hypodiploids.
Comment from the depositor
RCB1003
MKN1
CommentPotentially differentiatable to both direction of adenomatous and squamous epithelial cells.
Comment from the depositor
RCB1005
KP4
CommentPancreatic ductal cell carcinoma. Mother cell line of KP4-1, -2, and -3.
Comment from the depositor
RCB1006
KP4-1
CommentPancreatic ductal cell carcinoma. PTHrP producing.
Comment from the depositor
RCB1007
KP4-2
CommentPancreatic ductal cell carcinoma. PTHrP producing.
Comment from the depositor
RCB1008
KP4-3
CommentPancreatic ductal cell carcinoma. PTHrP producing.
Comment from the depositor
RCB1009
ECC12
CommentStomach cancer (small cell cancer + glandular cancer)-derived cell line. Expressing creatinine kinase of brain isoenzyme etc. ( PubMed ID: 8392984). Application consideration
Comment from the depositor
RCB1010
HOEF
CommentHuman fibroblasts derived from endometrium. The donor was suffering from infertility.
Comment from the depositor
RCB1011
H-AE-IV
CommentHuman fibroblasts derived from anencephalic fetus (11 weekly age).
Comment from the depositor
RCB1012
T3M-5
CommentG-CSF producing thyroidal squamous carcinoma.
Comment from the depositor
RCB1015
T3M-1 Clone2
CommentG-CSF producing oral squamous cell carcinoma, the same patient as T3M-1 Cl-10 and CJM.
Comment from the depositor
RCB1017
T3M-1 Cl-10
CommentG-CSF and IL-1 producing oral squamous cell carcinoma, the same patient as T3M-1 Clone2 and CJM.
Comment from the depositor
RCB1018
T3M-3
CommentTrophoblastic cell. Producing chorionic gonadotropin, estrogen, progesterone.
Comment from the depositor
RCB1020
T3M-10
CommentLung large cell carcinoma producing CSF.
Comment from the depositor
RCB1021
T3M-4
CommentPancreatic adenocarcinoma producing CEA. K-ras activated.
Comment from the depositor
RCB1022
T3M-11
CommentHuman cell line derived from lung cancer (small cell carcinoma). Expressing insulin-like growth factor II (IGF-II).
Comment from the depositor
RCB1024
IMR-90-SV
CommentSV40 transformed human lung fibroblast.
Comment from the depositor
RCB1025
RTH33
CommentSV40-Adeno Vector transformed hepatocytes. Albumin secretion and urea synthesis were reported.
Comment from the depositor
RCB1026
GM95
CommentGlucosylceramide synthetase-deficient B16 melanoma mutant.
Comment from the depositor
RCB1027
MEB4
CommentNot expressing melanoma antigen. Control for GM-95(RCB1026) cell line.
Comment from the depositor
RCB1032
NOS-1
CommentOsteoid producing in vitro and in nude mice.
Comment from the depositor
RCB1033
NOS-2
CommentHuman osteosarcoma producing osteoid in vitro and in vivo(mouse).
Comment from the depositor
RCB1034
CJM
CommentHuman cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
Comment from the depositor
RCB1035
CJM Cl4
CommentHuman cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
Comment from the depositor
RCB1036
CJM Cl5
CommentHuman cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
Comment from the depositor
RCB1037
CJM Cl6
CommentHuman cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
Comment from the depositor
RCB1038
CJM Cl7
CommentHuman cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
Comment from the depositor
RCB1039
CJM Cl8
CommentHuman cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
Comment from the depositor
RCB1062
LMSU
CommentHuman cell line derived from lymph node metastasis of gastric cancer.
Comment from the depositor
RCB1088
ψCRIP-P131
CommentHigh-titer producer of MoMLV-derived retrovirus. A subline of ψCRIP.
Comment from the depositor
RCB1089
ψCRIP-MFGmGM-CSF
CommentCell line producing MoMLV-derived retrovirus to express mouse GM-CSF. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1090
ψCRIP-MFGmIL-1α
CommentCell line producing MoMLV-derived retrovirus to express mouse IL-1alpha. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1091
ψCRIP-MFGmIL-1RA
CommentCell line producing MoMLV-derived retrovirus to express mouse IL-1 receptor antagonist. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1092
ψCRIP-MFGmIL-2
CommentCell line producing MoMLV-derived retrovirus to express mouse IL-2. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1093
ψCRIP-MFGmIL-3
CommentCell line producing MoMLV-derived retrovirus to express mouse IL-3. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1094
ψCRIP-MFGmIL-4
CommentCell line producing MoMLV-derived retrovirus to express mouse IL-4. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1095
ψCRIP-MFGmIL-6
CommentCell line producing MoMLV-derived retrovirus to express mouse IL-6. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1096
ψCRIP-MFGmIL-7
CommentCell line producing MoMLV-derived retrovirus to express mouse IL-7. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1097
ψCRIP-MFGmIL-10
CommentCell line producing MoMLV-derived retrovirus to express mouse IL-10. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1098
ψCRIP-MFGmIL-12p40
CommentCell line producing MoMLV-derived retrovirus to express mouse IL-12 (p40 subunit). Refer to RCB1099. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1099
ψCRIP-MFGmIL-12p35
CommentCell line producing MoMLV-derived retrovirus to express mouse IL-12 (p35 subunit). Refer to RCB1098. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1100
ψCRIP-MFGmTNF-α
CommentCell line producing MoMLV-derived retrovirus to express mouse TNF-alpha. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1101
ψCRIP-MFGhTNF-α
CommentCell line producing MoMLV-derived retrovirus to express human TNF-alpha. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1102
ψCRIP-MFGmLT
CommentCell line producing MoMLV-derived retrovirus to express mouse lymphotoxin. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1103
ψCRIP-MFGmG-CSF
CommentCell line producing MoMLV-derived retrovirus to express mouse G-CSF. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1104
ψCRIP-MFGhM-CSF
CommentCell line producing MoMLV-derived retrovirus to express human M-CSF. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1105
ψCRIP-MFGmIFN-γ
CommentCell line producing MoMLV-derived retrovirus to express mouse IFN-gamma. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1106
ψCRIP-MFGhMIF
CommentCell line producing MoMLV-derived retrovirus to express human MIF. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1107
ψCRIP-MFGmLIF
CommentCell line producing MoMLV-derived retrovirus to express mouse leukemia inhibitory factor (LIF). Long term culture results in decrease of virus production.
Comment from the depositor
RCB1108
ψCRIP-MFGmKitLigand
CommentCell line producing MoMLV-derived retrovirus to express mouse kit ligand (SCF). Long term culture results in decrease of virus production.
Comment from the depositor
RCB1109
ψCRIP-MFGhOncost-M
CommentCell line producing MoMLV-derived retrovirus to express human oncostatin M. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1110
ψCRIP-MFGmB7
CommentCell line producing MoMLV-derived retrovirus to express mouse B7 (CD80). Long term culture results in decrease of virus production.
Comment from the depositor
RCB1111
ψCRIP-MFGmB7-2
CommentCell line producing MoMLV-derived retrovirus to express mouse B7-2 (CD86). Long term culture results in decrease of virus production.
Comment from the depositor
RCB1112
ψCRIP-MFGtrγIFNR
CommentCell line producing MoMLV-derived retrovirus to express a truncated form of mouse IFN-gamma. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1113
ψCRIP-MFGrab-IL1RA
CommentCell line producing MoMLV-derived retrovirus to express rabbit IL-1 receptor antagonist. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1114
ψCRIP-MFGratGM-CSF
CommentCell line producing MoMLV-derived retrovirus to express rat GM-CSF. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1115
ψCRIP-MFGneo
CommentCell line producing MoMLV-derived retrovirus to express neomycin. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1116
ψCRIP-MFGHSVtk
CommentCell line producing MoMLV-derived retrovirus to express HSV thymidine kinase. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1117
ψCRE-MFGts-c-src
CommentProducer of MoMLV-derived retrovirus including mouse c-src cDNA with ts mutation.
Comment from the depositor
RCB1118
ψCRIP-MFGts-c-src
CommentCell line producing MoMLV-derived retrovirus to express mouse c-src possessing ts mutation. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1119
ψCRE-MFGtsT
CommentHigh-titer producer of MoMLV-derived retrovirus including SV40 large T temperature-sensitive cDNA.
Comment from the depositor
RCB1120
ψCRIP-MFGtsT
CommentCell line producing MoMLV-derived retrovirus to express temperature-sensitive SV40 large T. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1124
OP9
CommentSupport hematpoietic stem cell and ES cell differentiation to blood cells and lymphocytes.
Comment from the depositor
RCB1125
TOM-2
CommentGlassy cell carcinoma from cervix.
Comment from the depositor
RCB1126
MC3T3-E1
CommentDifferentiate to osteoblasts. Collagen producing.
Comment from the depositor
RCB1127
MC3T3-G2/PA6
CommentSupport hematpoietic stem cell and osteoclast differentiation. Pre-adipocyte.
Comment from the depositor
RCB1129
TGBC1TKB
CommentJapanese gallbadder carcinoma metastated to lymph node from the same patient of TGBC2TKB. Application consideration
Comment from the depositor
RCB1130
TGBC2TKB
CommentJapanese gallbladder carcinoma from the same patient of TGBC1TKB. Application consideration
Comment from the depositor
RCB1139
HFSKF-AE-V
CommentHuman fibroblasts derived from fetal skin (31 weekly age).
Comment from the depositor
RCB1142
10H-2
CommentAnti poly(ADP-ribose) IgG3 kappa producing.
Comment from the depositor
RCB1143
DA-1
CommentIL-3 dependent mouse myeloid cells. MoLV induced.
Comment from the depositor
RCB1144
DA-3
CommentIL-3 dependent mouse myeloid cells. MoLV induced.
Comment from the depositor
RCB1145
32D
CommentIL-3 dependent cells from Friend leukemia virus-infected mouse bone marrow.
Comment from the depositor
RCB1148
TGBC11TKB
CommentJapanese gastric cancer, lymph node metastated. Application consideration
Comment from the depositor
RCB1151
RCC10RGB
CommentKidney carcinoma from a Japanese patient.
Comment from the depositor
RCB1152
Sawano
CommentHuman cell line derived from endometrial adenocarcinoma of uterus. Resistant to cisplatin.
Comment from the depositor
RCB1153
S2 (Drosophila)
CommentFruit fly Oregon-R derived cell line. Highly sensitive in RNA interference compared with CHO-K1. Application consideration
Comment from the depositor
RCB1154
KGN
CommentHuman cell line derived from ovarian granulosa cell tumor. Aromatase activity is increased by stimulation of FSH and hMG.
Comment from the depositor
RCB1155
Hepa-E1
CommentEel hepatocyte. Application consideration
Comment from the depositor
RCB1157
UV-P3U1-B8
CommentAnti-thymine dimer antibody producing. Serum-free cultured hybridoma.
Comment from the depositor
RCB1158
B16F10/mGM
CommentMouse GM-CSF producing B16 melanoma.
Comment from the depositor
RCB1164
MOLT-3
CommentHuman T cell leukemia, the same patient as RCB0206 MOLT-4. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 84 prior to order.
Comment from the depositor
RCB1165
YAC-1
CommentNatural killer cell-sensitive mouse lymphoma.Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 96 prior to order.
Comment from the depositor
RCB1166
KG-1
CommentHuman acute myeloid leukemia. The variant subline (RCB1928 KG-1a) CD3-,CD13+,CD14-,CD15+,CD19-,CD33+. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 14 prior to order.
Comment from the depositor
RCB1167
P-815
CommentMouse mastocytoma. Used as a target cells for cytotoxic T cell assays. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 1 prior to order.
Comment from the depositor
RCB1168
SKW-3
CommentHuman cell line derived from acute lymphoblastic leukemia (ALL). A subline of KE-37. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 53 prior to order.
Comment from the depositor
RCB1169
TGBC18TKB
CommentPapillotubular adenocarcinoma of the Vater's papilla. Application consideration
Comment from the depositor
RCB1171
HOUFXXX
CommentHuman fibroblasts derived from vagina. 47,XX,+X
Comment from the depositor
RCB1174
GEM-81
CommentTumor cells derived from Gold Fish red pigment cells.
Comment from the depositor
RCB1175
GEM-199
CommentTumor cells derived from Gold Fish red pigment cells.
Comment from the depositor
RCB1176
GEM-218
CommentTumor cells derived from Gold Fish red pigment cells.
Comment from the depositor
RCB1178
HuG1-PI
CommentHuman cell line derived from ascites of a gastric cancer patient. Expressing hybrid type of alkaline phosphatase. HuG1-N is another cell line derived from the same patient.
Comment from the depositor
RCB1179
HuG1-N
CommentHuman cell line derived from ascites of a gastric cancer patient. Expressing Nagao-type alkaline phosphatase. HuG1-PI is another cell line derived from the same patient.
Comment from the depositor
RCB1180
Tanoue
CommentB-lineage acute lymphoblastic leukemia.
Comment from the depositor
RCB1181
ST
CommentA subclone of RCB1180 Tanoue.
Comment from the depositor
RCB1182
GR-ST
CommentRCB1181 ST cells transformed with human G-CSF receptor cDNA. Responds to G-CSF.
Comment from the depositor
RCB1184
Lu-165
CommentProducing high level of anti-diuretic hormone. Application consideration
Comment from the depositor
RCB1185
TT1TKB
CommentRectal carcinoma from a Japanese patient. Application consideration
Comment from the depositor
RCB1186
TGBC14TKB
CommentJapanese gallbladder tumor passed through a nude mouse. Application consideration
Comment from the depositor
RCB1187
TUHR3TKB
CommentJapanese kidney carcinoma cells. RCB original.
Comment from the depositor
RCB1188
NRS-1
CommentHuman rhabdomyosarcoma showing myogenic differentiation. TGFbeta inhibits it. Application consideration
Comment from the depositor
RCB1189
THP-1
CommentHuman cell line derived from acute monocytic leukemia. Differentiate to macrophage-like cells by treatment of phorbol ester. The characteristics are somewhat different from THP-1 distributed from ATCC such as in cell size and drug sensitivities. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 16 prior to order.Application consideration
Comment from the depositor
RCB1190
7-TD-1
CommentResponding to IL-6 in the bioassay. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 23 prior to order.
Comment from the depositor
RCB1191
5637
CommentDescribed to produce SCF, IL-1, IL-3, IL-6, G-CSF, GM-CSF, etc. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 35 prior to order.
Comment from the depositor
RCB1192
MDA-MB-453
CommentHuman breast carcinoma established from an effusion. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 65 prior to order.Application consideration
Comment from the depositor
RCB1193
COLO-320
CommentDescribed to produce serotonin, epinephrine. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 144 prior to order.
Comment from the depositor
RCB1196
TGBC24TKB
CommentJapanese gallbladder carcinoma established from metastated ascite. Application consideration
Comment from the depositor
RCB1197
P2UR/K-562
CommentExpressing P2U receptor acting in signal transduction pathway.
Comment from the depositor
RCB1198
TUHR4TKB
CommentJapanese renal carcinoma cells.
Comment from the depositor
RCB1200
MMAc·SF
CommentSerum-free medium-adapted MMAc cells. For SF culture, + insulin, hEGF, hydrocortisone, bovine pituit
Comment from the depositor
RCB1205
Anti-PT-S1-1B7
CommentAnti-pertussis toxin subunit S-1 MoAb (IgG2a) producing.
Comment from the depositor
RCB1208
Anti-PT-S1-10D6
CommentAnti-pertussis toxin subunit S-1 MoAb (IgG1) producing.
Comment from the depositor
RCB1209
Anti-PT-S1-8G4
CommentAnti-pertussis toxin subunit S-1 MoAb (IgG1) producing.
Comment from the depositor
RCB1212
Anti-PT-S1-3F10
CommentAnti-pertussis toxin subunit S-1 MoAb (IgG1) producing.
Comment from the depositor
RCB1214
Anti-PT-S1-4D10
CommentAnti-pertussis toxin subunit S-1 MoAb (IgG1) producing.
Comment from the depositor
RCB1215
Anti-PT-S23-11E6
CommentAnti-pertussis toxin subunit S-2,3 MoAb (IgG1) producing.
Comment from the depositor
RCB1220
Anti-PT-S2-3A12
CommentAnti-pertussis toxin subunit S-2 MoAb (IgG1) producing.
Comment from the depositor
RCB1222
Anti-PT-S2-9G8
CommentAnti-pertussis toxin subunit S-2 MoAb (IgG1) producing.
Comment from the depositor
RCB1223
Anti-PT-S3-7E10
CommentAnti-pertussis toxin subunit S-3 MoAb (IgG1) producing.
Comment from the depositor
RCB1229
Anti-PT-S4-7F2
CommentAnti-pertussis toxin subunit S-4 MoAb (IgG1) producing.
Comment from the depositor
RCB1233
Anti-PT-S4-1H2
CommentAnti-pertussis toxin subunit S-4 MoAb (IgG1) producing.
Comment from the depositor
RCB1238
Anti-FHA(2)2E9
CommentAnti-pertussis filamentous hemagglutinin (FHA) MoAb producing.
Comment from the depositor
RCB1239
Anti-FHA(1)1C6
CommentAnti-pertussis filamentous hemagglutinin (FHA) MoAb producing.
Comment from the depositor
RCB1240
Anti-α(1)1C6F4
CommentMoAb to Clostridium perfringens alpha-toxin (phospholipase C).
Comment from the depositor
RCB1243
Anti-α(4)11D9G5
CommentMoAb to Clostridium perfringens alpha-toxin (phospholipase C).
Comment from the depositor
RCB1244
Anti-α(5)11D10B6
CommentMoAb to Clostridium perfringens alpha-toxin (phospholipase C).
Comment from the depositor
RCB1246
Anti-α(7)7C9A10
CommentMoAb to Clostridium perfringens alpha-toxin (phospholipase C).
Comment from the depositor
RCB1247
Anti-α(8)9F3A6
CommentMoAb to Clostridium perfringens alpha-toxin (phospholipase C).
Comment from the depositor
RCB1248
Anti-α(9)12G8B11
CommentMoAb to Clostridium perfringens alpha-toxin (phospholipase C).
Comment from the depositor
RCB1250
Anti-θ(1)3H10
CommentMoAb to Clostridium perfringens theta-toxin.
Comment from the depositor
RCB1264
tsBN2
CommentTemperature-sensitive mutant of BHK-21. Causing premature chromosome condensation.
Comment from the depositor
RCB1267
tsBN7
CommentTemperature-sensitive mutant of BHK-21 with mutated DAD1 gene. Causing apoptosis at 39.5 C.
Comment from the depositor
RCB1268
tsBN462
CommentTemperature-sensitive mutant of BHK-21. Complemented with human X-linked CCG1 gene. Application consideration
Comment from the depositor
RCB1269
tsBN75
CommentTemperature-senstive mutant of BHK-21. Complemented with ubiquitin-activating enzyme E1 cDNA.
Comment from the depositor
RCB1270
tsBN51
CommentTemperature-sensitive mutant of BHK-21 with defect in RNA polymerase III subunit.
Comment from the depositor
RCB1271
tsBN67
CommentTemperature-sensitive mutant of BHK-21. Stop growth after 2-day culture at 39.5 C.
Comment from the depositor
RCB1272
tsBN250
CommentTemperature-sensitive mutant of BHK-21. Complementation group A. Dye rapidly at 39.5 C.
Comment from the depositor
RCB1273
tsBN269
CommentTemperature-sensitive mutant of BHK-21 selected after MNNG treatment.
Comment from the depositor
RCB1275
TUHR10TKB
CommentJapanese renal carcinoma cells expressing HLA-A2402.
Comment from the depositor
RCB1278
MtT/E
CommentRat cell line derived from pituitary tumor. Estrogen-induced tumor. Producing no pituitary hormone. Four cell lines (MtT/E, MtT/S, MtT/SM, MtT/Se) were established simultaneously.Application consideration.
Comment from the depositor
RCB1279
TtT/GF
CommentMouse cell line derived from pituitary tumor (thyrotropin-producing tumor). Pituitary folliculo-stellate-like cells. FGF-dependent cell line. GFAP positive. S-100 positive. Said producing IL-6.
Comment from the depositor
RCB1280
TGBC50TKB
Comment3 cell lines from different metastases were established from the same patient. See TGBC51TKB. Application consideration
Comment from the depositor
RCB1281
TGBC51TKB
Comment3 cell lines from different metastases were established from the same patient. See TGBC52TKB. Application consideration
Comment from the depositor
RCB1282
TGBC52TKB
Comment3 cell lines from different metastases were established from the same patient. See TGBC50TKB. Application consideration
Comment from the depositor
RCB1283
B16 melanoma
CommentMouse melanoma producing melanin. Application consideration
Comment from the depositor
RCB1284
B16 melanoma/lacZ
CommentMouse melanoma expressing E.coli lac Z. Strongly positive with beta-galactosidase.
Comment from the depositor
RCB1285
3A21
CommentAnti-ribonuclease A antibody producing.
Comment from the depositor
RCB1286
ECPC-3
CommentChoroid plexus carcinoma cell line transfected with IgH enhancer-SV40 T fusion gene.
Comment from the depositor
RCB1287
ECPC-4
CommentChoroid plexus carcinoma cell line transfected with IgH enhancer-SV40 T fusion gene. Different shape
Comment from the depositor
RCB1290
OIH-1
CommentA human cell line derived from acute myeloid leukemia (AML). AML was originated from MDS. Possessing a mutation in DCC gene. Application consideration
Comment from the depositor
RCB1292
RBE
CommentHuman intrahepatic cholangiocarcinoma.Please read carefully this information before use.
Comment from the depositor
RCB1293
SSP-25
CommentHuman intrahepatic cholangiocarcinoma. Please read carefully this information before use.
Comment from the depositor
RCB1294
HRC-17
CommentHybridoma producing anti-E antigen of the human Rh blood group system
Comment from the depositor
RCB1296
HNT-34
CommentA human cell line derived from acute myeloid leukemia (AML). AML was originated from CMMoL. Possessing Philadelphia chromosome and t(3;3)(q21;q26). Expressing EVI1 and BCR/ABL. Application consideration
Comment from the depositor
RCB1297
HYT-1
CommentA human cell line derived from acute myeloid leukemia (AML). Secondary AML. Able to differentiate to megakaryocyte-like cells.
Comment from the depositor
RCB1303
anti-αA-crystallin
CommentAnti-chick αA-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
Comment from the depositor
RCB1304
anti-αB-crystallin
CommentAnti-chick αB-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
Comment from the depositor
RCB1305
anti-β5-crystallin
CommentAnti-chick β5-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
Comment from the depositor
RCB1306
anti-β6-crystallin
CommentAnti-chick β6-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
Comment from the depositor
RCB1307
anti-γ1-crystallin
CommentAnti-newt γ1-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
Comment from the depositor
RCB1308
anti-δ-crystallin
CommentAnti-chick δ-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
Comment from the depositor
RCB1311
C3H/HeN-emb
CommentMouse(C3H/HeN Jcl) embryonic fibroblasts cultured under the 3T3 schedule.
Comment from the depositor
RCB1312
C57BL/6J-emb
CommentMouse(C57BL/6J) embryonic fibroblasts cultured under the 3T3 schedule.
Comment from the depositor
RCB1313
RERF-LC-KJ
CommentJapanese lung adenocarcinoma, highly metastatic in SCID mice. Also refer to RCB0444 RCRF-LC-AI.
Comment from the depositor
RCB1316
CTB-1
CommentFas-antigen expressing. Ligation with anti-Fas mAb does not induce apoptosis.
Comment from the depositor
RCB1317
KU-SN
CommentRare peripheral neuroectodermal tumor cells. Use collagen-coated dish.
Comment from the depositor
RCB1366
HuH-7
CommentSaid producing alpha-fetoprotein, alpha-antitrypsin, ceruloplasmin, fibrinogen, fibronectin, etc.
Comment from the depositor
RCB1367
HuH-6
CommentHepatoblastoma. Said albumin and alpha-fetoprotein producing.
Comment from the depositor
RCB1369
NBT-T1
CommentA subline of NBT-II. Low invasive bladder carcinoma. Relatively high cadherin expression.
Comment from the depositor
RCB1370
NBT-T2
CommentA subline of NBT-II. Almost non-invasive bladder carcinoma. Relatively high cadherin expression.
Comment from the depositor
RCB1371
NBT-L1
CommentA subline of NBT-II. Invasive bladder carcinoma. Relatively low cadherin expression.
Comment from the depositor
RCB1372
NBT-L2a
CommentA subline of NBT-II. Highly invasive bladder carcinoma. Relatively low cadherin expression.
Comment from the depositor
RCB1373
NBT-L2b
CommentA subline of NBT-II. The most invasive bladder carcinoma. Relatively low cadherin expression.
Comment from the depositor
RCB1374
1-8
CommentCAG-loxP-neopA-loxP-LacZ(incomplete) was inserted. Control cell line for 2-2 and 2-7 cells. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
Comment from the depositor
RCB1375
2-2
Comment35 copies of CAG-loxP-neopA-loxP-LacZ were tandemly inserted. Cre will delete neopA and induce LacZ. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
Comment from the depositor
RCB1376
2-7
CommentA copy of CAG-loxP-neopA-loxP-LacZ was inserted. Cre will delete neopA and induce LacZ. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
Comment from the depositor
RCB1377
32Dcl3
CommentMouse IL-3 dependent cells cloned from 32D. Differentiate with G-CSF stimulation. Conditioned medium.
Comment from the depositor
RCB1378
MuSS
CommentA-Jackson mouse-derived histiocyte-like cells from spontaneous sarcoma.
Comment from the depositor
RCB1382
CF1TKB
CommentJapanese cystic fibrosis fibroblast.
Comment from the depositor
RCB1383
TUHR14TKB
CommentJapanese renal carcinoma cells.
Comment from the depositor
RCB1422
L929
CommentTNFalpha-sensitive L929. Do not confuse with RCB0081 L929 that is insensitive to TNFalpha.
Comment from the depositor
RCB1423
BHK-21
CommentThe parent cell line used for the temperature sensitive cell line series of BN.
Comment from the depositor
RCB1425
LCAM1
CommentHuman lung cancer derived cell.
Comment from the depositor
RCB1426
PMF-ko14
CommentJapanese colon carcinoma. Family of the patient also exhibited high risk, but not so-called HNPCC.
Comment from the depositor
RCB1429
SN-512
CommentA human cell line derived from acute myeloid leukemia (AML, M2).
Comment from the depositor
RCB1433
TEN
CommentHuman cell line derived from endometrial cancer. Clear cell carcinoma. Said c-erb-2(+), cathepsin D(+), CA125(+) in a part of cells.
Comment from the depositor
RCB1434
KE-39
CommentHuman cell line derived from gastric cancer
Comment from the depositor
RCB1435
KE-97
CommentHuman cell line derived from intraperitoneal metastasis of gastric cancer
Comment from the depositor
RCB1437
AW-EBV-LCL
CommentB95-8 EB virus transformed leukemia cell line.
Comment from the depositor
RCB1438
TW-EBV-LCL
CommentB95-8 EB virus transformed (originally normal) B cell line.
Comment from the depositor
RCB1440
ATN-1
CommentAdult T-cell leukemia. HTLV-1 pro-virus DNA(+).
Comment from the depositor
RCB1444
MBHL-2
CommentInsect cell line derived from Mamestra brassicae.
Comment from the depositor
RCB1445
MBHL-3
CommentInsect cell line derived from Mamestra brassicae
Comment from the depositor
RCB1449
C7
Commentp53 deficient mouse bone marrow derived cell. Useful for study of p53 suppressor oncogene.
Comment from the depositor
RCB1450
LM8
CommentA highly metastatic cell line derived from Dunn's osteosarcoma (C3H mouse origin).
Comment from the depositor
RCB1451
L929
CommentSanford's original, brought by Katsuta at 7/5/1955. Insensitive to TNFalpha. Possible to culture in MEM medium.
Comment from the depositor
RCB1456
RCR-1
CommentAstroglia cell line. Possible to culture in DMEM medium. See RCB0075.
Comment from the depositor
RCB1460
PCM6
CommentHuman myeloma cell.
Comment from the depositor
RCB1464
DT40
CommentChicken B cell line transformed by avian leukosis virus. c-myc and IgM expressing.
Comment from the depositor
RCB1465
SHIP^(-) DT40
CommentSHIP deficient DT40 cells
Comment from the depositor
RCB1466
SHP1^(-) DT40
CommentSHP1 deficient DT40 cells
Comment from the depositor
RCB1467
IP3R^(-) DT40
CommentIP3R(type1,type2,type3) deficient DT40 cells
Comment from the depositor
RCB1468
Btk^(-) DT40
CommentBtk deficient DT40 cells
Comment from the depositor
RCB1469
PLC-γ2^(-) DT40
CommentPLC-γ2 deficient DT40 cells
Comment from the depositor
RCB1470
Syk^(-) DT40
CommentSyk deficient DT40 cells
Comment from the depositor
RCB1471
Lyn^(-) DT40
CommentLyn deficient DT40 cells
Comment from the depositor
RCB1472
M
CommentCapable to form collagen network. Possible to culture in DMEM medium. See RCB0067.
Comment from the depositor
RCB1473
LYM-1
CommentSticky cell from lymph node. Possible to culture in DMEM medium.
Comment from the depositor
RCB1474
RLC-16
CommentEpithelial cell from rat liver. Possible to culture in DMEM medium.
Comment from the depositor
RCB1477
CHO-RD
CommentSubline of CHO cells. Derived from CHO-K1 cell line. Serum-free medium adapted. Application consideration
Comment from the depositor
RCB1483
OV2944-HM-1
CommentLymphnode-metastatic ovarian tumor. So called HM-1 cells.
Comment from the depositor
RCB1484
RLC-18
CommentNon tumorigenic in nude mice. Possible to culture in DMEM medium.
Comment from the depositor
RCB1486
JTC-19
CommentRat lung fibroblast once said interferon-producing. Possible to culture in DMEM medium. See RCB0074 .
Comment from the depositor
RCB1487
MY-EBV-LCL
CommentB95-8 EB virus transformed (originally normal) B cell line.
Comment from the depositor
RCB1489
RLC-27
CommentLiver-derived cell, tumorigenic in nude mice. Possible to culture in DMEM medium.
Comment from the depositor
RCB1495
FU-RPNT-1
CommentScarcely found primitive neuroectodermal tumor from a Japanese kidney. Application consideration
Comment from the depositor
RCB1498
Grap^(-) DT40
CommentGrap deficient DT40 cells
Comment from the depositor
RCB1499
Grb2^(-) DT40
CommentGrb2 deficient DT40 cells
Comment from the depositor
RCB1500
Lyn^(-)/Syk^(-) DT40
CommentLyn and Sky deficient DT40 cells
Comment from the depositor
RCB1501
SHP1^(-)/SHP2^(-) DT40
CommentSHP1 and SHP2 deficient DT40 cells
Comment from the depositor
RCB1502
SHP2^(-) DT40
CommentSHP2 deficient DT40 cells
Comment from the depositor
RCB1503
Shc^(-) DT40
CommentShc deficient DT40 cells
Comment from the depositor
RCB1506
clone YP1N25
CommentSubline of mouse C127 cell line. Inducible expression of influenza virus protein (PB1, NP) is possible.
Comment from the depositor
RCB1507
clone YP1N27
CommentA subline of C127. PB1 RNA polymerase subunit and nucleoprotein are inducible by dexamethasone.
Comment from the depositor
RCB1508
clone 76
CommentSubline of mouse C127 cell line. Inducible expression of influenza virus protein (PB1, NP, PA, PB2) is possible.
Comment from the depositor
RCB1509
clone 64
CommentSubline of mouse C127 cell line. Inducible expression of influenza virus protein (PB1, NP, PA) is possible.
Comment from the depositor
RCB1510
BLNK^(-) DT40
CommentBLNK deficient DT40 cells
Comment from the depositor
RCB1512
MH7A
CommentRheumatoid fibroblast-like synoviocyte transformed with SV40 T antigen. Respond to IL-1beta.
Comment from the depositor
RCB1513
HOMM
CommentHuman cell line derived from melanoma occurred in uterine cervix. Possessing melanin granules.
Comment from the depositor
RCB1514
HOCE
CommentHuman cell line derived from choriocarcinoma. Application consideration
Comment from the depositor
RCB1517
A-6(ES derived)
CommentMouse ES ( AES0001 H-1 ) cell derived cell, useful for study of hematopoiesis.
Comment from the depositor
RCB1518
SS-A3-1
CommentF344 male rat fibrosarcoma cells, but with histiocytic and/or myofibroblastic characteristics.
Comment from the depositor
RCB1520
JHOC-5
CommentHuman cell line derived from ovarian clear cell adenocarcinoma. Said CA125 and CA72-4 producing. Application consideration
Comment from the depositor
RCB1521
JHOS-2
CommentHuman cell line derived from ovarian serous adenocarcinoma. Said CA125 and CA15-3 producing. Application consideration
Comment from the depositor
RCB1525
HeLa.S3
Comment= RCB0191 HeLa.S3, that has been cultured in MEM(susp.). This line is cultured in MEM.
Comment from the depositor
RCB1528
CCP-2
CommentBone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.
Comment from the depositor
RCB1530
CCP-7
CommentBone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.
Comment from the depositor
RCB1531
CCP-8
CommentBone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.
Comment from the depositor
RCB1534
MLC-1-B
CommentBone marrow stroma cell line, depositing calcified matrix on the culture surface.
Comment from the depositor
RCB1535
MLC-2-4
CommentBone marrow stroma cell line, depositing calcified matrix on the culture surface.
Comment from the depositor
RCB1536
MLC-6
CommentOsteoclast-like cell line derived from mouse (C3H/He).
Comment from the depositor
RCB1537
MLC-7
CommentBone marrow stroma cell line, depositing calcified matrix on the culture surface.
Comment from the depositor
RCB1538
32Dcl3
CommentSubclone of 32D cell line. Differentiate to mature granulocytes by G-CSF. Conditioned medium.
Comment from the depositor
RCB1539
P19.CL6
CommentMouse cell line derived from embryonal carcinoma. C3H strain. Following differentiation, beating cardiomyocytes appear. The efficiency of differentiation is lower compared to RCB 2318.
Comment from the depositor
RCB1541
HFL9t
CommentHuman fibroblasts derived from fetal lung (19 weekly age). 47,+del(9)(q12). RCB1542 is derived from the same fetus.
Comment from the depositor
RCB1542
HFSK9t
CommentHuman fibroblasts derived from fetal skin (19 weekly age). 47,+del(9)(q12). RCB1541 is derived from the same fetus.
Comment from the depositor
RCB1543
JHTKI-col-L
CommentHuman B cell-like cell line derived from colon cancer tissue.
Comment from the depositor
RCB1544
JHUAS-1
CommentHuman cell line derived from uterine adenosquamous carcinoma. Said CEA and CA125 producing. Application consideration
Comment from the depositor
RCB1545
JHUAS-2-L
CommentHuman B cell-like cell line derived from uterine cancer tissue (Adenosquamous carcinoma).
Comment from the depositor
RCB1546
JHOS-3
CommentHuman cell line derived from ovarian serous adenocarcinoma. Said CA125 producing. Application consideration
Comment from the depositor
RCB1547
JHUCS-1
CommentHuman cell line derived from uterine carcinosarcoma. Nude mouse transplantable. Application consideration
Comment from the depositor
RCB1548
JHUEM-1
CommentHuman cell line derived from uterine endometrioid adenocarcinoma. Said CA125 and CEA producing. Application consideration
Comment from the depositor
RCB1549
YSCCC
CommentHuman cell line derived from cholangiocellular carcinoma.
Comment from the depositor
RCB1550
HL-60-R2
CommentVariant of HL60. Resistant to retinoic acid and active Vit. D derivatives.
Comment from the depositor
RCB1551
JHUEM-2
CommentHuman cell line derived from uterine endometrioid adenocarcinoma. Application consideration
Comment from the depositor
RCB1552
JHUEM-3
CommentHuman cell line derived from uterine endometrioid adenocarcinoma. Application consideration
Comment from the depositor
RCB1555
F9
CommentSaid to differentiate to parietal endoderm with retinoic acid and dibutyryl cAMP.
Comment from the depositor
RCB1558
JHUS-nk1
CommentHuman cell line derived from uterine cervix cancer. Squamous cell carcinoma. Application consideration
Comment from the depositor
RCB1560
PWS-Yamaguchi
CommentPrader-Willi syndrome with obesity. del(15) was found in lymphocytes of the patient.
Comment from the depositor
RCB1561
RML-Yoshi
CommentSevere insulin-resistance by uncleaved insulin proreceptor. G->T mutation in interconnecting region.
Comment from the depositor
RCB1564
ψCRIP-RxnZ
CommentCell line producing MoMLV-derived retrovirus to express LacZ possessing nuclear localization signal. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1572
ψCRIP-hBax-i-hCD25-CS
CommentCell line producing MoMLV-derived retrovirus to express human Bax. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1573
ψCRIP-ATR-bsr
CommentCell line producing MoMLV-derived retrovirus to express angiotensin receptor and blasticidin S deaminase. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1574
ψCRIP-RxhCD82
CommentCell line producing MoMLV-derived retrovirus to express human CD82. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1575
ψCRIP-Rx-crmA-bsr
CommentCell line producing MoMLV-derived retrovirus to express anti-apoptotic crmA and blasticidin S deaminase. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1576
ψCRIP-Rx-ETBR-bsr
CommentCell line producing MoMLV-derived retrovirus to express human endothelin receptor and blasticidin S deaminase. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1577
ψCRIP-mPCNF1-bsr
CommentCell line producing MoMLV-derived retrovirus to express mouse calcineurin and blasticidin S deaminase. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1579
ψCRIP-MFG-Z
CommentCell line producing MoMLV-derived retrovirus to express lac Z. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1580
ψCRIP-MFG-T37
CommentCell line producing MoMLV-derived retrovirus to express SV40 large T antigen. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1581
ψCRIP-MSHR
CommentCell line producing MoMLV-derived retrovirus to express human MSH receptor. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1582
ψCRIP-NCre
CommentCell line producing MoMLV-derived retrovirus to express Cre recombinase. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1583
ψCRIP-hp53-bsr
CommentCell line producing MoMLV-derived retrovirus to express human p53 and blasticidin S deaminase. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1584
ψCRIP-RxBcl-XL-i-bsr
CommentCell line producing MoMLV-derived retrovirus to express human Bcl-xL and blasticidin S deaminase. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1585
ψCRIP-RxhFAS-i-CD80
CommentCell line producing MoMLV-derived retrovirus to express human FAS and human CD80. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1587
ψCRIP-RxhSecR-bsr
CommentCell line producing MoMLV-derived retrovirus to express human secretin receptor and blasticidin S deaminase. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1588
ψCRIP-hSSR-bsr
CommentCell line producing MoMLV-derived retrovirus to express human somatostatin receptor and blasticidin S deaminase. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1589
ψCRIP-RxmPCNT1-i-bsr
CommentCell line producing MoMLV-derived retrovirus to express a truncated form of mouse calcineurin and blasticidin S deaminase. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1590
ψCRIP-RxhVIPR-bsr
CommentCell line producing MoMLV-derived retrovirus to express human VIP receptor and blasticidin S deaminase. Long term culture results in decrease of virus production.
Comment from the depositor
RCB1591
SRA 01/04
Commentalpha, beta-crystaline expressing human lense epithelial cell line. plasmid DNA: pRSV-B-T Ag.
Comment from the depositor
RCB1593
OS3
Commentori- SV40 DNA transformed C3H mouse brain-derived cells. GFAP+ astrocytes and GFAP- oligodendrocytes
Comment from the depositor
RCB1597
KKC
CommentMouse T cell line transformed by Gross leukemia virus.
Comment from the depositor
RCB1598
NCKA
CommentMouse T cell line transformed by Gross leukemia virus.
Comment from the depositor
RCB1600
KKF
CommentMouse T cell line transformed by Gross leukemia virus.
Comment from the depositor
RCB1601
KKB
CommentMouse T cell line transformed by Gross leukemia virus.
Comment from the depositor
RCB1604
DHA3-1
CommentMouse T cell hybridoma expressing double HA-tag alone.
Comment from the depositor
RCB1605
DHA3-26
CommentMouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2.
Comment from the depositor
RCB1606
DMyc3-45
CommentMouse T cell hybridoma (DO-11.10) expressing double Myc-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2 .
Comment from the depositor
RCB1607
DHA9-3
CommentMouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein).
Comment from the depositor
RCB1608
DHA9-13
CommentMouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein).
Comment from the depositor
RCB1609
DHA9-15
CommentMouse T cell hybridoma (DO-11.10)expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein).
Comment from the depositor
RCB1610
DMyc9-36
CommentMouse T cell hybridoma (DO-11.10) expressing double Myc-tagged HS1BP3 (HS1 SH3 domain binding protein).
Comment from the depositor
RCB1611
M4
CommentAnti-chicken IgM antibody secreting. Able to stimulate DT40 cell surface antigen.
Comment from the depositor
RCB1613
HFL-AE-VI
CommentHuman fibroblasts derived from lung of anencephalic fetus (18 weekly age).
Comment from the depositor
RCB1615
HFSKF-AE-VII
CommentHuman fibroblasts derived from skin of anencephalic fetus (17 weekly age). RCB1617 and RCB1618 are derived from the same fetus.
Comment from the depositor
RCB1617
HFL-AE-VII
CommentHuman fibroblasts derived from lung of anencephalic fetus (17 weekly age). RCB1615 and RCB1618 are derived from the same fetus.
Comment from the depositor
RCB1618
HFLI-AE-VII
CommentHuman fibroblasts derived from liver of anencephalic fetus (17 weekly age). RCB1615 and RCB1617 are derived from the same fetus.
Comment from the depositor
RCB1620
ΔDNAPK-DT40
CommentDNA PK gene deleted DT40 (chicken B cell line).
Comment from the depositor
RCB1621
ΔKu70-DT40
CommentKu70 gene deleted DT40 (chicken B cell line).
Comment from the depositor
RCB1622
ΔRad51B-DT40
CommentRad51B gene deleted DT40 (chicken B cell line).
Comment from the depositor
RCB1623
ΔRad51C-DT40
CommentRad51C gene deleted DT40 (chicken B cell line).
Comment from the depositor
RCB1624
ΔRad51D-DT40
CommentRad51D gene deleted DT40 (chicken B cell line).
Comment from the depositor
RCB1625
ΔXRCC2-DT40
CommentXRCC2 gene deleted DT40 (chicken B cell line).
Comment from the depositor
RCB1626
ΔXRCC3-DT40
CommentXRCC3 gene deleted DT40 (chicken B cell line).
Comment from the depositor
RCB1627
ΔRad52-DT40
CommentRad52 gene deleted DT40 (chicken B cell line).
Comment from the depositor
RCB1628
ΔRad54-DT40
CommentRad54 gene deleted DT40 (chicken B cell line).
Comment from the depositor
RCB1629
ΔMre11-DT40(#190)
CommentMre11 gene deleted DT40 (chicken B cell line), subclone of RCB1630.
Comment from the depositor
RCB1630
ΔMre11-DT40(#194)
CommentMre11 gene deleted DT40 (chicken B cell line), subclone of RCB1629.
Comment from the depositor
RCB1631
ΔRad51+hRad51-DT40
CommentRad51 gene deleted and human Rad51 gene inserted DT40 (chicken B cell line).
Comment from the depositor
RCB1632
ΔKu70ΔRad54B-DT40
CommentKu70 and Rad54B gene double-deleted DT40 (chicken B cells).
Comment from the depositor
RCB1633
ΔMre11ΔKu70-DT40
CommentMre11 and Ku70 gene double-deleted DT40 (chicken B cells).
Comment from the depositor
RCB1634
ΔRad54ΔRad54B-DT40
CommentRad54 and Rad54B gene double-deleted DT40 (chicken B cells).
Comment from the depositor
RCB1635
K-562
CommentHuman CML derived cell line. Deposited directly from the institution that has established this cell.
Comment from the depositor
RCB1637
293
CommentA human cell line derived from kidney of a fetus. Transformed with sheared human Ad5 DNA. Sensitive to human adenoviruses and adenovirus DNA. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA 85120602 prior to order.
Comment from the depositor
RCB1638
Hepa 1-6
CommentMouse cell line derived from hepatoma. Derived from BW7756 tumour in a C57L mouse. Secretes several products such as albumin, alpha-fetoprotein, alpha 1-antitrypin and amylase. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA 92110305 prior to order.
Comment from the depositor
RCB1639
LoVo
CommentCEA-producing colon adenocarcinoma. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA 87060101 prior to order.
Comment from the depositor
RCB1640
DAUDI
CommentBurkitt's lymphoma. Sensitive to lymphokine-activated killer cells but resistant to natural killer cells. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA 85011437 prior to order.
Comment from the depositor
RCB1641
EL4
Comment9,10-dimethyl-1,2benzanthracene induced lymphoma. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA 85023105 prior to order.
Comment from the depositor
RCB1642
3T3 Swiss Albino
CommentContact inhibition. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA 85022108 prior to order.
Comment from the depositor
RCB1644
BeWo
CommentIt was initiated from a malignant gestational choriocarcinoma of the fetal placenta. Need to check response to hormones before use. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA 86082803 prior to order.
Comment from the depositor
RCB1645
Y79
CommentCaucasian retinoblastoma. May have reverse transcriptase. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA 86093003 prior to order.
Comment from the depositor
RCB1647
RAJI
CommentBurkitt's lymphoma. Sensitive to LAK cells but resistant to NK cells. Back up of culture ECA2673. Resistant to VSV. This cell line carries the latent Epstein-Barr Virus (EBV) genome and is positive for EBNA. RAJI is sometimes referred to as a 'non-producer'; the EBV genome carries deletions attributed to preventing the formation of virus particles. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA 85011429 prior to order.
Comment from the depositor
RCB1648
Hep G2
CommentHuman cell line derived from hepatoblastoma. Secretes several products such as albumin, alpha2-macroglobulin, alpha 1-antitrypsin, transferrin and plasminogen. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA85011430 prior to order. Information
Comment from the depositor
RCB1649
ΔAtm-DT40
CommentATM gene deleted DT40 (chicken B cells).
Comment from the depositor
RCB1650
ΔAtmΔKu70-DT40
CommentATM and Ku70 gene double-deleted DT40 (chicken B cells).
Comment from the depositor
RCB1651
ΔAtmΔRad54+hRad54-DT40
CommentATM and Rad54 gene double-deleted DT40 (chicken B cells). Inducible expression of human Rad54 is possible.
Comment from the depositor
RCB1652
G1MF285D
CommentHybridoma that produce anti-human G1MF (allotype of IgG1) antibody.
Comment from the depositor
RCB1668
293/CrmA
CommentA subline of 293. Expressing caspase-inhibiting CrmA gene.
Comment from the depositor
RCB1672
ΔRad54+hRad54-DT40
CommentRad54 gene deleted DT40 (chicken B cells). Inducible expression of human Rad54 is possible.
Comment from the depositor
RCB1675
Cbl^(-) DT40
CommentCbl deficient DT40 cells
Comment from the depositor
RCB1676
JHOM-1
CommentHuman cell line derived from ovarian mucinous adenocarcinoma. Application consideration
Comment from the depositor
RCB1677
JHUEM-7
CommentHuman cell line derived from uterine endometrioid adenocarcinoma. Application consideration
Comment from the depositor
RCB1678
JHOS-4
CommentHuman cell line derived from ovarian serous cyst adenocarcinoma. Application consideration
Comment from the depositor
RCB1680
TUHR25TKB
CommentHuman cell line derived from kidney cancer.
Comment from the depositor
RCB1681
GS-HepG2
CommentA subline of Hep G2. Expressing abundant glutamine synthetase. Information
Comment from the depositor
RCB1682
JHOM-2B
CommentHuman cell line derived from ovarian mucinous tubular adenocarcinoma. Application consideration
Comment from the depositor
RCB1687
ΔRad54ΔKu70-DT40
CommentRad54 and Ku70 gene double-deleted DT40 (chicken B cells).
Comment from the depositor
RCB1688
JHOC-7
CommentHuman cell line derived from ovarian clear cell carcinoma. Application consideration
Comment from the depositor
RCB1690
CPN4B
CommentCell line derived from embryo of Cynops pyrrhogaster.
Comment from the depositor
RCB1691
Tpit/F1
CommentPituitary folliculo-stellate-like cell line. Derived from a transgenic mouse expressing temperature sensitive SV40 large T antigen.
Comment from the depositor
RCB1692
Tpit/E
CommentVascular endothelial cell-like cell line derived from an anterior pituitary gland of a transgenic mouse expressing temperature sensitive SV40 large T antigen. Producing endothelin.
Comment from the depositor
RCB1695
RMS-YM
CommentEmbryonal rhabdomyosarcoma cell line derived from human. Transplantable in nude mouse.
Comment from the depositor
RCB1696
SPB-1
CommentSerine-palmitoyl transferase deficient (temperature-sensitive) cells derived from CHO-K1 cell line.
Comment from the depositor
RCB1697
SPB-1/cLCB1
CommentSPB-1 derivative complemented the Serine-palmitoyl transferase deficiency.
Comment from the depositor
RCB1698
LY-B
CommentSerine-palmitoyl transferase (LCB1 subunit) deficient cells derived from CHO-K1 cell line.
Comment from the depositor
RCB1699
LY-B/cLCB1
CommentLY-B derivative complemented the Serine-palmitoyl transferase (LCB1 subunit) deficiency.
Comment from the depositor
RCB1701
MY
CommentHuman cell line derived from p180-BCR-ABL dependent leukemia.
Comment from the depositor
RCB1702
SLVL
CommentHuman cell line derived from splenic B cell lymphoma.
Comment from the depositor
RCB1704
BLNK^(-)/Syk^(-) DT40
CommentBLNK and Syk deficient DT40 cells
Comment from the depositor
RCB1705
JHCA-ov
CommentHuman cell line derived from metastasis at ovary of colon cancer. Moderately differentiated adenocarcinoma. Application consideration
Comment from the depositor
RCB1706
JHCOLOYI
CommentHuman cell line derived from rectal cancer. Application consideration
Comment from the depositor
RCB1708
JHTSK-col-L
CommentHuman B cell-like cell line derived from colon cancer tissue.
Comment from the depositor
RCB1709
GE1
CommentMouse-derived gingival epithelial cell line. Derived from SV40-Large T antigen transgenic mouse. Application consideration
Comment from the depositor
RCB1716
BCAP^(-) DT40
CommentBCAP deficient DT40 cells
Comment from the depositor
RCB1717
IP3R type1^(-)/2^(-) DT40
CommentIP3R type1 and IP3R type2 deficient DT40 cells
Comment from the depositor
RCB1718
IP3R type1^(-)/3^(-) DT40
CommentIP3R type1 and IP3R type3 deficient DT40 cells
Comment from the depositor
RCB1719
IP3R type2^(-)/3^(-) DT40
CommentIP3R type2and IP3R type3 deficient DT40
Comment from the depositor
RCB1721
JHUCS-3
CommentHuman cell line derived from uterine cervix cancer. Application consideration
Comment from the depositor
RCB1723
JHOC-8
CommentHuman cell line derived from ovarian clear cell adenocarcinoma. Application consideration
Comment from the depositor
RCB1724
JHSK-rec
CommentHuman cell line derived from rectal cancer. Application consideration
Comment from the depositor
RCB1728
Hpr-4
CommentH2O2 resistant Chinese Hamster V79 cells
Comment from the depositor
RCB1731
TM-31
CommentHuman cell line derived from astrocytoma developed in a patient with NF-1 (neurofibromatosis type 1)
Comment from the depositor
RCB1734
LAH3
CommentMelanophore derived cell line. Derived from Rana porosa brevipoda (albino).
Comment from the depositor
RCB1741
NHOS
CommentMouse osteosarcoma cell line. Transplantable to mouse and form bone tissue in mouse.
Comment from the depositor
RCB1747
ΔNBS1-DT40
CommentSubline of DT40 (chicken B cell line), lacking Nbs1 expression.
Comment from the depositor
RCB1749
ΔDinB-DT40
CommentSubline of DT40 cell line, lacking DinB expression.
Comment from the depositor
RCB1750
ΔRad18-DT40
CommentSubline of DT40 cell line, lacking Rad18 expression.
Comment from the depositor
RCB1752
BS-SHI-4M
CommentHuman cell line derived from Bloom syndrome patient. Transformed by EBV. Can express certain antigen on the cell surface, such as cancer-specific antigen.
Comment from the depositor
RCB1753
KMY-J
CommentMeningioma derived cell line. Derived from rat F344.
Comment from the depositor
RCB1754
KMY-1
CommentSubline of KMY-J. Fibroblast-like.
Comment from the depositor
RCB1755
KMY-2
CommentSubline of KMY-J. Epithelial-like.
Comment from the depositor
RCB1756
KMY-3
CommentSubline of KMY-J. Polyploidy.
Comment from the depositor
RCB1757
HS-P
CommentRat cell line derived from histiocytic sarcoma. Possessing characteristics of macrophage.
Comment from the depositor
RCB1759
ΔDNAPKΔKu70-DT40
CommentSubline of DT40 cell line, lacking both of DNAPK and Ku70 expression.
Comment from the depositor
RCB1764
ΔRev3-DT40
CommentSubline of DT40 cell line, lacking Rev3 expression.
Comment from the depositor
RCB1766
ΔligIV-DT40
CommentSubline of DT40 cell line, lacking ligase IV expression.
Comment from the depositor
RCB1767
ΔRad52ΔXRCC3-DT40
CommentSubline of DT40 cell line, lacking both of Rad52 and XRCC3 expression.
Comment from the depositor
RCB1768
ΔXRCC3-cond1-DT40
CommentSubline of DT40 cell line, which lacks XRCC3 inducibly by tamoxifen.
Comment from the depositor
RCB1769
ΔXRCC3-cond2-DT40
CommentSubline of DT40 cell line, which lacks XRCC3 inducibly by tamoxifen.
Comment from the depositor
RCB1770
XRCC3+/--DT40
CommentSubline of DT40 cell line, lacking XRCC3 only in one allele.
Comment from the depositor
RCB1771
Lu-24
CommentHuman cell line derived from lung cancer. Oat cell type. Application consideration
Comment from the depositor
RCB1772
Lu-141
CommentHuman cell line derived from lung cancer. Small cell carcinoma. Application consideration
Comment from the depositor
RCB1773
Lu-143
CommentHuman cell line derived from lung cancer. Small cell carcinoma. Application consideration
Comment from the depositor
RCB1785
Lu-138
CommentHuman cell line derived from lung cancer. Small cell carcinoma. Application consideration
Comment from the depositor
RCB1788
AT805
CommentMouse teratoma-derived cell line. Parent cell line of ATDC5.
Comment from the depositor
RCB1790
P19C6
CommentEmbryonal carcinoma cell line derived from mouse C3H. Differentiate to nervous system.
Comment from the depositor
RCB1791
PCC3/A/1
CommentMouse teratoma-derived cell line.
Comment from the depositor
RCB1792
SIL-6/1
CommentSubline of A-6. Dependent on SCF and IL-6 for proliferation. Differentiate to erythroid cells by IL-3.
Comment from the depositor
RCB1794
ΔRad18ΔXPA-DT40
CommentSubline of DT40 cell line, lacking both of Rad18 and XPA expression.
Comment from the depositor
RCB1795
ΔRad18ΔDinB-DT40
CommentSubline of DT40 cell line, lacking both of Rad18 and DinB expression.
Comment from the depositor
RCB1797
BP7(R80)
CommentRat renal tumor derived cell line.
Comment from the depositor
RCB1798
BP11(R2)
CommentRat (Wistar) cell line derived from renal (kidney) tumor.
Comment from the depositor
RCB1799
BP11(R100)
CommentRat (Wistar) cell line derived from renal (kidney) tumor.
Comment from the depositor
RCB1800
BP13(R2)
CommentRat cells derived from kidney carcinoma. After passage 2. Wistar rat.
Comment from the depositor
RCB1801
BP13(R100)
CommentRat cell line derived from kidney carcinoma. After passage 100. Wistar rat.
Comment from the depositor
RCB1802
BP26(R2)
CommentRat cells derived from kidney carcinoma. After passage 2. Wistar rat.
Comment from the depositor
RCB1803
BP26(R80)
CommentRat cell line derived from kidney carcinoma. After passage 80. Wistar rat.
Comment from the depositor
RCB1804
BP30(R2)
CommentRat cells derived from kidney carcinoma. After passage 2. Wistar rat.
Comment from the depositor
RCB1805
BP30(R100)
CommentRat cell line derived from kidney carcinoma. After passage 100. Wistar rat.
Comment from the depositor
RCB1806
BP36B(R2)
CommentRat cells derived from kidney carcinoma. After passage 2. Wistar rat.
Comment from the depositor
RCB1807
BP36B(R100)
CommentRat cell line derived from kidney carcinoma. After passage 100. Wistar rat.
Comment from the depositor
RCB1809
Vav3^(-) DT40
CommentVav3 deficient DT40 cells
Comment from the depositor
RCB1810
PI3Kp110α^(-) DT40
CommentPI3Kp110α deficient DT40 cells
Comment from the depositor
RCB1811
ΔBLM-DT40
CommentSubline of DT40 cell line, lacking BLM (Bloom syndrome gene) expression.
Comment from the depositor
RCB1812
ΔWRN-DT40
CommentSubline of DT40 cell line, lacking WRN (Werner syndrome gene) expression.
Comment from the depositor
RCB1813
ΔWRNΔBLM-DT40
CommentSubline of DT40 cell line, lacking both of WRN (Werner syndrome gene) and BLM (Bloom syndrome gene) expression.
Comment from the depositor
RCB1814
ΔDinBΔXPA-DT40
CommentSubline of DT40 cell line, lacking both of DinB and XPA expression.
Comment from the depositor
RCB1817
DT40(v-myb^+)WT
CommentA subline of avian cell line, DT40, expressing v-myb exogenously.
Comment from the depositor
RCB1818
DT40(v-myb^+)Δpolβ
CommentA subline of avian cell line, DT40, expressing v-myb exogenously and lacking polβ gene.
Comment from the depositor
RCB1819
DT40(v-myb^+)Δpolλ
CommentA subline of avian cell line, DT40, expressing v-myb exogenously and lacking polλ gene.
Comment from the depositor
RCB1820
DT40(v-myb^+)Δpolλβ
CommentA subline of avian cell line, DT40, expressing v-myb exogenously and lacking both polβ and polλ gene.
Comment from the depositor
RCB1821
CHO-FLAG-hBLT1
CommentSubline of CHO-K1 that expresses human leukotriene B4 receptor (BLT1).
Comment from the depositor
RCB1822
CHO-HA-hBLT2
CommentSubline of CHO-K1 that expresses human leukotriene B4 receptor (BLT2).
Comment from the depositor
RCB1823
CHO·1F8
CommentSubline of CHO-K1 that expresses human platelet activating factor receptor.
Comment from the depositor
RCB1824
TRP1^(-) DT40
CommentTRP1 deficient DT40
Comment from the depositor
RCB1829
SC-1
CommentEmbryonal cell line derived from wild mouse. Sensitive to leukemia viruses.
Comment from the depositor
RCB1830
Rat-1
CommentRat fibroblast-like cell line that can be transformed by oncogenes.
Comment from the depositor
RCB1831
XC
CommentCell line for titration of murine leukemia virus.
Comment from the depositor
RCB1832
THK
CommentSV40 transformed hamster cell line. Fibroblast-like cells.
Comment from the depositor
RCB1833
Mink
CommentLung epithelial cell line derived from mink. Useful for focus forming assays for murine leukemia virus.
Comment from the depositor
RCB1834
S+L-Mink
CommentMink (RCB1833) cells transformed by Moloney murine sarcoma virus.
Comment from the depositor
RCB1835
Sirc
CommentFibroblast-like cell line derived from rabbit.
Comment from the depositor
RCB1836
Grb2^(-)/Grap^(-) DT40
CommentGrb2and Grap deficient DT40 cells
Comment from the depositor
RCB1837
MVP1
CommentHybridoma producing a monoclonal antibody against Medaka Vitellogenin.
Comment from the depositor
RCB1838
MVP25
CommentHybridoma producing a monoclonal antibody against Medaka Vitellogenin.
Comment from the depositor
RCB1839
MVP47
CommentHybridoma producing a monoclonal antibody against Medaka Vitellogenin.
Comment from the depositor
RCB1840
MVP49
CommentHybridoma producing a monoclonal antibody against Medaka Vitellogenin.
Comment from the depositor
RCB1841
MVP51
CommentHybridoma producing a monoclonal antibody against Medaka Vitellogenin.
Comment from the depositor
RCB1845
ΔUbc9+cUbc9-DT40
CommentEndogenous Ubc9 deficient DT40 cells but expressing Ubc9 exogenously
Comment from the depositor
RCB1846
HSC-F
CommentT cell line derived from Cynomolgus Monkey (Macaca fascicularis). Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
Comment from the depositor
RCB1847
ES-8040 20-2
CommentErythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.
Comment from the depositor
RCB1848
ES-8047 2-1
CommentErythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.
Comment from the depositor
RCB1849
C-8049
CommentErythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.
Comment from the depositor
RCB1850
C-8052
CommentErythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.
Comment from the depositor
RCB1851
DT40 Cre1
CommentA subline of avian cell line, DT40, expressing v-myb/pMerCreMer exogenously (see reference : BMC Biotechnol. 2001;1:7).
Comment from the depositor
RCB1853
MSH6-1-[ClX3.16]DT40
CommentA subline of avian cell line, DT40, lacking MSH6 (see reference : BMC Biotechnol. 2001;1:7).
Comment from the depositor
RCB1854
HSP-239
CommentT cell line derived from Chimpanzee (Pan troglodytes). Chimpanzee cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
Comment from the depositor
RCB1855
HSP-250
CommentT cell line derived from Chimpanzee (Pan troglodytes). Chimpanzee cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
Comment from the depositor
RCB1856
TX-7F (hybridoma)
CommentHybridoma producing a monoclonal antibody against tetrodotoxin.
Comment from the depositor
RCB1857
DA-3 (hybridoma)
CommentHybridoma producing a monoclonal antibody against domoic acid.
Comment from the depositor
RCB1858
GT-13A (hybridoma)
CommentHybridoma producing a monoclonal antibody against gonyautoxin.
Comment from the depositor
RCB1859
MDBK-NST
CommentA cell line derived from kidney of bovine. FBS independent for culture.
Comment from the depositor
RCB1860
BLNK^(-)Grb2^(-)DT40
CommentBLNK and Grb2 deficient DT40 cells
Comment from the depositor
RCB1861
T-23
CommentLung fibroblastic cell line derived from Tupaia belangeri. Tupaia cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
Comment from the depositor
RCB1862
NIH3T3-3-4
CommentSubclone of NIH3T3
Comment from the depositor
RCB1863
GRP1^(-)DT40
CommentRas GRP1 deficient DT40 cells
Comment from the depositor
RCB1864
GRP3^(-)DT40
CommentSubline of DT40 cell line, lacking RasGRP3 expression.
Comment from the depositor
RCB1865
GRP1^(-)/GRP3^(-)DT40
CommentSubline of DT40 cell line, lacking both of RasGRP1 and RasGRP3 expression.
Comment from the depositor
RCB1866
Sos1^(-)DT40
CommentSubline of DT40 cell line, lacking Sos1 expression.
Comment from the depositor
RCB1867
Sos2^(-)DT40
CommentSubline of DT40 cell line, lacking Sos2 expression.
Comment from the depositor
RCB1868
Sos1^(-)/Sos2^(-)DT40
CommentSubline of DT40 cell line, lacking both Sos1 and Sos2 expression.
Comment from the depositor
RCB1869
LY-A
CommentSubline of CHO-K1 cell line in which trafficking of ceramide is deficient
Comment from the depositor
RCB1870
LY-A/hCERT
CommentSubline of LY-A in which human CERT cDNA are expressed and trafficking of ceramide is recovered
Comment from the depositor
RCB1871
TL-1
CommentHuman lymphoid cell line derived from Burkitt's lymphoma. Tumorigenic in nude mouse. TKG0607 (Deposited from Tohoku Univ.). Application consideration
Comment from the depositor
RCB1872
A431
CommentHuman cell line derived from epidermoid carcinoma. TKG0182 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1873
JTK-LCL
CommentHuman B cell line transformed by Epstein-Barr Virus. HLA: A0206 and A2402. TKG0585 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1874
KOIA-LCL
CommentEBV-transformed cell line from a patient (male) with p53 germ line mutation. Mutation was noted at codon 242 (TGC→TAC) by FASAY. TKG0506 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1875
XPL 5
CommentLymphoblastoid cell line established by EBV infection from XP patient, variant type. TKG0309 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1876
211-LCL-MUC1
CommentHuman B lymphoblastoid cell line (RCB2288 211-LCL) transformed with APR-MUC1 and PRC-MUC1 cDNAs. TKG0615 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1878
RPMI1788
CommentIgM (lambda) secreting B cell line. Established from peripheral blood lymphocytes of apparently normal 33-y-o male. HLA profile: A2, Aw33, B7, B14. TKG0464 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1879
PEER
CommentHuman T cell line derived from acute T cell leukemia. TKG0377 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1881
TL-Mor
CommentHuman derived T cell line. HTLV-1 pro-virus DNA(+). TKG0369 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1882
BALL-1
CommentHuman cell line derived from B cell leukemia. TKG0467 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1884
H-111-TC
CommentHuman cell line derived from gastric cancer. TKG0411 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1886
Hep G2
CommentHuman cell line derived from hepatoblastoma. Secretes several products such as albumin, alpha2-macroglobulin, alpha 1-antitrypsin, transferrin and plasminogen. TKG0205 (Deposited from Tohoku Univ.). Information
Comment from the depositor
RCB1889
HEp-2
CommentSupports growth of arvovirus and measles virus. A subline of HeLa cell (HeLa contamination). TKG0403 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1890
MG-63
CommentOsteosarcoma cell line derived from human. High yield of IFN production by induction with poly IC, cyclohexmide, actinomycin D. Antigenically, MG-63 IFN is closely related to human fibroblast IFN. TKG0294 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1891
HeLa TG
CommentA subline of HeLa. 6-thioguanine resistant. TKG0204 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1892
SKG-IIIa
CommentCervical carcinoma cell line derived from human. TA-4, CA-4, TPA, placental ALP are positive. Regan isoenzyme producing. p53 normal, p51 mutation (+), HLA-A 2402/. TKG0462 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1894
TE-1
CommentHuman cell line derived from esophageal cancer. Squamous cell carcinoma. TKG0252 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1896
TN-2
CommentHuman cell line derived from neuroblastoma of adrenal gland. TKG0278 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1897
K562
CommentHuman cell line derived from chronic myelogenous leukemia. Differentiate into mature erythrocytes. TKG0210 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1898
K562/Adr
CommentSubline of K562. Resistant to adriamycin. TKG0211 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1900
Lu99
CommentLung giant cell carcinoma cell line derived from human. TKG0495 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1901
PK-59
CommentHuman cell line derived from pancreatic cancer. TKG0492 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1902
HSC-4
CommentHuman tongue squamous cell carcinoma derived cell line. TKG0489 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1903
OVK18
CommentHuman cell line derived from ovarial cancer, subclone of RCB2535. TKG0323 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1904
MCF7
CommentHuman cell line derived from breast adenocarcinoma. TKG0479 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1905
Sq-1
CommentHuman cell line derived from lung squamous cell carcinoma. Many granules are found in cytoplasma. HLA-A 11/24. TKG0301 (Deposited from Tohoku Univ.). Application consideration
Comment from the depositor
RCB1907
TKKK
CommentHuman cell line derived from intrahepatic bile duct cancer. TKG0456 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1909
8305C
CommentHuman thyroid anaplastic carcinoma derived cell line. TKG0446 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1911
CCD-IC
CommentRabbit kidney cell line transformed by SV40 large T antigen. Derived from renal cortical collecting tubules.
Comment from the depositor
RCB1912
CNT
CommentRabbit kidney cell line transformed by SV40 large T antigen. Derived from renal distal tubules.
Comment from the depositor
RCB1913
PST-S2
CommentRabbit kidney cell line transformed by SV40 large T antigen. Derived from renal proximal tubules.
Comment from the depositor
RCB1914
BBWV-22K3-9B
CommentHybridoma producing a monoclonal antibody against Broad bean wilt virus 2 22-kDa coat protein.
Comment from the depositor
RCB1915
BBWV-22K5-12A
CommentHybridoma producing a monoclonal antibody against Broad bean wilt virus 2 22-kDa coat protein.
Comment from the depositor
RCB1916
BBWV-22K6-2A
CommentHybridoma producing a monoclonal antibody against Broad bean wilt virus 2 22-kDa coat protein.
Comment from the depositor
RCB1918
J#176-3.2
CommentHybridoma producing a monoclonal antibody against mouse JDP2.
Comment from the depositor
RCB1919
J#214.2-2
CommentHybridoma producing a monoclonal antibody against mouse JDP2. The antibody recognizes a truncated from of JDP2.
Comment from the depositor
RCB1920
J#249.1-1
CommentHybridoma producing a monoclonal antibody against mouse JDP2.
Comment from the depositor
RCB1921
NRG
CommentMouse bone marrow derived fibroblast-like cells line. Differentiates to neuron.
Comment from the depositor
RCB1922
1C7
CommentHybridoma producing antibody against the purified basal apparatus of sperm of the an-1 strain of fern Lygodium.
Comment from the depositor
RCB1923
13D10
CommentHybridoma producing antibody against the purified basal apparatus of sperm of the an-1 strain of fern Lygodium.
Comment from the depositor
RCB1924
h1c
CommentHybridoma producing antibody against the purified basal apparatus of sperm of the an-1 strain of fern Lygodium.
Comment from the depositor
RCB1925
WA-mFib
CommentMouse stromal cell line for human lung small cell carcinoma cell line, WA-ht.
Comment from the depositor
RCB1926
OT11
CommentRBP-J deficient mouse fibroblasts
Comment from the depositor
RCB1927
OT13
CommentControl cell line for OT11 (normal fibroblasts derived from the same mouse strain)
Comment from the depositor
RCB1928
KG-1a
CommentHuman cell line derived from acute myelogenous leukemia. The variant subline of KG-1(RCB1166) cell line. TKG0402 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1932
T2
CommentHuman hybrid (T and B lymphoblast) cell line. Fusion cll line between 174 and CEM.T2. This hybrid cells do not express MHC class II. HLA-A2 positive. TKG0599 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1933
NALM-6
CommentHuman cell line derived from B cell leukemia. TKG0413 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1934
HUT78
CommentHuman cell line derived from T cell of a patient with Sezary syndrome. Producing IL-2. TKG0375 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1935
HPB-ALL
CommentHuman cell line derived from T cell leukemia. TKG0199 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1936
MOLT-4F
CommentHuman T leukemic cell line (CD4+). CR2 receptor (+). TKG0229 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1938
P30/OHK
CommentHuman cell line derived from T cell leukemia. TKG0463 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1939
NUGC-4
CommentHuman cell line derived from signet ring cell carcinoma of stomach. TKG0449 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1940
SH-10-TC
CommentHuman cell line derived from gastric cancer. Derived from nude mouse xenograft tumor (TKG 0338, SH-10). TKG0412 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1941
Li-7
CommentHuman hepatoma cell line. This cell line was established from nude mouse xenograft tumor (Dr. Hirohashi., National Cancer Center, Tokyo) by Tanno, H. (Tohoku Univ., 1st Surg). AFP producing. TKG0368 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1943
HuH-28
CommentHuman cell line derived from cholangiocellular carcinoma. TKG0438 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1945
HSC-2
CommentHuman cell line derived from oral squamous cell carcinoma occurred in 69-yo, male patient. HLA-A 24/. TKG0487 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1947
Ca Ski
CommentHuman cell line derived from uterine cervical epidermoid carcinoma. TKG0366 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1949
TE-5
CommentHuman cell line derived from poorly differntiated esophageal squamous cell carcinoma. Not transplantable to nude mouse. TKG0256 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1950
TE-6
CommentHighly differentiated squamous carcinoma (esophagus), not transplantable to nude mouse. Progeny were cured by Treatments with BM Cycline and MC210. TKG0257 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1951
TE-15
CommentHuman cell line derived from esophageal cancer (highly differentiated squamous cell carcinoma). Not transplantable to nude mouse. TKG0266 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1952
SCCH-26
CommentHuman neuroblastoma cell line. TKG0460 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1953
NB-1
CommentHuman cell line derived from neuroblastoma. Dibuty-cAMP (1 mM) induces differentiation. TKG0486 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1954
T98G
CommentHuman cell line derived from glioblastoma multiforme (Caucasian). Hyperpentaploid chromosome count. TKG0471 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1955
KMST-6
CommentHuman cell line derived from embryonic fibroblasts. Characteristics Embryonal fibroblast immortalized by 60-Co irradiation (400 Rad x 1 time and 200 rad x 12 times). Non-tumorigenic. TKG0482 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1960
HuCCT1
CommentHuman bile duct carcinoma. This cell line produces carbohydrate antigen 19/9 in serum-free medium. TKG0389 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1963
VMRC-RCW
CommentHuman renal cell carcinoma cell line. TKG0447 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1965
EBC-1
CommentHuman lung squamous cell carcinoma cell line. TKG0481 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1966
S1
CommentHuman cell line derived from lung cancer. Small cell carcinoma. TKG0244 (Deposited from Tohoku Univ.). Application consideration
Comment from the depositor
RCB1967
LU65
CommentHuman lung carcinoma cell line. TKG0442 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1970
LK-2
CommentHuman lung squamous cell carcinoma cell line. TKG0494 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1971
Lu99B
CommentHuman lung giant cell carcinoma cell line. TKG0496 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1972
PK-1
CommentHuman pancreatic carcinoma cell line. RCB2138 was derived from the same patient. TKG0239 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1973
PK-45H
CommentHuman pancreatic carcinoma cell line, the same patient as RCB2141. TKG0491 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1974
SAS
CommentHuman cell line derived from tongue cancer. Squamous cell carcinoma. TKG0470 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1975
HSC-3
CommentHuman tongue squamous cell carcinoma cell line. HLA-A 2/24. TKG0484 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1976
Ca9-22
CommentHuman gingival carcinoma cell line. Expressing remarkable EGF receptor. HLA-A 2/24. TKG0485 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1980
CCRF-CEM
CommentHuman cell line derived from T cell leukemia. TKG0563 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1981
HD-Mar2
CommentHuman cell line derived from Hodgkin's lymphoma. TKG0198 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1988
TE-9
CommentHuman esophageal squamous cell carcinoma (poorly differentiated) cell line. Not transplantable to nude mouse. TKG0260 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB1990
KUSA-H1
CommentMouse bone marrow-derived stromal cells.
Comment from the depositor
RCB1991
KUSA-O
CommentMouse multipotent mesenchymal cells. Derived from bone marrow.
Comment from the depositor
RCB1992
UV♂1d
CommentMouse cell line derived from UV-induced fibroblast sarcome.
Comment from the depositor
RCB1993
UV♀1A
CommentMouse cell line derived from UV-induced fibroblast sarcome.
Comment from the depositor
RCB1994
UV♀2
CommentMouse cell line derived from UV-induced angioendothelioma-like tumor.
Comment from the depositor
RCB1995
UV·BAL-1.1
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB1996
UV·BAL-2.1D
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB1997
UV·B6-1.1
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB1998
UV·B6-2.1A
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB1999
UV·B6-4.1
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2000
UV·B6-5.1
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2013
GMR3
CommentHybridoma producing a monoclonal antibody against N-glycolylneuraminic acid-containing gangliosides (GD3 gangliosides).
Comment from the depositor
RCB2014
GMB7
CommentHybridoma producing a monoclonal antibody against GD2 gangliosides (b-pathway gangliosides).
Comment from the depositor
RCB2015
GMR8
CommentHybridoma producing a monoclonal antibody against N-glycolylneuraminic acid-containing gangliosides (GM3 gangliosides).
Comment from the depositor
RCB2016
AMR19
CommentHybridoma producing a monoclonal antibody against ganglioside lactones.
Comment from the depositor
RCB2021
GGR41
CommentHybridoma producing a monoclonal antibody against GQ1ba gangliosides.
Comment from the depositor
RCB2024
UV·BAL-3.3
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2025
UV·BAL-5.4G
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2026
UV·BAL-6.1E
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2027
UV·BAL-7.1
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2028
UV·BAL-8.1
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2029
UV·BAL-8.1C
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2030
UV·BAL-12.1
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2031
UV·BAL-13.1
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2032
UV·BAL-14.2
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2033
UV·BAL-15.1
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2034
UV·BAL-16.1
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2035
UV·BAL-17.1
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2036
UV·BAL-18.1
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2037
NGR54
CommentHybridoma producing a monoclonal antibody against 2-3NeuAca-nLc4Cer gangliosides.
Comment from the depositor
RCB2039
NMR52
CommentHybridoma producing a monoclonal antibody against nLc4Cer.
Comment from the depositor
RCB2040
NGR50
CommentHybridoma producing a monoclonal antibody against SGPG.
Comment from the depositor
RCB2041
AMR20
CommentHybridoma producing a monoclonal antibody against GalCer.
Comment from the depositor
RCB2042
AGB43
CommentHybridoma producing a monoclonal antibody against Sulfatide.
Comment from the depositor
RCB2046
BMR26
CommentHybridoma producing a monoclonal antibody against Globoside.
Comment from the depositor
RCB2048
OMB4
CommentHybridoma producing a monoclonal antibody against N-linked neutral oligosaccharides of glycoproteins.
Comment from the depositor
RCB2049
OMR5
CommentHybridoma producing a monoclonal antibody against F1-linked neutral oligosaccharides of glycoproteins.
Comment from the depositor
RCB2050
OMR6
CommentHybridoma producing a monoclonal antibody against M1-linked neutral oligosaccharides of glycoproteins.
Comment from the depositor
RCB2053
UV·C3H-3.3
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2056
UV·C3H-8.2
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2057
UV·BAL-19.1A
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2058
UV·BAL-20.1
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2059
UV·BAL-21.1
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2060
UV·BAL-23.1
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2061
UV·C3B6-1.1
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2062
UV·C3B6-1.1C
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2065
UV·CB6-2.1F
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2066
UV·CB6-3.4B
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2067
UV·CB6-4.1D
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2068
UV·CB6-4.1F
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2070
UV·CB6-5.2
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2071
UV·CB6-5.2B
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2072
UV·CB6-6.1
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2073
UV·CB6-6.1B
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2074
UV·CC3-11.1
CommentMouse cell line derived from UV-induced skin tumor.
Comment from the depositor
RCB2076
Has
CommentChinese hamster cell line. Epithelial-like adherent cells.
Comment from the depositor
RCB2078
FU-RPNT-2
CommentHuman primitive neuroectodermal tumor cell line derived from kidney.
Comment from the depositor
RCB2081
KUSA-A1
CommentMesenchymal stem cell line derived from C3H/He mouse strain.
Comment from the depositor
RCB2082
103-LCL
CommentHuman B cell line transformed by Epstein-Barr Virus. TKG0614 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2083
141-LCL
CommentHuman B cells transformed by Epstein-Barr virus. RCB2541 was derived from the same patient. TKG0611 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2084
TALL-1
CommentHuman T-cell line derived from acute lynphblastic leukemia. TKG0251 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2088
Kato III
CommentHuman cell line derived from gastric cancer. Signet ring carcinoma. TKG0213 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2092
87-5
CommentHuman cell line derived from lung cancer. Small cell carcinoma. TKG0503 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2093
II-18
CommentHuman cell line derived from lung cancer. Adenocarcinoma. TKG0177 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2094
MIA Paca2
CommentHuman cell line derived from pancreatic cancer. TKG0227 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2095
PANC-1
CommentHuman cell line derived from pancreatic cancer. Ductal origin. TKG0606 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2097
TE-4
CommentHuman cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma. TKG0255 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2098
TE-8
CommentHuman cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0259 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2099
TE-10
CommentHuman cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma. TKG0261 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2100
TE-11
CommentHuman cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0262 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2101
TE-14
CommentHuman cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0265 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2102
HO-1-u-1
CommentHuman cell line derived from squamous cell carcinoma at mouth floor. TKG0455 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2103
8505C
CommentHuman cell line derived from thyroid cancer. Poorly differentiated papillary adenocarcinoma. TKG0439 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2104
HuO-3N1
CommentHuman cell line derived from osteosarcoma. TKG0452 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2105
D98-AH2
CommentHuman cell line derived from cervical cancer. The cells were converted to HGPRT(-). A subline of HeLa cell. TKG0191 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2106
ME-180
CommentHuman cell line derived from cervical cancer. TKG0437 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2107
TN-1
CommentHuman cell line derived from neuroblastoma formed at adrenal gland. TKG0277 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2108
NH-12
CommentHuman cell line derived from neuroblastoma. TKG0448 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2109
NH-6
CommentHuman cell line derived from neroblastoma of adrenal gland. TKG0468 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2110
YKG1
CommentHuman cell line derived from glioblastoma. TKG0453 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2111
K562/Vin
CommentSubline of K562 cell line. Resistant to vincristine. TKG0212 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2112
KUM4
CommentMouse mesenchymal cell line derived from bone marrow. C3H/He
Comment from the depositor
RCB2113
KUM6
CommentMouse mesenchymal cell line derived from bone marrow. C3H/He
Comment from the depositor
RCB2114
KUM7
CommentMouse mesenchymal cell line derived from bone marrow. C3H/He
Comment from the depositor
RCB2115
KUM9
CommentMouse mesenchymal cell line derived from bone marrow. C3H/He
Comment from the depositor
RCB2116
TSt-4
CommentMurine mesenchymal cell line derived from fetal thymus tissue. Can support the generation of myeloid cells and B cells from muirne hematopietic stem/progenitors.
Comment from the depositor
RCB2117
TSt-4/G
CommentMurine mesenchymal cell line derived from fetal thymus tissue. Can support the generation of myeloid cells and B cells from muirne hematopietic stem/progenitors. Established originally as a cotrol cells for TSt-4/G-DLL1. By retorviral transduction, EGFP is expressed.
Comment from the depositor
RCB2118
TSt-4/G-DLL1
CommentOriginal murine mesenchymal cell line was derived from fetal thymus tissue. DLL1 gene was retrovirally introduced. Can support the generation of T cells (up to DP stage) from muirne hematopietic stem/progenitors. EGFP was also introduced, and is expressed as a marker.
Comment from the depositor
RCB2119
TSt-4/N
CommentOriginal murine mesenchymal cell line was derived from fetal thymus tissue. Can support the generation of myeloid cells and B cells from muirne hematopietic stem/progenitors. Established originally as a cotrol cells for TSt-4/N-DLL1. By retorviral transduction, huma NGF receptor is expressed.
Comment from the depositor
RCB2120
TSt-4/N-DLL1
CommentOriginal murine mesenchymal cell line was derived from fetal thymus tissue. By retrovirally introducing DLL1 gene, this cell line can support the generation of T cells (up to DP stage) from muirne hematopietic stem/progenitors. Human NGF receptor is also introduced, and is expressed as a marker on cell surface.
Comment from the depositor
RCB2125
BmN4-DR
CommentSilkworm (Bombyx mori) cell line derived from ovary. Useful for the identification and analysis of homologous recombination-related genes in the silkworm. Application consideration
Comment from the depositor
RCB2126
BmN4-IR
CommentSilkworm (Bombyx mori) cell line derived from ovary. Useful for the identification and analysis of homologous recombination-related genes in the silkworm. Application consideration
Comment from the depositor
RCB2127
COLO205
CommentHuman cell line derived from colon cancer. Derived from ascites metastasis. TKG0457 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2128
A-THP-1
CommentHuman cell line derived from acute monocytic leukemia. A subline of THP-1. Possessing characteristics of macrophage. TKG0296 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2133
S2
CommentHuman cell line derived from lung cancer. Small cell carcinoma. TKG0245 (Deposited from Tohoku Univ.).Application consideration
Comment from the depositor
RCB2134
86-2
CommentHuman cell line derived from lung cancer. Large cell carcinoma. TKG0181 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2135
NIH:OVCAR-3
CommentHuman cell line derived from adenocarcinoma of ovary. TKG0602 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2136
YST-1
CommentHuman cell line derived from schwannoma. TKG0454 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2138
KLM-1
CommentHuman cell line derived from pancreatic cancer. RCB1972 was derived from the same patient. TKG0490 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2141
PK-45P
CommentHuman cell line derived from pancreatic carcinoma. RCB1973 was derived from the same patient. TKG0493 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2143
DU145
CommentHuman cell line derived from brain metastasis of prostate carcinoma. TKG0604 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2144
LNCap.FGC
CommentHuman cell line derived from prostate adenocarcinoma. Derived from lymph node metastasis. TKG0603 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2145
PC-3
CommentHuman cell line derived from bone metastasis of prostatic cancer. TKG0600 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2146
WERI-Rb-1
CommentHuman cell line derived from retinoblastoma. TKG0601 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2147
KUM3
CommentMouse mesenchymal cell line derived from bone marrow. C3H/He
Comment from the depositor
RCB2148
KOP
CommentMouse fibroblast-like cell line lacking p38 MAP kinase expression.
Comment from the depositor
RCB2149
RKOP
CommentSubline of KOP cell line, expressing FLAG-tagged p38 MAP kinase. Zeocin-resistant.
Comment from the depositor
RCB2150
EKOP
CommentSubline of KOP cell line, expressing FLAG-tagged EXIP. Zeocin-resistant.
Comment from the depositor
RCB2151
ZKOP
CommentSubline of KOP cell line. Zeocin-resistant.
Comment from the depositor
RCB2163
UE6E7-16
CommentHuman mesenchymal cell line derived from bone marrow. Immortalized by HPV E6 and E7. RCB2152- RCB2163 are derived from the same bone marrow.
Comment from the depositor
RCB2202
293T
CommentA subline of 293. Expressing SV40 large T antigen.
Comment from the depositor
RCB2203
TFS-2
CommentHybridoma producing monoclonal antibody against a surface antigen of small cell carcinoma of lung.
Comment from the depositor
RCB2204
TFS-4
CommentHybridoma producing monoclonal antibody against a surface antigen of small cell carcinoma of lung.
Comment from the depositor
RCB2205
NCC-RbC-39
CommentHuman retinoblastoma cell line.
Comment from the depositor
RCB2206
NCC-RbC-51
CommentHuman retinoblastoma cell line derived from cervical lymph node metastasis.
Comment from the depositor
RCB2208
NCC-RbC-54
CommentHuman cell line derived from retinoblastoma.
Comment from the depositor
RCB2212
NCC-RbC-59
CommentHuman cell line derived from retinoblastoma.
Comment from the depositor
RCB2213
NCC-RbC-60
CommentHuman cell line derived from retinoblastoma.
Comment from the depositor
RCB2214
NCC-RbC-67
CommentHuman cell line derived from retinoblastoma.
Comment from the depositor
RCB2217
NCC-RbC-83
CommentHuman cell line derived from retinoblastoma.
Comment from the depositor
RCB2218
NCC-RbC-92
CommentHuman cell line derived from retinoblastoma.
Comment from the depositor
RCB2219
NCC-RbC-T1
CommentHuman cell line derived from retinoblastoma.
Comment from the depositor
RCB2223
NCC-OvC-K119
CommentHuman cell line derived from ovarian cancer.
Comment from the depositor
RCB2224
NCC-StC-K140
CommentHuman cell line derived from stomach cancer.
Comment from the depositor
RCB2225
JHUEM-14
CommentHuman cell line derived from uterine endometrioid adenocarcinoma. Application consideration
Comment from the depositor
RCB2226
JHOC-9
CommentHuman cell line derived from ovarian clear cell carcinoma. Application consideration
Comment from the depositor
RCB2227
JMSU1
CommentHuman cell line derived from urinary bladder carcinoma. Derived from ascites.
Comment from the depositor
RCB2229
HS-Os-1
CommentHuman cell line derived from osteosarcoma.
Comment from the depositor
RCB2230
HS-Sch-2
CommentHuman cell line derived from malignant peripheral nerve sheath tumor (MPNST).
Comment from the depositor
RCB2231
HS-SY-II
CommentHuman cell line derived from synovial sarcoma. Application consideration
Comment from the depositor
RCB2233
HE12
CommentHuman fibroblast-like cells derived from embryo. Not immortalized. Application consideration
Comment from the depositor
RCB2234
HE13
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2237
HE16
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2238
HE18
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2239
HE19
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2240
HE21
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2241
HE22
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2244
HE27
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2245
HE28
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2246
HE29
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2247
HE30
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2248
HE31
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2249
HE32
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2250
HE33
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2251
HE34
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2253
HKb20
CommentA subline of 293. Expressing BtR175b (Cry 1Aa receptor).
Comment from the depositor
RCB2254
HE36
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2256
HE37
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2257
HE38
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2258
HE39
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2259
HE40
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2260
HE41
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2261
HE42
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2262
HE46
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2263
HE47
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2264
HE48
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2265
HE49
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2266
HE50
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2267
HE51
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2268
HE52
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2269
HE53
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2270
HE54
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2271
HE55
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2273
HE57
CommentHuman fibroblast-like cells derived from embryo. Not immortalized.
Comment from the depositor
RCB2277
GSS
CommentHuman gastric cancer cell line derived from metastasis at liver.
Comment from the depositor
RCB2278
GSU
CommentHuman cell line derived from gastric cancer. Established from the cells in ascites.
Comment from the depositor
RCB2279
WA-hT
CommentHuman cell line derived from lung cancer. Small cell carcinoma. Mouse WA-mFib cells are the stromal cells for this cell line.
Comment from the depositor
RCB2280
HCE-T
CommentSV40-Adeno vector transformed cornea cells. 64kD keratin producing. Choleratoxin-free medium. Caution! PDF 91KB
Comment from the depositor
RCB2281
T3M-12
CommentHuman lung small cell carcinoma cell line. ADH producing.
Comment from the depositor
RCB2282
701-LCL
CommentHuman cell line derived from B cells of healthy volunteer. Transformed by EB virus. TKG0610 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2283
277-LCL
CommentHuman B cells transformed by Epstein-Barr virus. TKG0609 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2286
XPL 17
CommentHuman B cells derived from a patient of xeroderma pigmentosum. Transformed by Epstein-Barr virus. TKG0311 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2287
XPL 20
CommentHuman B cells derived from a patient of xeroderma pigmentosum. Transformed by Epstein-Barr virus. TKG0313 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2288
211-LCL
CommentHuman cell line derived from B cells of healthy volunteer. Transformed by EB virus. TKG0616 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2292
ACC-MESO-1
CommentHuman malignant pleural mesothelioma cell line.
Comment from the depositor
RCB2293
ACC-MESO-4
CommentHuman malignant pleural mesothelioma cell line.
Comment from the depositor
RCB2295
KUM10
CommentMouse mesenchymal cell line derived from bone marrow. C57/B6.
Comment from the depositor
RCB2296
CARMA1^(-)DT40
CommentSubline of DT40 cell line, lacking CARMA1 expression.
Comment from the depositor
RCB2297
PKCβ^(-)DT40
CommentSubline of DT40 cell line, lacking PKC-β expression.
Comment from the depositor
RCB2298
TAK1^(-)DT40
CommentSubline of DT40 cell line, lacking TAK1 expression.
Comment from the depositor
RCB2299
RMC-1
CommentRat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
Comment from the depositor
RCB2300
RMC-2
CommentRat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
Comment from the depositor
RCB2301
RMC-3
CommentRat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
Comment from the depositor
RCB2302
RMC-6
CommentRat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
Comment from the depositor
RCB2303
RMC-11
CommentRat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
Comment from the depositor
RCB2304
RMC-17
CommentRat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
Comment from the depositor
RCB2305
MIH5(GIT)
CommentHybridoma producing a monoclonal antibody against mouse B7-H1.
Comment from the depositor
RCB2306
PC3.1
CommentHybridoma producing monoclonal antibody against latexin.
Comment from the depositor
RCB2307
T1.7
CommentHybridoma producing monoclonal antibody against C-terminal peptide of rat GSK3-beta.
Comment from the depositor
RCB2308
802C11
CommentHybridoma producing monoclonal antibody against MuSc.
Comment from the depositor
RCB2309
JFP-J1
CommentHybridoma producing monoclonal antibody against GFP. Rat IgG2a monoclonal antibody.
Comment from the depositor
RCB2310
JFP-J5
CommentHybridoma producing monoclonal antibody against GFP. Rat IgG2a monoclonal antibody.
Comment from the depositor
RCB2311
JFP-K2
CommentHybridoma producing monoclonal antibody against GFP. Rat IgG2a monoclonal antibody.
Comment from the depositor
RCB2312
859H5
CommentHybridoma producing monoclonal antibody against bacterial unknown molecule. Rat IgG2a monoclonal antibody.
Comment from the depositor
RCB2313
884F11
CommentHybridoma producing monoclonal antibody against mouse apolipoprotein E.
Comment from the depositor
RCB2314
F9/LM10
CommentMouse cell line derived from embryonal carcinoma. Expressing laminin alpha-5 exogenously.
Comment from the depositor
RCB2315
F9/LM(1+10)
CommentMouse cell line derived from embryonal carcinoma. Expressing laminin alpha-5 exogenously.
Comment from the depositor
RCB2316
AB1
CommentHybridoma producing monoclonal antibody against GD1b gangliosides.
Comment from the depositor
RCB2317
AC1
CommentHybridoma producing monoclonal antibody against GD1c gangliosides.
Comment from the depositor
RCB2318
P19.CL6
CommentMouse cell line derived from embryonal carcinoma. C3H strain. Following differentiation, beating cardiomyocytes appear efficiently.
Comment from the depositor
RCB2321
IP-B12
CommentCurrently not ready.
Comment from the depositorRat pulmonary carcinoma-derived cell line producing parathyroid hormone-related protein (PTHrP).
RCB2322
KUM5
CommentMouse mesenchymal cell line derived from bone marrow. C3H/He
Comment from the depositor
RCB2323
9-15C
CommentMouse mesenchymal cell line derived from bone marrow. C3H/He
Comment from the depositor
RCB2324
MIH5(RPMI)
CommentHybridoma producing a monoclonal antibody against mouse B7-H1. Possible to culture in RPMI1640 medium.
Comment from the depositor
RCB2326
CHO-AA8
CommentA subline of the CHO-K1 cell line. Widely used for the isolation of repair-deficient mutants. Useful for gene mutation assays at the APRT and HPRT loci.
Comment from the depositor
RCB2327
EM-9
CommentA subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC1 gene deficient.
Comment from the depositor
RCB2328
irs1SF
CommentA subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC3 gene deficient.
Comment from the depositor
RCB2329
V-3
CommentA subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC7(DNA-PK) gene deficient.
Comment from the depositor
RCB2330
CHO-K1
CommentChinese hamster ovary cell line. Widely used for the isolation of mutants by mutagenesis.
Comment from the depositor
RCB2331
XR-1
CommentA subline of the CHO-K1 cell line. X-ray-sensitive mutant. XRCC4 gene deficient.
Comment from the depositor
RCB2332
V79-4
CommentA subline of the V79 cell line following cloning. Widely used for radiation biology, mutagenesis and mammalian cell genetics.
Comment from the depositor
RCB2335
V-E5
CommentX-ray-sensitive mutant derived from the V79 cell line. XRCC8 gene deficient.
Comment from the depositor
RCB2336
V-G8
CommentA subline of the V79 cell line. X-ray-sensitive mutant. XRCC8 gene deficient.
Comment from the depositor
RCB2337
V79B
CommentA subline of the V79 cell line. Widely used for radiation biology, mutagenesis and mammalian cell genetics.
Comment from the depositor
RCB2338
XR-V9B-4
CommentA subline of the V79B cell line. X-ray-sensitive mutant. XRCC5(ku80) gene deficient.
Comment from the depositor
RCB2339
XR-V15B
CommentA subline of the V79 cell line. X-ray-sensitive mutant. XRCC5(ku80) gene deficient.
Comment from the depositor
RCB2341
NCR-G1
CommentHuman cell line derived from embryonal carcinoma of testis.
Comment from the depositor
RCB2342
NCR-G2
CommentHuman cell line derived from embryonal carcinoma of testis.
Comment from the depositor
RCB2343
NCR-G3
CommentHuman cell line derived from embryonal carcinoma of testis.Application consideration
Comment from the depositor
RCB2344
NCR-G4
CommentHuman cell line derived from embryonal carcinoma of testis.
Comment from the depositor
RCB2345
EEB
CommentHuman cell line derived from erythroblastic leukemia.
Comment from the depositor
RCB2346
NMFH-1
CommentHuman cell line derived from myxofibrosarcoma.
Comment from the depositor
RCB2347
NMS-2
CommentHuman cell line derived from malignant peripheral nerve sheath tumor.
Comment from the depositor
RCB2348
NOS-10
CommentHuman cell line derived from osteosarcoma.
Comment from the depositor
RCB2351
OGU1
CommentHuman cell line derived from primary effusion lymphoma (PEL). Application consideration
Comment from the depositor
RCB2352
633
CommentHuman lung cancer cell line expressing capsid protein of human adenovirus.
Comment from the depositor
RCB2354
293gp
CommentA subline of 293. Expressing MoMLV (Moloney murine leukemia virus) gag/pol. A retroviral vector packaging cell line.
Comment from the depositor
RCB2355
HeLa CD4+Clone1022
CommentA subline of the HeLa cells. Expressing human CD4 and Neomycin-resistant gene.
Comment from the depositor
RCB2356
HeLa-CD4-LTR-β-gal
CommentA subline of the HeLa cells. Expressing human CD4 and Neomycin-resistant gene. One copy of the HIV-1 LTR (nt-138 to +80) linked to the β-galactosidase gene is integrated.
Comment from the depositor
RCB2358
HLtat
CommentA subline of the HeLa cells. HeLa cells contained stably integrated copies of the HIV-1 LTR promoter linked to a synthetic tat gene.
Comment from the depositor
RCB2360
HS-ES-2M
CommentHuman cell line derived from epithelioid sarcoma. RCB2360 and RCB2361 were derived from the same patient. HS-ES-1 (RCB2364) was derived from another patient.
Comment from the depositor
RCB2361
HS-ES-2R
CommentHuman cell line derived from epithelioid sarcoma. RCB2360 and RCB2361 were derived from the same patient. HS-ES-1 (RCB2364) was derived from another patient.
Comment from the depositor
RCB2362
HS-PSS
CommentHuman cell line derived from malignant peripheral nerve sheath tumor.
Comment from the depositor
RCB2364
HS-ES-1
CommentHuman cell line derived from epithelioid sarcoma. RCB2360 and RCB2361 were derived from another different patient.
Comment from the depositor
RCB2365
JHONA
CommentHuman cell line derived from ovarian squamous cell carcinoma. Application consideration
Comment from the depositor
RCB2367
KT01
CommentHybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule.
Comment from the depositor
RCB2368
KT02
CommentHybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule.
Comment from the depositor
RCB2369
KT03
CommentHybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule and body wall muscle.
Comment from the depositor
RCB2372
KT06
CommentHybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule and body wall muscle.
Comment from the depositor
RCB2375
KT09
CommentHybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.
Comment from the depositor
RCB2376
KT10
CommentHybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.
Comment from the depositor
RCB2377
KT11
CommentHybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.
Comment from the depositor
RCB2378
KT12
CommentHybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.
Comment from the depositor
RCB2379
KT13
CommentHybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that seam cell.
Comment from the depositor
RCB2380
KT14
CommentHybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx basement membrane.
Comment from the depositor
RCB2381
KT16
CommentHybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx.
Comment from the depositor
RCB2382
KT17
CommentHybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx.
Comment from the depositor
RCB2383
KT18
CommentHybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx.
Comment from the depositor
RCB2386
KT21
CommentHybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on intestine.
Comment from the depositor
RCB2388
KT23
CommentHybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on nuclear membrane.
Comment from the depositor
RCB2389
KT26
CommentHybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on centrosome.
Comment from the depositor
RCB2390
KT27
CommentHybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on hypodermis.
Comment from the depositor
RCB2392
KT29
CommentHybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on egg shell.
Comment from the depositor
RCB2393
KT30
CommentHybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on egg shell.
Comment from the depositor
RCB2395
KT32
CommentHybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule and pharynx.
Comment from the depositor
RCB2400
KT54
CommentHybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on centrosome and P-granule.
Comment from the depositor
RCB2402
STIM1^(-)DT40
CommentSubline of DT40 cell line, lacking STIM1 expression.
Comment from the depositor
RCB2403
MG6
CommentMouse microglial cell line immortalized by a replication-deficient retroviral vector containing human c-myc gene. No significant production of infectious viral particles from MG6 cells was confirmed by bioassay using SC-1 cells.
Comment from the depositor
RCB2530
A172
CommentHuman cell line derived from glioblastoma. TKG0183 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2531
CB-3512
CommentHuman cell line derived from B cells in umbilical cord blood. Transformed by EB virus. TKG0305 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2532
HuO 9N2 (O9N2)
CommentHuman cell line derived from osteosarcoma. TKG0451 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2534
M-MOK
CommentHuman cell line derived from megakaryoblastic leukemia. TKG0458 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2535
OVK18#102
CommentHuman cell line derived from ovarian endometrioid carcinoma, subclone of RCB1903. TKG0357 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2536
T24
CommentHuman cell line derived from bladder cancer. Transitional cell carcinoma. TKG0443 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2537
TFK-1
CommentHuman cell line derived from extrahepatic bile duct carcinoma. TKG0367 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2539
XPL 19
CommentHuman B cell line derived from xeroderma pigmentosum (XP) patient and transformed by Epstein-Barr Virus. TKG0312 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2540
XPL 24
CommentHuman cell line derived from B cells of Xeroderma pigmentosum (XP) patient. Transformed by EB virus. TKG0314 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2541
141-LCL-MUC1
CommentHuman cell line derived from B cells of healthy volunteer. Transformed by EB virus. RCB2083 was derived from the same patient. TKG0634 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2610
FELV3281-AD
CommentCat cell line derived from lymphoma.
Comment from the depositor
RCB2611
MDCK-AD
CommentDog cell line derived from kidney.
Comment from the depositor
RCB2614
KLN205-MUC1
CommentMouse cell line derived from lung squamous cell carcinoma. TKG0473 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2618
BCL1-B20
CommentMouse cell line derived from B cell leukemia. TKG0435 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2619
L929
CommentMouse fibroblast-like cell line. TKG0217 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2620
C-1300N18
CommentMouse cell line derived from neuroblastoma. TKG0307 (Deposited from Tohoku Univ.). Application consideration
Comment from the depositor
RCB2621
M1(D+)
CommentMouse cell line derived from meyloid leukemia. TKG0319 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2623
KLN205
CommentMouse cell line derived from lung squamous cell carcinoma. TKG0214 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2627
BOY-12E
CommentHuman cell line derived from urinary bladder carcinoma. TKG0641 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2630
B16F10
CommentMouse cell line derived from melanoma. TKG0348 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2633
MM46 CEA1-2
CommentMouse cell line derived from mammary carcinoma. TKG0597 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2634
MM46-APR-MUC1 cl.1
CommentMouse cell line derived from mammary carcinoma. Expressing human MUC1 (APR-MUC1) exogenously. TKG0595 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2637
A4
CommentSubline of NIH/3T3 transformed with an active type c-erb B-2 (V-659 was changed to E659). c-erb B-2 prouct (+). G418 resistant. TKG0298 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2638
B16/BL6
CommentMouse cell line derived from melanoma.  TKG0598 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2639
NB2a
CommentMouse cell line derived from neuroblastoma. TKG0509 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2640
G-415
CommentHuman cell line derived from gallbladder carcinoma. TKG0642 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2642
MUSS
CommentMouse cell line derived from spontaneous malignant fibrous histiocytoma. A/J strain. TKG0497 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2643
F9
CommentMouse cell line derived from embryonal carcinoma. 129 strain. TKG0519 (Deposited from Tohoku Univ.). Application consideration
Comment from the depositor
RCB2648
D4
CommentA subline of the NIH/3T3 cell line. NIH/3T3 cell line transfected with wild type c-erb B2 gene with carboxyl-terminal deletion. Swiss strain.TKG0300(Deposited from Tohoku Univ.). TKG0300 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2649
B16F1
CommentMouse cell line derived from melanoma. C57BL/6J strain. TKG0347 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2651
JLS-V9
CommentMouse cell line derived from bone marrow. Fibroblast-like cells. BALB/c strain. TKG0355 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2652
J774-1
CommentMouse cell line derived from ascites. Macrophage-like cells. BALB/c strain. TKG0208 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2657
Colon-26
CommentMouse cell line derived from colon cancer. BALB/c strain. TKG0518 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2660
MEDEP-E14
CommentMouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, E14TG2a. Epo(Erythropoietin) dependent.
Comment from the depositor
RCB2686
JTC-35
CommentBovine granulosa cell line.
Comment from the depositor
RCB2691
MEDEP-E14 clone 4
CommentA subclone of MEDEP-E14(RCB2660) following cloning procedure.
Comment from the depositor
RCB2692
MEDEP-BRC4-1
CommentMouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, BRC4 (AES0008). SCF(Stem cell factor) and Dex(dexamethasone) dependent.
Comment from the depositor
RCB2693
MEDMC-NT2
CommentMouse cell line possessing the characteristics of mast cells. IL-3 (Interleukin-3) dependent.
Comment from the depositor
RCB2694
MEDMC-BRC6
CommentMouse cell line derived from mouse ES cell line, BRC6 (AES0010). Mast cell-like cells. SCF (Stem cell factor) and IL-3 (Interleukin-3) dependent. C57BL/6 strain.
Comment from the depositor
RCB2695
RD-C2
CommentMouse osteoblast-like cell line derived from Runx2 deficient mouse.
Comment from the depositor
RCB2696
RD-C6
CommentMouse osteoblast-like cell line derived from Runx2 deficient mouse.
Comment from the depositor
RCB2700
PK-8
CommentHuman cell line derived from liver metastasis of pancreas carcinoma. TKG0383 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2709
2F8
CommentHybridoma producing monoclonal antibody against oxitocin receptor.
Comment from the depositor
RCB2710
Atg5^(+/+)MEF
CommentMouse embryonic fibroblasts. Wild type control for RCB2711.
Comment from the depositor
RCB2711
Atg5^(-/-)MEF
CommentMouse embryonic fibroblasts lacking Atg5 gene expression.
Comment from the depositor
RCB2712
MAEC
CommentVascular endothelial cell line derived from aorta of p53-deficient mouse.
Comment from the depositor
RCB2718
MT-7
CommentRat cell line derived from fibrous histiocytoma. After cloning.
Comment from the depositor
RCB2719
MT-10
CommentRat cell line derived from fibrous histiocytoma. After cloning.
Comment from the depositor
RCB2720
MT-R8
CommentA subline of MT-8, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin.
Comment from the depositor
RCB2721
MT-R9
CommentA subline of MT-9, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin.
Comment from the depositor
RCB2722
MT-10R
CommentA subline of MT-10, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin.
Comment from the depositor
RCB2723
MT-PR
CommentA subline of MT-P, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin. T
Comment from the depositor
RCB2724
KB-D8
CommentRat cell line derived from dendritic cell carcinoma in thymus.
Comment from the depositor
RCB2725
KJ-A
CommentRat cell line derived from malignant fibrous histiocytoma.
Comment from the depositor
RCB2726
KE-F11
CommentRat cell line derived from malignant schwannoma.
Comment from the depositor
RCB2727
RY-B-E3
CommentRat cell line derived from endometrial stromal sarcoma.
Comment from the depositor
RCB2728
LY-H12
CommentRat non-neoplastic cell line derived from malignant peripheral nerve sheath tumor.
Comment from the depositor
RCB2729
LY-PPB6
CommentRat cell line derived from malignant peripheral nerve sheath tumor.
Comment from the depositor
RCB2740
5A5-WASP
CommentHybridoma producing monoclonal antibody against WASP (Wiskott-Aldrich syndrome protein). TKG0631 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2745
A20
CommentMouse cell line derived from lymphoma. Balb/c strain. TKG0571 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2758
LAG
CommentMouse cell line derived from connective tissue. Fibroblast-like. C3H strain. TKG0218 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2766
Morris 5123D-TC
CommentRat (Buffalo) cell line derived from hepatoma. TKG0365 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2767
NIH/3T3
CommentMouse fibroblast-like cell line. TKG0299 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2776
P388
CommentMouse cell line derived from lymphoid tumor. DBA/2 strain. TKG0326 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2782
RBL 2H3
CommentRat cell line derived from basophilic leukemia cells. TKG0321 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2783
RGC-6
CommentRat cell line derived from glioma induced by N-nitrosomethylurea. TKG0242 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2784
RL♂1(Gloria)
CommentMouse cell line derived from lymphoid tumor. BALB/c strain. TKG0292 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2799
YAC-1
CommentMouse cell line derived from lymphoma. A/Sn strain. TKG0387 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2800
PC12-F7
CommentA subline of PC-12 lacking synaptotagmin-1.
Comment from the depositor
RCB2801
PC12-G11
CommentA subline of PC-12 expressing synaptotagmin-1, a control cell line for PC12-F7.
Comment from the depositor
RCB2806
MSK-C5.8G
CommentRat cell line derived from osteosarcoma. F344 strain.
Comment from the depositor
RCB2808
Odf2-deficient F9 cells
CommentA subline of mouse ES cell line, F9 (129), lacking Odf2.
Comment from the depositor
RCB2809
CH12F3-2A
CommentMouse cell line derived from B cell lymphoma.
Comment from the depositor
RCB2811
7F9 (hybridoma)
CommentHybridoma. Anti-Rat Carboxypeptidase M MoAb producing.
Comment from the depositor
RCB2812
HeLa/Fucci
CommentA subline of the HeLa cell line expressing Fucci, a cell cycle marker. Cell line name : HeLa/Fucci #4.Important notice regarding nomenclature of Fucci.
Comment from the depositor
RCB2813
NMuMG/Fucci
CommentA subline of the NMuMG cell line expressing Fucci, a cell cycle marker. Cell line name : NMuMG/Fucci #1.Important notice regarding nomenclature of Fucci.
Comment from the depositor
RCB2815
P20.1
CommentHybridoma producing monoclonal antibody against a peptide, GYPGQV.
Comment from the depositor
RCB2816
A110L
CommentHuman cell line derived from lung adenocarcinoma cells.
Comment from the depositor
RCB2817
A529L
CommentHuman cell line derived from lung adenosquamous cell carcinoma. HLA A2402/, B5201/, Cw01201/.
Comment from the depositor
RCB2818
B1203L
CommentHuman cell line derived from lung adenocarcinoma. HLA A2402/2402, B5201/5401, C0102/1202.
Comment from the depositor
RCB2819
C831L
CommentHuman cell line derived from lung large cell carcinoma. HLA A0206/2601, B0702/3501, Cw0702/0801.
Comment from the depositor
RCB2820
N0003(<50)
Comment
Comment from the depositor
RCB2821
N0003(>300)
Comment
Comment from the depositor
RCB2822
N0005(<50)
Comment
Comment from the depositor
RCB2823
N0005(>500)
Comment
Comment from the depositor
RCB2824
N0005-A1
Comment
Comment from the depositor
RCB2825
N0013(<50)
Comment
Comment from the depositor
RCB2826
N0013(>300)
Comment
Comment from the depositor
RCB2827
N6803(<50)
Comment
Comment from the depositor
RCB2828
N6803(>500)
Comment
Comment from the depositor
RCB2830
OMC-2
CommentHuman cell line derived from endometrial adenocarcinoma.
Comment from the depositor
RCB2831
DEOC-1
CommentHuman cell line derived from malignant melanoma.
Comment from the depositor
RCB2832
OMC-9
CommentHuman cell line derived from endometrial stromal sarcoma.
Comment from the depositor
RCB2833
L23immo
CommentHuman immortalized cell line derived from MRC5 cells.
Comment from the depositor
RCB2834
L12.9-2(1)
CommentHuman immortalized cell line derived from MRC5 cells.
Comment from the depositor
RCB2843
43L
CommentSomatic tumor hybrid (fusion cell between C3H mammary tumor FM3A#2 and 8-Ag resistant L cell). This hybrid tumor cells induce resistance to MM Ag positive tumor cells. TKG0381 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2844
L1210 TGR4
CommentMouse cell line derived from leukemia. Resistant to 6TG (10 microgram/ml). DBA/2 strain. TKG0478 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2845
L1210-5FU-R-TC
CommentMouse cell line derived from leukemia. Lymphoblastoid cells. DBA/2 strain. TKG0409 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2846
LAG-MUC1
CommentA subline of LAG (RCB2758) expressing MUC1. 8-Ag resistant. TKG0466 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2848
OTT6050(B)
CommentMouse cell line derived from testicular teratoma. This cell line was established by inoculation of tibia (6 days old) to A/He x 129/sv mouse testis. Primary tumor was developed in testis. TKG0330 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2852
TSA8
CommentMouse cell line derived from erythroleukemia cells transformed by Friend leukemia virus. TKG0370 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2853
WEHI-3B
CommentMouse cell line derived from myelomonocytic leukemia cells. BALB/c strain. TKG0584 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2854
C6
CommentRat cell line derived from glial cell tumor induced by N-nitrosomethylurea. TKG0589 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2859
K-251
CommentRat cell line derived from hepatoma cells in ascites. TKG0130 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2860
MRMT-1
CommentRat cell line derived from mammary carcinoma. TKG0132 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2862
SLC
CommentRat cell line derived from lung cancer. TKG0135 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2863
N14.5
CommentRat neuronal cell line derived from the ventrolateral region of the suprachiasmatic nucleus
Comment from the depositor
RCB2864
OLP6
CommentRat neuronal cell line derived from the ventrolateral region of the suprachiasmatic nucleus
Comment from the depositor
RCB2867
HeLa/Fucci2
CommentA subline of the HeLa cell line expressing Fucci2, a cell cycle marker. Cell line name : HeLa/Fucci2 #3. Important notice regarding nomenclature of Fucci.
Comment from the depositor
RCB2868
NMuMG/Fucci2
CommentA subline of the NMuMG cell line expressing Fucci2, a cell cycle marker. Cell line name : NMuMG/Fucci2 #5. Important notice regarding nomenclature of Fucci.
Comment from the depositor
RCB2869
CHO-K1
CommentA subline of CHO cells. Require proline. TKG0328 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2896
JLS-V9 6TG
CommentMouse cell line derived from bone marrow. Fibroblast-like. 6TG resistant. BALB/c strain. TKG0350 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2899
S180-Kumamoto-TC
CommentMouse cell line derived from Swiss Webster Sarcoma 180. CFW strain. TKG0637 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2900
S180-Meiji-TC
CommentMouse cell line derived from sarcoma cells in ascites. CFW strain. TKG0672 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2901
S180-NCC-TC
CommentMouse cell line derived from sarcoma cells in ascites. CFW strain. TKG0638 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2904
WEHI164R
CommentMouse cell line derived from fibrosarcoma. TNF resistant. BALB/c strain. TKG0281 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2905
WEHI164S
CommentMouse cell line derived from fibrosarcoma. TNF sensitive. BALB/c strain. TKG0282 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2908
AH272-TC
CommentRat cell line derived from hepatoma cells in ascites. TKG0535 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2909
Walker256-TC
CommentRat cell line derived from mammary carcinoma. TKG0565 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2910
LY-6-TC
CommentRat cell line derived from sarcoma cells in ascites. TKG0648 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB2911
MEDEP-BRC5
CommentMouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, BRC5 (AES0009). SCF(Stem cell factor) dependent.
Comment from the depositor
RCB2924
OP9/G
CommentSubline of OP9 cell line, expressing EGFP. See RCB2117 TSt-4/G.
Comment from the depositor
RCB2925
OP9/G-DLL1
CommentSubline of OP9 cell line, expressing DLL1 and EGFP. See RCB2118 TSt-4/G-DLL1.
Comment from the depositor
RCB2926
OP9/N
CommentSubline of OP9 cell line, expressing human NGF receptor. See RCB2119 TSt-4/N.
Comment from the depositor
RCB2927
OP9/N-DLL1
CommentSubline of OP9 cell line, expressing DLL1 and human NGF receptor. See RCB2120 TSt-4/N-DLL1.
Comment from the depositor
RCB2931
6E2
CommentHybridoma cell line expressing anti-human SSEA-4 monoclonal antibody.
Comment from the depositor
RCB2932
MEDEP-BRC4-2
CommentMouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, BRC4 (AES0008). SCF (Stem cell factor) and Dexamethasone dependent. C57BL/6 strain.
Comment from the depositor
RCB2942
OLHNI-2
CommentMedaka cell line derived from HNI strain.
Comment from the depositor
RCB2943
OLHdrR-e3
CommentMedaka cell line derived from HdrR strain.
Comment from the depositor
RCB2944
OLCAB-e31
CommentMedaka cell line.
Comment from the depositor
RCB2945
DIT29
CommentMedaka cell line derived from hepatoma cells.
Comment from the depositor
RCB2946
OLCAB-e3
CommentMedaka cell line.
Comment from the depositor
RCB2979
HCT116
CommentHuman cell line derived from colon cancer. Loss of the DNA mismatch repair gene (hMLH1).
Comment from the depositor
RCB2980
HCT116-XRCC4(+/-)
CommentSubline of HCT116 cell line lacking XRCC4 gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).
Comment from the depositor
RCB2981
HCT116-XRCC4(-/-)
CommentSubline of HCT116 cell line lacking XRCC4 gene in both alleles. Loss of the DNA mismatch repair gene (hMLH1).
Comment from the depositor
RCB2982
HCT116-RAD18(+/-)
CommentSubline of HCT116 cell line lacking RAD18 gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).
Comment from the depositor
RCB2983
HCT116-RAD18(-/-)
CommentSubline of HCT116 cell line lacking RAD18 gene in both alleles. Loss of the DNA mismatch repair gene (hMLH1).
Comment from the depositor
RCB2984
HCT116-ARTEMIS(+/-)
CommentSubline of HCT116 cell line lacking ARTEMIS gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).
Comment from the depositor
RCB2985
HCT116-ARTEMIS(-/-)
CommentSubline of HCT116 cell line lacking ARTEMIS gene in both alleles. Loss of the DNA mismatch repair gene (hMLH1).
Comment from the depositor
RCB2986
HCT116-MDC1(+/-)
CommentSubline of HCT116 cell line lacking MDC1 gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).
Comment from the depositor
RCB2987
HCT116-MDC1(-/-)
CommentSubline of HCT116 cell line lacking MDC1 gene in both alleles. Loss of the DNA mismatch repair gene (hMLH1).
Comment from the depositor
RCB2988
HCT116-REV1(+/-)
CommentSubline of HCT116 cell line lacking REV1 gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).
Comment from the depositor
RCB2989
HCT116-REV1(-/-)
CommentSubline of HCT116 cell line lacking REV1 gene in both alleles. Loss of the DNA mismatch repair gene (hMLH1).
Comment from the depositor
RCB2990
HCT116-REV3L(+/-)
CommentSubline of HCT116 cell line lacking REV3L gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).
Comment from the depositor
RCB2991
HCT116-KU70(+/-)
CommentSubline of HCT116 cell line lacking Ku70 gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).
Comment from the depositor
RCB2992
HCT116-DNAPKcs(+/-)
CommentSubline of HCT116 cell line lacking DNAPKcs gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).
Comment from the depositor
RCB2993
HCT116-POLM(+/-)
CommentSubline of HCT116 cell line lacking DNA polymerase m gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).
Comment from the depositor
RCB2994
HCT116-LIG3(+/-)
CommentSubline of HCT116 cell line lacking Ligase 3 gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).
Comment from the depositor
RCB2995
HCT116-LIG4(+/-)
CommentSubline of HCT116 cell line lacking Ligase 4 gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).
Comment from the depositor
RCB2996
HCT116-53BP1(+/-)
CommentSubline of HCT116 cell line lacking 53BPI gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).
Comment from the depositor
RCB2997
H414
CommentSubline of HCT116 cell line which has intact DNA mismatch repair gene (hMLH1).
Comment from the depositor
RCB2998
H414-RAD18(+/-)
CommentSubline of H414 cell line lacking RAD18 gene in one allele.
Comment from the depositor
RCB2999
H414-RAD18(-/-)
CommentSubline of H414 cell line lacking RAD18 gene in both alleles.
Comment from the depositor
RCB3000
H414-MDC1(+/-)
CommentSubline of H414 cell line lacking MDC1 gene in one allele.
Comment from the depositor
RCB3001
H414-MDC1(-/-)
CommentSubline of H414 cell line lacking MDC1 gene in both alleles.
Comment from the depositor
RCB3002
H414-LIG4(+/-)
CommentSubline of H414 cell line lacking Ligase 4 gene in one allele.
Comment from the depositor
RCB3007
MOPC-70A
CommentMouse cell line derived from myeloma. This cell line was established from a cell line maintained by in vivo transplantation. TKG0167 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB3010
RPMI8226
CommentHuman cell line derived from myeloma. IgG producer. TKG0243 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB3052
Jurkat
CommentHuman T cell leukemia. IL-2 receptor (-). Progeny were cured by Treatments with BM Cycline and MC210. TKG0209 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB3515
JLS-V9 BudR
CommentMouse cell line derived from bone marrow. Fibroblast-like. BudR resistant. BALB/c strain. TKG0356 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB3516
ASMF
Comment
Comment from the depositor
RCB3517
LLKF
Comment
Comment from the depositor
RCB3529
G603L
CommentHuman cell line derived from lung large cell carcinoma cells.
Comment from the depositor
RCB3530
B901L
CommentHuman cell line derived from lung adenocarcinoma cells.
Comment from the depositor
RCB3531
A904L
CommentHuman cell line derived from lung large cell carcinoma cells.
Comment from the depositor
RCB3532
A129L
CommentHuman cell line derived from lung adenocarcinoma cells.
Comment from the depositor
RCB3533
ED-40515(+)
CommentATL patient derived leukemic cell line (IL-2 dependent).
Comment from the depositorATL patient derived leukemic cell line (IL-2 dependent). ED-40515, ED-40810, ED-41214, ED-50828, ED-70423CB cell lines were established from the same patient's blood.
RCB3534
ED-40515(-)
CommentATL patient derived leukemic cell line (IL-2 independent).
Comment from the depositorATL patient derived leukemic cell line (IL-2 independent). ED-40515, ED-40810, ED-41214, ED-50828, ED-70423CB cell lines were established from the same patient's blood.
RCB3535
ATL-48T(+)
CommentATL patient derived leukemic cell line (IL-2 dependent).
Comment from the depositorATL patient derived leukemic cell line (IL-2 dependent).
RCB3536
ATL-48Tb(-)
CommentATL patient derived leukemic cell line (IL-2 independent).
Comment from the depositorATL patient derived leukemic cell line (IL-2 independent).
RCB3537
ATL-55T(+)
CommentATL patient derived leukemic cell line (IL-2 dependent).
Comment from the depositorATL patient derived leukemic cell line (IL-2 dependent).
RCB3538
ATL-55T(-)
CommentATL patient derived leukemic cell line (IL-2 independent).
Comment from the depositorATL patient derived leukemic cell line (IL-2 independent).
RCB3539
ED-50823(+)
CommentATL patient derived non-leukemic cell line (IL-2 dependent).
Comment from the depositorATL patient derived non-leukemic cell line (IL-2 dependent). ED-40515, ED-40810, ED-41214, ED-50828, ED-70423CB cell lines were established from the same patient's blood.
RCB3540
ED-50823(-)
CommentATL patient derived non-leukemic cell line (IL-2 independent).
Comment from the depositorATL patient derived non-leukemic cell line (IL-2 independent). ED-40515, ED-40810, ED-41214, ED-50828, ED-70423CB cell lines were established from the same patient's blood.
RCB3541
ATL-72/2(+)
CommentATL patient derived non-leukemic cell line (IL-2 dependent).
Comment from the depositorATL patient derived non-leukemic cell line (IL-2 dependent). ATL-72/2, ATL-72b, ATL-72T cell lines were established from the same patient's blood.
RCB3542
ATL-72/2(-)
CommentATL patient derived non-leukemic cell line (IL-2 independent).
Comment from the depositorATL patient derived non-leukemic cell line (IL-2 independent). ATL-72/2, ATL-72b, ATL-72T cell lines were established from the same patient's blood.
RCB3543
SezM3(+)
CommentSezary syndrome like patient’s mother derived T cell line (IL-2 dependent).
Comment from the depositorSezary syndrome like patient’s mother derived T cell line (IL-2 dependent).
RCB3544
SezM3(-)
CommentSezary syndrome like patient’s mother derived T cell line (IL-2 independent).
Comment from the depositorSezary syndrome like patient’s mother derived T cell line (IL-2 independent).
RCB3545
ATL-2(+)
CommentATL patient derived non-leukemic cell line (IL-2 dependent).
Comment from the depositorATL patient derived non-leukemic cell line (IL-2 dependent).
RCB3546
ATL-2(-)
CommentATL patient derived non-leukemic cell line (IL-2 independent).
Comment from the depositorATL patient derived non-leukemic cell line (IL-2 independent).
RCB3547
Sez627(+)
CommentSezary syndrome like patient derived T cell line (IL-2 dependent).
Comment from the depositorSezary syndrome like patient derived T cell line (IL-2 dependent).
RCB3548
Sez627C(-)
CommentSezary syndrome like patient derived T cell line (IL-2 independent).
Comment from the depositorSezary syndrome like patient’s derived T cell line (IL-2 independent).
RCB3549
ATL-72b(+)
CommentATL patient derived non-leukemic cell line (IL-2 dependent).
Comment from the depositorATL patient derived non-leukemic cell line (IL-2 dependent). ATL-72/2, ATL-72b, ATL-72T cell lines were established from the same patient's blood.
RCB3550
ATL-72b(-)
CommentATL patient derived non-leukemic cell line (IL-2 independent).
Comment from the depositorATL patient derived non-leukemic cell line (IL-2 independent). ATL-72/2, ATL-72b, ATL-72T cell lines were established from the same patient's blood.
RCB3551
ATL-21C(+)
Commentnon-leukemic cell line (IL-2 dependent).
Comment from the depositornon-leukemic cell line (IL-2 dependent).
RCB3552
ATL-21C(-)/2
Commentnon-leukemic cell line (IL-2 independent).
Comment from the depositornon-leukemic cell line (IL-2 independent). Cultured for 2-years without IL-2.
RCB3553
ATL-21C(-)/8.9
Commentnon-leukemic cell line (IL-2 independent).
Comment from the depositornon-leukemic cell line (IL-2 independent). Cultured for 8.9-years without IL-2.
RCB3554
ATL-16T(-)
Commentnon-leukemic cell line (IL-2 independent).
Comment from the depositornon-leukemic cell line (IL-2 independent).
RCB3555
ATL-35T(-)
Commentnon-leukemic cell line (IL-2 independent).
Comment from the depositornon-leukemic cell line (IL-2 independent).
RCB3556
ED-40810(-)
Commentleukemic cell line (IL-2 independent).
Comment from the depositorleukemic cell line (IL-2 independent). ED-40515, ED-40810, ED-41214, ED-50828, ED-70423CB cell lines were established from the same patient's blood.
RCB3557
ED-41214(-)
Commentleukemic cell line (IL-2 independent).
Comment from the depositorleukemic cell line (IL-2 independent). ED-40515, ED-40810, ED-41214, ED-50828, ED-70423CB cell lines were established from the same patient's blood.
RCB3558
ED-70423CB(-)
Commentleukemic cell line (IL-2 independent).
Comment from the depositorleukemic cell line (IL-2 independent). ED-40515, ED-40810, ED-41214, ED-50828, ED-70423CB cell lines were established from the same patient's blood.
RCB3559
ATL-6(+)
Commentnon-leukemic cell line (IL-2 dependent).
Comment from the depositornon-leukemic cell line (IL-2 dependent).
RCB3560
ATL-7(+)
Commentnon-leukemic cell line (IL-2 dependent).
Comment from the depositornon-leukemic cell line (IL-2 dependent).
RCB3561
ATL-11-6(+)
Commentnon-leukemic cell line (IL-2 dependent).
Comment from the depositornon-leukemic cell line (IL-2 dependent).
RCB3562
ATL-12A(+)
Commentnon-leukemic cell line (IL-2 dependent).
Comment from the depositornon-leukemic cell line (IL-2 dependent).
RCB3563
ATL-17C(+)
Commentnon-leukemic cell line (IL-2 dependent).
Comment from the depositornon-leukemic cell line (IL-2 dependent). ATL-17C, ATL-17-2(+) cell lines were established from the same patient's blood.
RCB3564
ATL-17-2(+)
Commentnon-leukemic cell line (IL-2 dependent).
Comment from the depositornon-leukemic cell line (IL-2 dependent). ATL-17C, ATL-17-2(+) cell lines were established from the same patient's blood.
RCB3565
ATL-18C(+)
Commentnon-leukemic cell line (IL-2 dependent).
Comment from the depositornon-leukemic cell line (IL-2 dependent).
RCB3566
ATL-23(+)
Commentnon-leukemic cell line (IL-2 dependent).
Comment from the depositornon-leukemic cell line (IL-2 dependent).
RCB3567
ATL-26C(+)
Commentnon-leukemic cell line (IL-2 dependent).
Comment from the depositornon-leukemic cell line (IL-2 dependent).
RCB3568
ATL-42T(+)
Commentleukemic cell line (IL-2 dependent).
Comment from the depositorleukemic cell line (IL-2 dependent).
RCB3569
ATL-46T(+)
Commentnon-leukemic cell line (IL-2 dependent).
Comment from the depositornon-leukemic cell line (IL-2 dependent).
RCB3570
ATL-48T(+)
Commentleukemic cell line (IL-2 dependent).
Comment from the depositorleukemic cell line (IL-2 dependent).
RCB3571
ATL-67T(+)
Commentnon-leukemic cell line (IL-2 dependent).
Comment from the depositornon-leukemic cell line (IL-2 dependent).
RCB3572
ATL-72T(+)
Commentnon-leukemic cell line (IL-2 dependent).
Comment from the depositornon-leukemic cell line (IL-2 dependent). ATL-72/2, ATL-72b, ATL-72T cell lines were established from the same patient's blood.
RCB3573
CATL-2(+)
Commentnon-leukemic cell line derived from healthy carrier (IL-2 dependent).
Comment from the depositornon-leukemic cell line derived from healthy carrier (IL-2 dependent).
RCB3574
CATL-3(+)
Commentnon-leukemic cell line derived from healthy carrier (IL-2 dependent).
Comment from the depositornon-leukemic cell line derived from healthy carrier (IL-2 dependent).
RCB3576
Aska-SS
CommentHuman cell line derived from synovial sarcoma.
Comment from the depositor
RCB3577
Yamato-SS
CommentHuman cell line derived from synovial sarcoma.
Comment from the depositor
RCB3579
ASF-4-2
CommentRCB3579〜RCB3585 were derived from the same person.
Comment from the depositor
RCB3580
ASF-4-3L
CommentRCB3579〜RCB3585 were derived from the same person.
Comment from the depositor
RCB3582
ASF-4-4L1
CommentRCB3579〜RCB3585 were derived from the same person.
Comment from the depositor
RCB3583
ASF-4-4L2
CommentRCB3579〜RCB3585 were derived from the same person.
Comment from the depositor
RCB3585
ASF-4-4R2
CommentRCB3579〜RCB3585 were derived from the same person.
Comment from the depositor
RCB3586
hPSC-1
CommentHuman cell line derived from choronic pancreatitis. Pancreatic stellate cells.
Comment from the depositor
RCB3588
hPSC-5
CommentHuman cell line derived from pacreatic cancer. Pancreatic stellate cells.
Comment from the depositor
RCB3589
hPSC-14
CommentHuman cell line derived from pacreatic cancer. Pancreatic stellate cells.
Comment from the depositor
RCB3600
SDR-P-1D5
CommentRat prolactin secreting cell line derived from anterior pituitary lacking growth hormone.
Comment from the depositor
RCB3601
SDRL-1
CommentRat cell line derived from liver lacking growth hormone.
Comment from the depositor
RCB3602
SDRL-2
CommentRat cell line derived from liver lacking growth hormone.
Comment from the depositor
RCB3673
Raji
CommentHuman cell line derived from Burkitt lymphoma. EBNA (EBV—nuclear antigen) positive. TKG0371 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB3675
SCC-TC
CommentRectal carcinoma. Culture cell line of SCC (TKG 0340) . TKG0646 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB3676
5637
CommentHuman cell line derived from bladder carcinoma. TKG0605 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB3677
A549
CommentHuman cell line derived from lung cancer. Epithelial-like cells. HLA-A 2603/3001. A culture submitted to the Cell Resource Center for Biomedical Research was found to be contaminated with mycoplasma. Progeny were cured by Treatments with BM Cycline and MC210. TKG0184 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB3678
BeWo
CommentHuman cell line derived from choriocarcinoma. TKG0567 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB3680
HeLa
CommentHuman cell line derived from cervical cancer. A culture submitted to the Cell Resource Center for Biomedical Research was found to be contaminated with mycoplasma. Progeny were cured by Treatments with BM Cycline and MC210. TKG0331 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB3681
HeLa.P3(S)
CommentSubline of HeLa cell line. Serum-free culture is possible. TKG0465 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB3682
HeLa S3
CommentHuman cell line derived from cervical cancer. TKG0444 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB3683
HL-60
CommentHuman cell line derived from promyelocytic leukemia cells. TKG0345 (Deposited from Tohoku Univ.).Application consideration
Comment from the depositor
RCB3685
HMV-II
CommentHuman cell line derived from melanotic melanoma (highly melanotic). TKG0318 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB3686
THP-1
CommentHuman cell line derived from monocytic leukemia. TKG0267 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB3687
MKN-7
CommentHuman cell line derived from stomach cancer (gastric cancer; highly differentiated tubular adenocarcinoma). TKG0228 (Deposited from Tohoku Univ.).
Comment from the depositor
RCB3706
Atg7 +/+ MEFs
CommentMouse embryonic fibroblasts derived from wild type mouse (C57BL/6).
Comment from the depositor
RCB3707
Atg7 -/- MEFs
CommentMouse embryonic fibroblasts derived from Atg-deficient mouse (C57BL/6).
Comment from the depositor
RCB3708
Atg3 +/+ MEFs
CommentMouse embryonic fibroblast cell line derived from wild type C57BL/6 strain.
Comment from the depositor
RCB3709
Atg3 -/- MEFs
CommentMouse embryonic fibroblast cell line derived from Atg3-deficient C57BL/6 strain.
Comment from the depositor
RCB3710
CRP2(A1311A)
CommentCurrently not ready. Hybridoma against CRP2 (full length) antigen.
Comment from the depositor
RCB3711
CDX2(A3701A)
CommentCurrently not ready. Hybridoma against CDX2 (full length) antigen.
Comment from the depositor
RCB3712
CDX2(A3707A)
CommentCurrently not ready. Hybridoma against CDX2 (full length) antigen.
Comment from the depositor
RCB3713
CDX2(A3715A)
CommentCurrently not ready. Hybridoma against CDX2 (full length) antigen.
Comment from the depositor
RCB3714
CDX2(A3719A)
CommentCurrently not ready. Hybridoma against CDX2 (full length) antigen.
Comment from the depositor
RCB3715
CDX2(A3722A)
CommentCurrently not ready. Hybridoma against CDX2 (full length) antigen.
Comment from the depositor
RCB3716
NNMT(A2402A)
CommentCurrently not ready. Hybridoma against NNMT (full length) antigen.
Comment from the depositor
RCB3717
NNMT(A2418A)
CommentCurrently not ready. Hybridoma against NNMT (full length) antigen.
Comment from the depositor
RCB3718
NNMT(A2433A)
CommentCurrently not ready. Hybridoma against NNMT (full length) antigen.
Comment from the depositor
RCB3719
NNMT(A2434A)
CommentCurrently not ready. Hybridoma against NNMT (full length) antigen.
Comment from the depositor
RCB3720
NNMT(A2438A)
CommentCurrently not ready. Hybridoma against NNMT (full length) antigen.
Comment from the depositor
RCB3721
NNMT(A2440A)
CommentCurrently not ready. Hybridoma against NNMT (full length) antigen.
Comment from the depositor
RCB3722
Olig1(A5501A)
CommentCurrently not ready. Hybridoma against Olig1 (full length) antigen.
Comment from the depositor
RCB3723
Olig1(A5507A)
CommentCurrently not ready. Hybridoma against Olig1 (full length) antigen.
Comment from the depositor
RCB3724
Olig1(A5508A)
CommentCurrently not ready. Hybridoma against Olig1 (full length) antigen.
Comment from the depositor
RCB3725
Olig1(A5515A)
CommentCurrently not ready. Hybridoma against Olig1 (full length) antigen.
Comment from the depositor
RCB3726
Olig1(A5518A)
CommentCurrently not ready. Hybridoma against Olig1 (full length) antigen.
Comment from the depositor
RCB3727
Olig2(A5618A)
CommentCurrently not ready. Hybridoma against Olig2 (full length) antigen.
Comment from the depositor
RCB3728
Olig2(A5628A)
CommentCurrently not ready. Hybridoma against Olig2 (full length) antigen.
Comment from the depositor
RCB3729
Olig2(A5629A)
CommentCurrently not ready. Hybridoma against Olig2 (full length) antigen.
Comment from the depositor
RCB3730
Olig2(A5643A)
CommentCurrently not ready. Hybridoma against Olig2 (full length) antigen.
Comment from the depositor
RCB3731
SFRP4(A7113A)
CommentCurrently not ready. Hybridoma against SFRP4 (full length) antigen.
Comment from the depositor
RCB3732
SFRP4(A7116-2A)
CommentCurrently not ready. Hybridoma against SFRP4 (full length) antigen.
Comment from the depositor
RCB3733
SFRP4(A7118A)
CommentCurrently not ready. Hybridoma against SFRP4 (full length) antigen.
Comment from the depositor
RCB3734
SFRP4(A7123A)
CommentCurrently not ready. Hybridoma against SFRP4 (full length) antigen.
Comment from the depositor
RCB3735
SFRP4(A7127-74A)
CommentCurrently not ready. Hybridoma against SFRP4 (full length) antigen.
Comment from the depositor
RCB3736
EPST11(H9209)
CommentCurrently not ready. Hybridoma against EPST11 (full length) antigen.
Comment from the depositor
RCB3737
EPST11(H9214)
CommentCurrently not ready. Hybridoma against EPST11 (full length) antigen.
Comment from the depositor
RCB3738
EPST11(H9219)
CommentCurrently not ready. Hybridoma against EPST11 (full length) antigen.
Comment from the depositor
RCB3739
EPST11(H9220)
CommentCurrently not ready. Hybridoma against EPST11 (full length) antigen.
Comment from the depositor
RCB3740
EPST11(H9228)
CommentCurrently not ready. Hybridoma against EPST11 (full length) antigen.
Comment from the depositor
RCB3741
C20-ORF102(H9613)
CommentCurrently not ready. Hybridoma against C20-0RF102 (full length) antigen.
Comment from the depositor
RCB3742
C20-ORF102(H9615)
CommentCurrently not ready. Hybridoma against C20-0RF102 (full length) antigen.
Comment from the depositor
RCB3743
C20-ORF102(H9616)
CommentCurrently not ready. Hybridoma against C20-0RF102 (full length) antigen.
Comment from the depositor
RCB3744
C20-ORF102(H9625)
CommentCurrently not ready. Hybridoma against C20-0RF102 (full length) antigen.
Comment from the depositor
RCB3745
C20-ORF102(H9627)
CommentCurrently not ready. Hybridoma against C20-0RF102 (full length) antigen.
Comment from the depositor
RCB3746
C20-ORF102(H9638)
CommentCurrently not ready. Hybridoma against C20-0RF102 (full length) antigen.
Comment from the depositor
RCB3747
C20-ORF102(H9645)
CommentCurrently not ready. Hybridoma against C20-0RF102 (full length) antigen.
Comment from the depositor
RCB3748
SP-5AD5(N2901)
CommentCurrently not ready. Hybridoma against SP-5AD5 (full length) antigen.
Comment from the depositor
RCB3749
SP-5AD5(N2906)
CommentCurrently not ready. Hybridoma against SP-5AD5 (full length) antigen.
Comment from the depositor
RCB3750
SP-5AD5(N2922)
CommentCurrently not ready. Hybridoma against SP-5AD5 (full length) antigen.
Comment from the depositor
RCB3751
SP-5AD5(N2927)
CommentCurrently not ready. Hybridoma against SP-5AD5 (full length) antigen.
Comment from the depositor
RCB3752
SP-5AD5(N2931)
CommentCurrently not ready. Hybridoma against SP-5AD5 (full length) antigen.
Comment from the depositor
RCB3753
SP-5AD5(N2933)
CommentCurrently not ready. Hybridoma against SP-5AD5 (full length) antigen.
Comment from the depositor
RCB3754
SP-5AD5(N2935)
CommentCurrently not ready. Hybridoma against SP-5AD5 (full length) antigen.
Comment from the depositor
RCB3755
SP-5AD5(N2942)
CommentCurrently not ready. Hybridoma against SP-5AD5 (full length) antigen.
Comment from the depositor
RCB3756
PTCH1-2(N7333)
CommentCurrently not ready. Hybridoma against PTCH1-2 : Patched 1 (268-319(52aa)) antigen.
Comment from the depositor
RCB3757
PTCH1-2(N7346)
CommentCurrently not ready. Hybridoma against PTCH1-2 : Patched 1 (268-319(52aa)) antigen.
Comment from the depositor
RCB3758
PTCH1-2(N7357)
CommentCurrently not ready. Hybridoma against PTCH1-2 : Patched 1 (268-319(52aa)) antigen.
Comment from the depositor
RCB3759
PLCη2C(N8320)
CommentCurrently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
Comment from the depositor
RCB3760
PLCη2C(N8328)
CommentCurrently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
Comment from the depositor
RCB3761
PLCη2C(N8339)
CommentCurrently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
Comment from the depositor
RCB3762
PLCη2C(N8346)
CommentCurrently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
Comment from the depositor
RCB3763
PLCη2C(N8351)
CommentCurrently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
Comment from the depositor
RCB3764
PLCη2C(N8353)
CommentCurrently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
Comment from the depositor
RCB3765
PLCη2C(N8357)
CommentCurrently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
Comment from the depositor
RCB3766
PLCη2C(N8360)
CommentCurrently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
Comment from the depositor
RCB3767
PLCη2C(N8361)
CommentCurrently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
Comment from the depositor
RCB3768
Prdm14-2(N8028)
CommentCurrently not ready. Hybridoma against Prdm14-2 : PR domain containing 14 (181-280(100aa)) antigen.
Comment from the depositor
RCB3769
Prdm14-2(N8048)
CommentCurrently not ready. Hybridoma against Prdm14-2 : PR domain containing 14 (181-280(100aa)) antigen.
Comment from the depositor
RCB3770
Prdm14-2(N8070)
CommentCurrently not ready. Hybridoma against Prdm14-2 : PR domain containing 14 (181-280(100aa)) antigen.
Comment from the depositor
RCB3771
Prdm1-2(N6902)
CommentCurrently not ready. Hybridoma against Prdm1-2+AP75: PR domain containing1 (757-856(100aa)) antigen.
Comment from the depositor
RCB3772
Prdm1-2(N6915)
CommentCurrently not ready. Hybridoma against Prdm1-2+AP75: PR domain containing1 (757-856(100aa)) antigen.
Comment from the depositor
RCB3773
Prdm1-2(N6916)
CommentCurrently not ready. Hybridoma against Prdm1-2+AP75: PR domain containing1 (757-856(100aa)) antigen.
Comment from the depositor
RCB3774
Prdm1-2(N6917)
CommentCurrently not ready. Hybridoma against Prdm1-2+AP75: PR domain containing1 (757-856(100aa)) antigen.
Comment from the depositor
RCB3775
Prdm1-2(N6927)
CommentCurrently not ready. Hybridoma against Prdm1-2+AP75: PR domain containing1 (757-856(100aa)) antigen.
Comment from the depositor
RCB3776
HZF2(Y3701)
CommentCurrently not ready. Hybridoma against HZF2 : Hematopoietic zinc finger (1-50(50aa)) antigen.
Comment from the depositor
RCB3777
HZF2(Y3713)
CommentCurrently not ready. Hybridoma against HZF2 : Hematopoietic zinc finger (1-50(50aa)) antigen.
Comment from the depositor
RCB3778
HZF2(Y3716)
CommentCurrently not ready. Hybridoma against HZF2 : Hematopoietic zinc finger (1-50(50aa)) antigen.
Comment from the depositor
RCB3779
HZF3(Y3901)
CommentCurrently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
Comment from the depositor
RCB3780
HZF3(Y3916)
CommentCurrently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
Comment from the depositor
RCB3781
HZF3(Y3919)
CommentCurrently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
Comment from the depositor
RCB3782
HZF3(Y3921)
CommentCurrently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
Comment from the depositor
RCB3783
HZF3(Y3923)
CommentCurrently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
Comment from the depositor
RCB3784
HZF3(Y3924)
CommentCurrently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
Comment from the depositor
RCB3785
HZF3(Y3928)
CommentCurrently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
Comment from the depositor
RCB3786
HZF3(Y3932)
CommentCurrently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
Comment from the depositor
RCB3787
HZF3(Y3942)
CommentCurrently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
Comment from the depositor
RCB3788
HZF4(Y4006)
CommentCurrently not ready. Hybridoma against HZF4 : Hematopoietic zinc finger (294-365(72aa)+1amino acid [Ser]) antigen.
Comment from the depositor
RCB3789
HZF4(Y4019)
CommentCurrently not ready. Hybridoma against HZF4 : Hematopoietic zinc finger (294-365(72aa)+1amino acid [Ser]) antigen.
Comment from the depositor
RCB3790
tead2(Y3312)
CommentCurrently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
Comment from the depositor
RCB3791
tead2(Y3321)
CommentCurrently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
Comment from the depositor
RCB3792
tead2(Y3324)
CommentCurrently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
Comment from the depositor
RCB3793
tead2(Y3325)
CommentCurrently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
Comment from the depositor
RCB3794
tead2(Y3329)
CommentCurrently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
Comment from the depositor
RCB3795
tead2(Y3331)
CommentCurrently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
Comment from the depositor
RCB3796
tead2(Y3336)
CommentCurrently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
Comment from the depositor
RCB3797
tead2(Y3339)
CommentCurrently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
Comment from the depositor
RCB3798
tead2(Y3342)
CommentCurrently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
Comment from the depositor
RCB3799
tead2(Y3343)
CommentCurrently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
Comment from the depositor
RCB3800
SOCS1-1(Y9208)
CommentCurrently not ready. Hybridoma against SOCS1-1 : Suppressor of Cytokine Signaling1 (1-60(60aa)) antigen.
Comment from the depositor
RCB3801
SOCS1-1(Y9213)
CommentCurrently not ready. Hybridoma against SOCS1-1 : Suppressor of Cytokine Signaling1 (1-60(60aa)) antigen.
Comment from the depositor
RCB3802
SOCS1-1(Y9215)
CommentCurrently not ready. Hybridoma against SOCS1-1 : Suppressor of Cytokine Signaling1 (1-60(60aa)) antigen.
Comment from the depositor
RCB3803
Prdm14-1(N8902)
CommentCurrently not ready. Hybridoma against Prdm14-1 : PR domain containing14 (1-100(100aa)) antigen.
Comment from the depositor
RCB3804
CDK-11(Z0410)
CommentCurrently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
Comment from the depositor
RCB3805
CDK-11(Z0418)
CommentCurrently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
Comment from the depositor
RCB3806
CDK-11(Z0425)
CommentCurrently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
Comment from the depositor
RCB3807
CDK-11(Z0430)
CommentCurrently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
Comment from the depositor
RCB3808
CDK-11(Z0432)
CommentCurrently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
Comment from the depositor
RCB3809
CDK-11(Z0441)
CommentCurrently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
Comment from the depositor
RCB3810
Neurotonin3(Z0835)
CommentCurrently not ready. Hybridoma against Neurotonin3 : Neurotonin (409-507(99aa)) antigen.
Comment from the depositor
RCB3811
Neurotonin4(Z0901-265)
CommentCurrently not ready. Hybridoma against Neurotonin4 : Neurotonin (1-77(77aa)) antigen.
Comment from the depositor
RCB3812
Neurotonin4(Z0937)
CommentCurrently not ready. Hybridoma against Neurotonin4 : Neurotonin (1-77(77aa)) antigen.
Comment from the depositor
RCB3813
Neurotonin4(Z0953)
CommentCurrently not ready. Hybridoma against Neurotonin4 : Neurotonin (1-77(77aa)) antigen.
Comment from the depositor
RCB3814
Neurotonin4(Z0956(222))
CommentCurrently not ready. Hybridoma against Neurotonin4 : Neurotonin (1-77(77aa)) antigen.
Comment from the depositor
RCB3815
AKAP15(Y0319)
CommentCurrently not ready. Hybridoma against AKAP15 : A kinase anchor protein15 (23-75(53aa)) antigen.
Comment from the depositor
RCB3816
AKAP15(Y0329)
CommentCurrently not ready. Hybridoma against AKAP15 : A kinase anchor protein15 (23-75(53aa)) antigen.
Comment from the depositor
RCB3817
AKAP15(Y0332)
CommentCurrently not ready. Hybridoma against AKAP15 : A kinase anchor protein15 (23-75(53aa)) antigen.
Comment from the depositor
RCB3818
AKAP15(Y0335)
CommentCurrently not ready. Hybridoma against AKAP15 : A kinase anchor protein15 (23-75(53aa)) antigen.
Comment from the depositor
RCB3819
AKAP15(Y0348)
CommentCurrently not ready. Hybridoma against AKAP15 : A kinase anchor protein15 (23-75(53aa)) antigen.
Comment from the depositor
RCB3820
mGli2-2(N9106)
CommentCurrently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
Comment from the depositor
RCB3821
mGli2-2(N9109)
CommentCurrently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
Comment from the depositor
RCB3822
mGli2-2(N9110)
CommentCurrently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
Comment from the depositor
RCB3823
mGli2-2(N9113)
CommentCurrently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
Comment from the depositor
RCB3824
mGli2-2(N9119)
CommentCurrently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
Comment from the depositor
RCB3825
mGli2-2(N9122)
CommentCurrently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
Comment from the depositor
RCB3826
mGli2-2(N9124)
CommentCurrently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
Comment from the depositor
RCB3827
mGli2-2(N9133)
CommentCurrently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
Comment from the depositor
RCB3828
mGli2-2(N9143)
CommentCurrently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
Comment from the depositor
RCB3829
mGli2-2(N9144)
CommentCurrently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
Comment from the depositor
RCB3830
mGli2-2(N9145)
CommentCurrently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
Comment from the depositor
RCB3831
SMO-2(B7115B)
CommentCurrently not ready. Hybridoma against SMO-2 : SMO (470-519 (50aa)) antigen.
Comment from the depositor
RCB3832
Wnt4(N0716)
CommentCurrently not ready. Hybridoma against Wnt4 : Wnt4 (37-77 (41aa)) antigen.
Comment from the depositor
RCB3833
Gli1(N5510)
CommentCurrently not ready. Hybridoma against Gli1 : GLI family zinc finger 1 (2-68 (67aa)) antigen.
Comment from the depositor
RCB3834
Gli1(N5516-191)
CommentCurrently not ready. Hybridoma against Gli1 : GLI family zinc finger 1 (2-68 (67aa)) antigen.
Comment from the depositor
RCB3835
Gli1(N5537)
CommentCurrently not ready. Hybridoma against Gli1 : GLI family zinc finger 1 (2-68 (67aa)) antigen.
Comment from the depositor
RCB3836
SMO-1(N5813)
CommentCurrently not ready. Hybridoma against SMO-1 : SMO (90-172 (83aa)) antigen.
Comment from the depositor
RCB3837
Gli3(N6202)
CommentCurrently not ready. Hybridoma against gp64 fusion Gli3 : GLI family zinc finger 3 (2-60 (59aa)) antigen expressed by baculovirus.
Comment from the depositor
RCB3838
Calp7-1(Y0717)
CommentCurrently not ready. Hybridoma against Calp7-1 : Calpain7 (78-157(80aa)) antigen.
Comment from the depositor
RCB3839
Calp7-1(Y0737)
CommentCurrently not ready. Hybridoma against Calp7-1 : Calpain7 (78-157(80aa)) antigen.
Comment from the depositor
RCB3840
PEG10-1(H1805)
CommentCurrently not ready. Hybridoma against PEG10-1 (full length) antigen.
Comment from the depositor
RCB3841
PEG10-1(H1807)
CommentCurrently not ready. Hybridoma against PEG10-1 (full length) antigen.
Comment from the depositor
RCB3842
PEG10-1(H1812)
CommentCurrently not ready. Hybridoma against PEG10-1 (full length) antigen.
Comment from the depositor
RCB3843
PEG10-1(H1827)
CommentCurrently not ready. Hybridoma against PEG10-1 (full length) antigen.
Comment from the depositor
RCB3844
PEG10-1(H1829)
CommentCurrently not ready. Hybridoma against PEG10-1 (full length) antigen.
Comment from the depositor
RCB3845
PEG10-1(H1831)
CommentCurrently not ready. Hybridoma against PEG10-1 (full length) antigen.
Comment from the depositor
RCB3846
TFF1deltaN(H6110)
CommentCurrently not ready. Hybridoma against TFF1 deltaN : TFF1 (full length) antigen.
Comment from the depositor
RCB3847
TFF1deltaN(H6111)
CommentCurrently not ready. Hybridoma against TFF1 deltaN : TFF1 (full length) antigen.
Comment from the depositor
RCB3848
TFF1deltaN(H6112)
CommentCurrently not ready. Hybridoma against TFF1 deltaN : TFF1 (full length) antigen.
Comment from the depositor
RCB3849
TFF1deltaN(H6123)
CommentCurrently not ready. Hybridoma against TFF1 deltaN : TFF1 (full length) antigen.
Comment from the depositor
RCB3850
TFF1deltaN(H6134)
CommentCurrently not ready. Hybridoma against TFF1 deltaN : TFF1 (full length) antigen.
Comment from the depositor
RCB3851
STIP1(H3401)
CommentCurrently not ready. Hybridoma against STIP1 (full length) antigen.
Comment from the depositor
RCB3852
STIP1(H3408)
CommentCurrently not ready. Hybridoma against STIP1 (full length) antigen.
Comment from the depositor
RCB3853
STIP1(H3420)
CommentCurrently not ready. Hybridoma against STIP1 (full length) antigen.
Comment from the depositor
RCB3854
STIP1(H3425)
CommentCurrently not ready. Hybridoma against STIP1 (full length) antigen.
Comment from the depositor
RCB3855
STIP1(H3430)
CommentCurrently not ready. Hybridoma against STIP1 (full length) antigen.
Comment from the depositor
RCB3856
STIP1(H3444)
CommentCurrently not ready. Hybridoma against STIP1 (full length) antigen.
Comment from the depositor
RCB3857
STIP1(H3445)
CommentCurrently not ready. Hybridoma against STIP1 (full length) antigen.
Comment from the depositor
RCB3858
STIP1(H3454)
CommentCurrently not ready. Hybridoma against STIP1 (full length) antigen.
Comment from the depositor
RCB3859
STIP1(H3455)
CommentCurrently not ready. Hybridoma against STIP1 (full length) antigen.
Comment from the depositor
RCB3860
STIP1(H3456)
CommentCurrently not ready. Hybridoma against STIP1 (full length) antigen.
Comment from the depositor
RCB3861
STIP1(H1726)
CommentCurrently not ready. Hybridoma against STIP1 (full length) antigen.
Comment from the depositor
RCB3862
STIP1(H1731)
CommentCurrently not ready. Hybridoma against STIP1 (full length) antigen.
Comment from the depositor
RCB3863
Rab32(H3502)
CommentCurrently not ready. Hybridoma against Rab32 (full length) antigen.
Comment from the depositor
RCB3864
Rab32(H3506)
CommentCurrently not ready. Hybridoma against Rab32 (full length) antigen.
Comment from the depositor
RCB3865
Rab32(H3512)
CommentCurrently not ready. Hybridoma against Rab32 (full length) antigen.
Comment from the depositor
RCB3866
Rab32(H3513)
CommentCurrently not ready. Hybridoma against Rab32 (full length) antigen.
Comment from the depositor
RCB3867
Rab32(H3516)
CommentCurrently not ready. Hybridoma against Rab32 (full length) antigen.
Comment from the depositor
RCB3868
Rab32(H3519)
CommentCurrently not ready. Hybridoma against Rab32 (full length) antigen.
Comment from the depositor
RCB3869
Rab32(H3521)
CommentCurrently not ready. Hybridoma against Rab32 (full length) antigen.
Comment from the depositor
RCB3870
GBR7(H4720)
CommentCurrently not ready. Hybridoma against GBR7 (full length) antigen.
Comment from the depositor
RCB3871
GBR7(H4722)
CommentCurrently not ready. Hybridoma against GBR7 (full length) antigen.
Comment from the depositor
RCB3872
GBR7(H4733)
CommentCurrently not ready. Hybridoma against GBR7 (full length) antigen.
Comment from the depositor
RCB3873
GBR7(H4739)
CommentCurrently not ready. Hybridoma against GBR7 (full length) antigen.
Comment from the depositor
RCB3874
GBR7(H4747)
CommentCurrently not ready. Hybridoma against GBR7 (full length) antigen.
Comment from the depositor
RCB3875
GBR7(H4749)
CommentCurrently not ready. Hybridoma against GBR7 (full length) antigen.
Comment from the depositor
RCB3876
GBR7(H4750)
CommentCurrently not ready. Hybridoma against GBR7 (full length) antigen.
Comment from the depositor
RCB3877
GBR7(H4751)
CommentCurrently not ready. Hybridoma against GBR7 (full length) antigen.
Comment from the depositor
RCB3878
GBR7(H4752)
CommentCurrently not ready. Hybridoma against GBR7 (full length) antigen.
Comment from the depositor
RCB3879
GBR7(H4755)
CommentCurrently not ready. Hybridoma against GBR7 (full length) antigen.
Comment from the depositor
RCB3880
FLJ20442(H5409)
CommentCurrently not ready. Hybridoma against FLJ20442 (full length) antigen.
Comment from the depositor
RCB3881
FLJ20442(H5413)
CommentCurrently not ready. Hybridoma against FLJ20442 (full length) antigen.
Comment from the depositor
RCB3882
FLJ20442(H5422)
CommentCurrently not ready. Hybridoma against FLJ20442 (full length) antigen.
Comment from the depositor
RCB3883
FLJ20442(H5425)
CommentCurrently not ready. Hybridoma against FLJ20442 (full length) antigen.
Comment from the depositor
RCB3884
FLJ20442(H5429)
CommentCurrently not ready. Hybridoma against FLJ20442 (full length) antigen.
Comment from the depositor
RCB3885
FLJ20442(H5432)
CommentCurrently not ready. Hybridoma against FLJ20442 (full length) antigen.
Comment from the depositor
RCB3886
FLJ20442(H5433)
CommentCurrently not ready. Hybridoma against FLJ20442 (full length) antigen.
Comment from the depositor
RCB3887
Galectin4(H6004)
CommentCurrently not ready. Hybridoma against Galectin4 (full length) antigen.
Comment from the depositor
RCB3888
Galectin4(H6005)
CommentCurrently not ready. Hybridoma against Galectin4 (full length) antigen.
Comment from the depositor
RCB3889
Galectin4(H6006)
CommentCurrently not ready. Hybridoma against Galectin4 (full length) antigen.
Comment from the depositor
RCB3890
Galectin4(H6007)
CommentCurrently not ready. Hybridoma against Galectin4 (full length) antigen.
Comment from the depositor
RCB3891
Galectin4(H6009)
CommentCurrently not ready. Hybridoma against Galectin4 (full length) antigen.
Comment from the depositor
RCB3892
Galectin4(H6013)
CommentCurrently not ready. Hybridoma against Galectin4 (full length) antigen.
Comment from the depositor
RCB3893
Galectin4(H6015)
CommentCurrently not ready. Hybridoma against Galectin4 (full length) antigen.
Comment from the depositor
RCB3894
Galectin4(H6024)
CommentCurrently not ready. Hybridoma against Galectin4 (full length) antigen.
Comment from the depositor
RCB3895
Galectin4(H6026)
CommentCurrently not ready. Hybridoma against Galectin4 (full length) antigen.
Comment from the depositor
RCB3896
Galectin4(H6034)
CommentCurrently not ready. Hybridoma against Galectin4 (full length) antigen.
Comment from the depositor
RCB3897
Galectin4(H6038)
CommentCurrently not ready. Hybridoma against Galectin4 (full length) antigen.
Comment from the depositor
RCB3898
Galectin4(H6043)
CommentCurrently not ready. Hybridoma against Galectin4 (full length) antigen.
Comment from the depositor
RCB3899
PAEP(H7001)
CommentCurrently not ready. Hybridoma against PAEP (full length) antigen.
Comment from the depositor
RCB3900
PAEP(H7005)
CommentCurrently not ready. Hybridoma against PAEP (full length) antigen.
Comment from the depositor
RCB3901
PAEP(H7006)
CommentCurrently not ready. Hybridoma against PAEP (full length) antigen.
Comment from the depositor
RCB3902
PAEP(H7011)
CommentCurrently not ready. Hybridoma against PAEP (full length) antigen.
Comment from the depositor
RCB3903
PAEP(H7015A)
CommentCurrently not ready. Hybridoma against PAEP (full length) antigen.
Comment from the depositor
RCB3904
PAEP(H7020A)
CommentCurrently not ready. Hybridoma against PAEP (full length) antigen.
Comment from the depositor
RCB3905
PAEP(H7026)
CommentCurrently not ready. Hybridoma against PAEP (full length) antigen.
Comment from the depositor
RCB3906
PAEP(H7033)
CommentCurrently not ready. Hybridoma against PAEP (full length) antigen.
Comment from the depositor
RCB3907
PGC-1(H5953)
CommentCurrently not ready. Hybridoma against PGC-1 (2-81(80aa)) antigen.
Comment from the depositor
RCB3908
STK15(H5701)
CommentCurrently not ready. Hybridoma against STK15 (full length) antigen.
Comment from the depositor
RCB3909
STK15(H5706)
CommentCurrently not ready. Hybridoma against STK15 (full length) antigen.
Comment from the depositor
RCB3910
STK15(H5716)
CommentCurrently not ready. Hybridoma against STK15 (full length) antigen.
Comment from the depositor
RCB3911
STK15(H5723)
CommentCurrently not ready. Hybridoma against STK15 (full length) antigen.
Comment from the depositor
RCB3912
STK15(H5725)
CommentCurrently not ready. Hybridoma against STK15 (full length) antigen.
Comment from the depositor
RCB3913
STK15(H5728)
CommentCurrently not ready. Hybridoma against STK15 (full length) antigen.
Comment from the depositor
RCB3914
STK15(H5737)
CommentCurrently not ready. Hybridoma against STK15 (full length) antigen.
Comment from the depositor
RCB3915
STK15(H5743)
CommentCurrently not ready. Hybridoma against STK15 (full length) antigen.
Comment from the depositor
RCB3916
STK15(H5754)
CommentCurrently not ready. Hybridoma against STK15 (full length) antigen.
Comment from the depositor
RCB3917
STK15(H5755)
CommentCurrently not ready. Hybridoma against STK15 (full length) antigen.
Comment from the depositor
RCB3918
TOP1MT(H8602)
CommentCurrently not ready. Hybridoma against TOP1MT (full length) antigen.
Comment from the depositor
RCB3919
TOP1MT(H8607)
CommentCurrently not ready. Hybridoma against TOP1MT (full length) antigen.
Comment from the depositor
RCB3920
TOP1MT(H8619)
CommentCurrently not ready. Hybridoma against TOP1MT (full length) antigen.
Comment from the depositor
RCB3921
TOP1MT(H8624)
CommentCurrently not ready. Hybridoma against TOP1MT (full length) antigen.
Comment from the depositor
RCB3922
TOP1MT(H8629)
CommentCurrently not ready. Hybridoma against TOP1MT (full length) antigen.
Comment from the depositor
RCB3923
TOP1MT(H8637)
CommentCurrently not ready. Hybridoma against TOP1MT (full length) antigen.
Comment from the depositor
RCB3924
TOP1MT(H8638)
CommentCurrently not ready. Hybridoma against TOP1MT (full length) antigen.
Comment from the depositor
RCB3925
TOP1MT(H8644)
CommentCurrently not ready. Hybridoma against TOP1MT (full length) antigen.
Comment from the depositor
RCB3926
TOP1MT(H8650)
CommentCurrently not ready. Hybridoma against TOP1MT (full length) antigen.
Comment from the depositor
RCB3927
TOP1MT(H8655)
CommentCurrently not ready. Hybridoma against TOP1MT (full length) antigen.
Comment from the depositor
RCB3928
DUSP9(H8901)
CommentCurrently not ready. Hybridoma against DUSP9 (full length) antigen.
Comment from the depositor
RCB3929
DUSP9(H8902)
CommentCurrently not ready. Hybridoma against DUSP9 (full length) antigen.
Comment from the depositor
RCB3930
DUSP9(H8905)
CommentCurrently not ready. Hybridoma against DUSP9 (full length) antigen.
Comment from the depositor
RCB3931
DUSP9(H8913)
CommentCurrently not ready. Hybridoma against DUSP9 (full length) antigen.
Comment from the depositor
RCB3932
DUSP9(H8914)
CommentCurrently not ready. Hybridoma against DUSP9 (full length) antigen.
Comment from the depositor
RCB3933
DUSP9(H8915)
CommentCurrently not ready. Hybridoma against DUSP9 (full length) antigen.
Comment from the depositor
RCB3934
DUSP9(H8921)
CommentCurrently not ready. Hybridoma against DUSP9 (full length) antigen.
Comment from the depositor
RCB3935
DUSP9(H8922)
CommentCurrently not ready. Hybridoma against DUSP9 (full length) antigen.
Comment from the depositor
RCB3936
DUSP9(H8925)
CommentCurrently not ready. Hybridoma against DUSP9 (full length) antigen.
Comment from the depositor
RCB3937
DUSP9(H8942)
CommentCurrently not ready. Hybridoma against DUSP9 (full length) antigen.
Comment from the depositor
RCB3938
TIF2(H8403)
CommentCurrently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
Comment from the depositor
RCB3939
TIF2(H8407)
CommentCurrently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
Comment from the depositor
RCB3940
TIF2(H8411)
CommentCurrently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
Comment from the depositor
RCB3941
TIF2(H8414)
CommentCurrently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
Comment from the depositor
RCB3942
TIF2(H8424)
CommentCurrently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
Comment from the depositor
RCB3943
TIF2(H8427)
CommentCurrently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
Comment from the depositor
RCB3944
SKIP(H8514)
CommentCurrently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
Comment from the depositor
RCB3945
SKIP(H8515)
CommentCurrently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
Comment from the depositor
RCB3946
SKIP(H8529)
CommentCurrently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
Comment from the depositor
RCB3947
SKIP(H8530)
CommentCurrently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
Comment from the depositor
RCB3948
SKIP(H8524)
CommentCurrently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
Comment from the depositor
RCB3949
SKIP(H8531)
CommentCurrently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
Comment from the depositor
RCB3950
TRIP13(H9319)
CommentCurrently not ready. Hybridoma against TRIP13 (2-99 (98aa)) antigen.
Comment from the depositor
RCB3951
TRIP13(H9341)
CommentCurrently not ready. Hybridoma against TRIP13 (2-99 (98aa)) antigen.
Comment from the depositor
RCB3952
RCN2(H9757)
CommentCurrently not ready. Hybridoma against RCN2 (2-99 (98aa)) antigen.
Comment from the depositor
RCB3953
RBP2(H9807)
CommentCurrently not ready. Hybridoma against RBP2 (2-99 (98aa)) antigen.
Comment from the depositor
RCB3954
PGC1b-2(N5702)
CommentCurrently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
Comment from the depositor
RCB3955
PGC1b-2(N5704)
CommentCurrently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
Comment from the depositor
RCB3956
PGC1b-2(N5708)
CommentCurrently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
Comment from the depositor
RCB3957
PGC1b-2(N5715)
CommentCurrently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
Comment from the depositor
RCB3958
PGC1b-2(N5719)
CommentCurrently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
Comment from the depositor
RCB3959
PGC1b-2(N5720)
CommentCurrently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
Comment from the depositor
RCB3960
PGC1b-2(N5722)
CommentCurrently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
Comment from the depositor
RCB3961
PGC1b-2(N5723)
CommentCurrently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
Comment from the depositor
RCB3962
PGC1b-2(N5739)
CommentCurrently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
Comment from the depositor
RCB3963
gp64(B8109B)
CommentCurrently not ready. Hybridoma against gp64 : glycoprotein 64 (full length) antigen.
Comment from the depositor
RCB3964
gp64(B8121A)
CommentCurrently not ready. Hybridoma against gp64 : glycoprotein 64 (full length) antigen.
Comment from the depositor
RCB3965
gp64(B8137A)
CommentCurrently not ready. Hybridoma against gp64 : glycoprotein 64 (full length) antigen.
Comment from the depositor
RCB3966
gp64(B8140A)
CommentCurrently not ready. Hybridoma against gp64 : glycoprotein 64 (full length) antigen.
Comment from the depositor
RCB3967
gp64(B8147A)
CommentCurrently not ready. Hybridoma against gp64 : glycoprotein 64 (full length) antigen.
Comment from the depositor
RCB3968
mMTMR6(N7705)
CommentCurrently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
Comment from the depositor
RCB3969
mMTMR6(N7706)
CommentCurrently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
Comment from the depositor
RCB3970
mMTMR6(N7712)
CommentCurrently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
Comment from the depositor
RCB3971
mMTMR6(N7715)
CommentCurrently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
Comment from the depositor
RCB3972
mMTMR6(N7725)
CommentCurrently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
Comment from the depositor
RCB3973
mMTMR6(N7739)
CommentCurrently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
Comment from the depositor
RCB3974
SAV-1-N1(Z2011)
CommentCurrently not ready. Hybridoma against SAV-1-N1 : Salvador homolog 1 (100-149(50aa)) antigen.
Comment from the depositor
RCB3975
SAV-1-N1(Z2020)
CommentCurrently not ready. Hybridoma against SAV-1-N1 : Salvador homolog 1 (100-149(50aa)) antigen.
Comment from the depositor
RCB3976
hPPARα-1(Y1820)
CommentCurrently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
Comment from the depositor
RCB3977
hFRS2β1(Y7607)
CommentCurrently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
Comment from the depositor
RCB3978
hPPARα-1(Y1846)
CommentCurrently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
Comment from the depositor
RCB3979
hRev-erbα-1(Y2313)
CommentCurrently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
Comment from the depositor
RCB3980
hRev-erbα-1(Y2319)
CommentCurrently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
Comment from the depositor
RCB3981
hRev-erbα-1(Y2325)
CommentCurrently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
Comment from the depositor
RCB3982
hRev-erbα-1(Y2336)
CommentCurrently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
Comment from the depositor
RCB3983
hRev-erbα-1(Y2339)
CommentCurrently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
Comment from the depositor
RCB3984
hRev-erbα-1(Y2340)
CommentCurrently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
Comment from the depositor
RCB3985
hRev-erbα-1(Y2347)
CommentCurrently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
Comment from the depositor
RCB3986
DKK1(H2907)
CommentCurrently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
Comment from the depositor
RCB3987
DKK1(H2910)
CommentCurrently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
Comment from the depositor
RCB3988
DKK1(H2913)
CommentCurrently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
Comment from the depositor
RCB3989
DKK1(H2914)
CommentCurrently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
Comment from the depositor
RCB3990
DKK1(H2922)
CommentCurrently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
Comment from the depositor
RCB3991
DKK1(H2927)
CommentCurrently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
Comment from the depositor
RCB3992
DKK1(H2928)
CommentCurrently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
Comment from the depositor
RCB3993
DKK1(H2933)
CommentCurrently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
Comment from the depositor
RCB3994
DKK1(H2936)
CommentCurrently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
Comment from the depositor
RCB3995
DKK1(H2940)
CommentCurrently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
Comment from the depositor
RCB3996
DKK1(H2945)
CommentCurrently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
Comment from the depositor
RCB3997
hNDR2C(Z1419)
CommentCurrently not ready. Hybridoma against hNDR2C : Nodal-related 2 (365-464(100aa)) antigen.
Comment from the depositor
RCB3998
hNDR2C(Z1440)
CommentCurrently not ready. Hybridoma against hNDR2C : Nodal-related 2 (365-464(100aa)) antigen.
Comment from the depositor
RCB3999
hNDR2C(Y5118)
CommentCurrently not ready. Hybridoma against hNDR2C : Nodal-related 2 (365-464(100aa)) antigen.
Comment from the depositor
RCB4000
NFIA1(Y2230)
CommentCurrently not ready. Hybridoma against NFIA1 : Nuclear factor I-A1 (256-315(60aa)) antigen.
Comment from the depositor
RCB4001
NFIA1(Y2236)
CommentCurrently not ready. Hybridoma against NFIA1 : Nuclear factor I-A1 (256-315(60aa)) antigen.
Comment from the depositor
RCB4002
NFIA1(Y2238)
CommentCurrently not ready. Hybridoma against NFIA1 : Nuclear factor I-A1 (256-315(60aa)) antigen.
Comment from the depositor
RCB4003
NFIA1(Y2240)
CommentCurrently not ready. Hybridoma against NFIA1 : Nuclear factor I-A1 (256-315(60aa)) antigen.
Comment from the depositor
RCB4004
NFIB3(Y2823)
CommentCurrently not ready. Hybridoma against NFIB3 : Nuclear factor I-B3 (347-414(68aa)) antigen.
Comment from the depositor
RCB4005
NFIB3(Y2833)
CommentCurrently not ready. Hybridoma against NFIB3 : Nuclear factor I-B3 (347-414(68aa)) antigen.
Comment from the depositor
RCB4006
NFIX1(Y4402)
CommentCurrently not ready. Hybridoma against NFIX1 : Nuclear factor I-X1 (258-318(61aa)) antigen.
Comment from the depositor
RCB4007
NFIX1(Y4406)
CommentCurrently not ready. Hybridoma against NFIX1 : Nuclear factor I-X1 (258-318(61aa)) antigen.
Comment from the depositor
RCB4008
NFIX1(Y4418)
CommentCurrently not ready. Hybridoma against NFIX1 : Nuclear factor I-X1 (258-318(61aa)) antigen.
Comment from the depositor
RCB4009
NFIX1(Y4424)
CommentCurrently not ready. Hybridoma against NFIX1 : Nuclear factor I-X1 (258-318(61aa)) antigen.
Comment from the depositor
RCB4010
hNRF2-3(Y4902)
CommentCurrently not ready. Hybridoma against NFIX1 : hNRF2-3 : Nuclear factor erythroid2-related factor 2 (331-390(60aa)) antigen.
Comment from the depositor
RCB4011
Bach1-H1(N9502)
CommentCurrently not ready. Hybridoma against NFIX1 : Bach1-H1 : BTB and CNC homology 1 (317-390(74aa)) antigen.
Comment from the depositor
RCB4012
Bach1-H1(N9516)
CommentCurrently not ready. Hybridoma against NFIX1 : Bach1-H1 : BTB and CNC homology 1 (317-390(74aa)) antigen.
Comment from the depositor
RCB4013
Bach1-H2(Y0208)
CommentCurrently not ready. Hybridoma against NFIX1 : Bach1-H2 : BTB and CNC homology 1 (637-725(89aa)) antigen.
Comment from the depositor
RCB4014
Bach1-M1(N9602)
CommentCurrently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(75aa)) antigen.
Comment from the depositor
RCB4015
Bach1-M1(N9609)
CommentCurrently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(75aa)) antigen.
Comment from the depositor
RCB4016
Bach1-M1(N9610)
CommentCurrently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(75aa)) antigen.
Comment from the depositor
RCB4017
Bach1-M1(N9611)
CommentCurrently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(75aa)) antigen.
Comment from the depositor
RCB4018
Bach1-M1(N9613)
CommentCurrently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(75aa)) antigen.
Comment from the depositor
RCB4019
Bach1-M1(N9628)
CommentCurrently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(75aa)) antigen.
Comment from the depositor
RCB4020
Bach1-M1(N9639)
CommentCurrently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(75aa)) antigen.
Comment from the depositor
RCB4021
Bach1-M1(N9642)
CommentCurrently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(75aa)) antigen.
Comment from the depositor
RCB4022
Bach1-M1(N9647)
CommentCurrently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(75aa)) antigen.
Comment from the depositor
RCB4023
Bach1-M1(N9648)
CommentCurrently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(75aa)) antigen.
Comment from the depositor
RCB4024
Bach1-M2(Y2103)
CommentCurrently not ready. Hybridoma against Bach1-M2 : BTB and CNC homology 1 (640-728(89aa)) antigen.
Comment from the depositor
RCB4025
Bach1-M2(Y2117)
CommentCurrently not ready. Hybridoma against Bach1-M2 : BTB and CNC homology 1 (640-728(89aa)) antigen.
Comment from the depositor
RCB4026
Bach1-M2(Y2133)
CommentCurrently not ready. Hybridoma against Bach1-M2 : BTB and CNC homology 1 (640-728(89aa)) antigen.
Comment from the depositor
RCB4027
DRPLA-2(N9330)
CommentCurrently not ready. Hybridoma against DRPLA-2 : Dentato-rubro-pallido-luysian atrophy (101-200(100aa)) antigen.
Comment from the depositor
RCB4028
DRPLA-2(N9331)
CommentCurrently not ready. Hybridoma against DRPLA-2 : Dentato-rubro-pallido-luysian atrophy (101-200(100aa)) antigen.
Comment from the depositor
RCB4029
DRPLA-4(Y0435)
CommentCurrently not ready. Hybridoma against DRPLA-4 : Dentato-rubro-pallido-luysian atrophy (1085-1184(100aa)) antigen.
Comment from the depositor
RCB4030
hPTK7-Cyto(Y2040)
CommentCurrently not ready. Hybridoma against hPTK7-Cyto : Tyrosine-protein kinase-like 7 (725-795(70aa)) antigen.
Comment from the depositor
RCB4031
hPTK7-Extra(Y1927)
CommentCurrently not ready. Hybridoma against hPTK7-Extra : Tyrosine-protein kinase-like 7 (31-130 (100aa)) antigen.
Comment from the depositor
RCB4032
hPTK7-Extra(Y1937)
CommentCurrently not ready. Hybridoma against hPTK7-Extra : Tyrosine-protein kinase-like 7 (31-130 (100aa)) antigen.
Comment from the depositor
RCB4033
MEF2A-3(Y0809)
CommentCurrently not ready. Hybridoma against MEF2A-3 : Myocyte-specific enhancer factor 2A (318-403(86aa)) antigen.
Comment from the depositor
RCB4034
MEF2A-3(Y0833)
CommentCurrently not ready. Hybridoma against MEF2A-3 : Myocyte-specific enhancer factor 2A (318-403(86aa)) antigen.
Comment from the depositor
RCB4035
MEF2A-3(Y0834)
CommentCurrently not ready. Hybridoma against MEF2A-3 : Myocyte-specific enhancer factor 2A (318-403(86aa)) antigen.
Comment from the depositor
RCB4036
MEF2A-3(Y0841)
CommentCurrently not ready. Hybridoma against MEF2A-3 : Myocyte-specific enhancer factor 2A (318-403(86aa)) antigen.
Comment from the depositor
RCB4037
MEF2A-3(Y0847)
CommentCurrently not ready. Hybridoma against MEF2A-3 : Myocyte-specific enhancer factor 2A (318-403(86aa)) antigen.
Comment from the depositor
RCB4038
MEF2C-2(Y1728)
CommentCurrently not ready. Hybridoma against MEF2C-2 : Myocyte-specific enhancer factor 2C (161-248(88aa)) antigen.
Comment from the depositor
RCB4039
MEF2C-2(Y1740)
CommentCurrently not ready. Hybridoma against MEF2C-2 : Myocyte-specific enhancer factor 2C (161-248(88aa)) antigen.
Comment from the depositor
RCB4040
AFP(B2007C)
CommentCurrently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
Comment from the depositor
RCB4041
AFP(B2011D)
CommentCurrently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
Comment from the depositor
RCB4042
AFP(B2015C)
CommentCurrently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
Comment from the depositor
RCB4043
AFP(B2117C)
CommentCurrently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
Comment from the depositor
RCB4044
AFP(B2150D)
CommentCurrently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
Comment from the depositor
RCB4045
AFP(B2151D)
CommentCurrently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
Comment from the depositor
RCB4046
TFF1(N2306)
CommentCurrently not ready. Hybridoma against TFF1 (27-75 (49aa)) antigen.
Comment from the depositor
RCB4047
TFF1(N2309)
CommentCurrently not ready. Hybridoma against TFF1 (27-75 (49aa)) antigen.
Comment from the depositor
RCB4048
TFF1(N2320)
CommentCurrently not ready. Hybridoma against TFF1 (27-75 (49aa)) antigen.
Comment from the depositor
RCB4049
TFF1(N2325)
CommentCurrently not ready. Hybridoma against TFF1 (27-75 (49aa)) antigen.
Comment from the depositor
RCB4050
mGCNF-Hinge(N6724)
CommentCurrently not ready. Hybridoma against mGCNF-Hinge : Germ cell nuclear factor (160-263(104aa)) antigen.
Comment from the depositor
RCB4051
mGCNF-Hinge(N6729)
CommentCurrently not ready. Hybridoma against mGCNF-Hinge : Germ cell nuclear factor (160-263(104aa)) antigen.
Comment from the depositor
RCB4052
mGCNF-Hinge(N6737)
CommentCurrently not ready. Hybridoma against mGCNF-Hinge : Germ cell nuclear factor (160-263(104aa)) antigen.
Comment from the depositor
RCB4053
mGCNF-Hinge(N6760)
CommentCurrently not ready. Hybridoma against mGCNF-Hinge : Germ cell nuclear factor (160-263(104aa)) antigen.
Comment from the depositor
RCB4054
mGCNF-N(N6807)
CommentCurrently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
Comment from the depositor
RCB4055
mGCNF-N(N6812)
CommentCurrently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
Comment from the depositor
RCB4056
mGCNF-N(N6813)
CommentCurrently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
Comment from the depositor
RCB4057
mGCNF-N(N6816)
CommentCurrently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
Comment from the depositor
RCB4058
mGCNF-N(N6819)
CommentCurrently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
Comment from the depositor
RCB4059
mGCNF-N(N6823)
CommentCurrently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
Comment from the depositor
RCB4060
mGCNF-N(N6824)
CommentCurrently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
Comment from the depositor
RCB4061
mGCNF-N(N6831)
CommentCurrently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
Comment from the depositor
RCB4062
mGCNF-N(N6832)
CommentCurrently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
Comment from the depositor
RCB4063
mGCNF-N(N6836)
CommentCurrently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
Comment from the depositor
RCB4064
mGCNF-N(N6839)
CommentCurrently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
Comment from the depositor
RCB4065
hFOXP3(B8905-6)
CommentCurrently not ready. Hybridoma against hFOXP3 : Forkhead box P3 (105-190(86aa)) antigen.
Comment from the depositor
RCB4066
hFOXP3(B8916B)
CommentCurrently not ready. Hybridoma against hFOXP3 : Forkhead box P3 (105-190(86aa)) antigen.
Comment from the depositor
RCB4067
PPARdelta-1(2-45)(C0309A)
CommentCurrently not ready. Hybridoma against PPARdelta-1 (2-45) : Peroxisome proliferator-activated receptor delta (2-45(44aa)) antigen.
Comment from the depositor
RCB4068
PPARdelta-1(2-45)(C0309B)
CommentCurrently not ready. Hybridoma against PPARdelta-1 (2-45) : Peroxisome proliferator-activated receptor delta (2-45(44aa)) antigen.
Comment from the depositor
RCB4069
PPARdelta-1(2-45)(C0309C)
CommentCurrently not ready. Hybridoma against PPARdelta-1 (2-45) : Peroxisome proliferator-activated receptor delta (2-45(44aa)) antigen.
Comment from the depositor
RCB4070
hRev-erbα-2(Y2408)
CommentCurrently not ready. Hybridoma against hRev-erbα-2 : Rev-erbα (41-80(40aa)) antigen.
Comment from the depositor
RCB4071
hHNF4ɤ-1(Y4602)
CommentCurrently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
Comment from the depositor
RCB4072
hHNF4ɤ-1(Y4611)
CommentCurrently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
Comment from the depositor
RCB4073
hHNF4ɤ-1(Y4618)
CommentCurrently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
Comment from the depositor
RCB4074
hHNF4ɤ-1(Y4621)
CommentCurrently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
Comment from the depositor
RCB4075
hHNF4ɤ-1(Y4623)
CommentCurrently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
Comment from the depositor
RCB4076
hHNF4ɤ-1(Y4625)
CommentCurrently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
Comment from the depositor
RCB4077
hHNF4ɤ-1(Y4626)
CommentCurrently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
Comment from the depositor
RCB4078
hHNF4ɤ-1(Y4635)
CommentCurrently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
Comment from the depositor
RCB4079
hHNF4ɤ-1(Y4643)
CommentCurrently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
Comment from the depositor
RCB4080
Cys-SN2(N3306)
CommentHybridoma against Cys-SN2 : Cystatin (92-117 (26aa)) antigen.
Comment from the depositorCystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4081
Cys-SN2(N3312)
CommentHybridoma against Cys-SN2 :Cystatin (92-117 (26aa)) antigen.
Comment from the depositorCystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4082
Cys-SN2(N3316)
CommentHybridoma against Cys-SN2 :Cystatin (92-117 (26aa)) antigen.
Comment from the depositorCystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4083
Cys-SN2(N3323)
CommentHybridoma against Cys-SN2 : Cystatin (92-117 (26aa)) antigen.
Comment from the depositor
RCB4084
Cys-SN2(N3331)
CommentHybridoma against Cys-SN2 : Cystatin (92-117 (26aa)) antigen.
Comment from the depositorCystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4085
Cys-SN2(N3338)
CommentHybridoma against Cys-SN2 : Cystatin (92-117 (26aa)) antigen.
Comment from the depositorCystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4086
Cys-SN2(N3344)
CommentCurrently not ready. Hybridoma against Cys-SN2 : Cystatin (92-117 (26aa)) antigen.
Comment from the depositor
RCB4087
Cys-SN2(N3346)
CommentCurrently not ready. Hybridoma against Cys-SN2 : Cystatin (92-117 (26aa)) antigen.
Comment from the depositor
RCB4088
Cys-SN2(N3349)
CommentHybridoma against Cys-SN2 : Cystatin (92-117 (26aa)) antigen.
Comment from the depositorCystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4089
Cys-SN2(N3372)
CommentHybridoma against Cys-SN2 : Cystatin (92-117 (26aa)) antigen.
Comment from the depositorCystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4090
TRβ-CT(H9401)
CommentCurrently not ready. Hybridoma against TRβ-CT : TRβ (199-227 (29aa)) antigen.
Comment from the depositor
RCB4091
TRβ-CT(H9420)
CommentCurrently not ready. Hybridoma against TRβ-CT : TRβ (199-227 (29aa)) antigen.
Comment from the depositor
RCB4092
TRβ-CT(H9431)
CommentCurrently not ready. Hybridoma against TRβ-CT : TRβ (199-227 (29aa)) antigen.
Comment from the depositor
RCB4093
TRβ-CT(H9437)
CommentCurrently not ready. Hybridoma against TRβ-CT : TRβ (199-227 (29aa)) antigen.
Comment from the depositor
RCB4094
mGli2(N7206)
CommentCurrently not ready. Hybridoma against mGli2 : GLI family zinc finger 2 (3-49 (47aa)) antigen.
Comment from the depositor
RCB4095
mGli2(N7212)
CommentCurrently not ready. Hybridoma against mGli2 : GLI family zinc finger 2 (3-49 (47aa)) antigen.
Comment from the depositor
RCB4096
mGli2(N7219)
CommentCurrently not ready. Hybridoma against mGli2 : GLI family zinc finger 2 (3-49 (47aa)) antigen.
Comment from the depositor
RCB4097
mGli2(N7237)
CommentCurrently not ready. Hybridoma against mGli2 : GLI family zinc finger 2 (3-49 (47aa)) antigen.
Comment from the depositor
RCB4098
mTES101-RP(N6002)
CommentCurrently not ready. Hybridoma against mTES101-RP : Testicular germ cell specific antigen101 (194-217(24aa)) antigen.
Comment from the depositor
RCB4099
mTES101-RP(N6022A)
CommentCurrently not ready. Hybridoma against mTES101-RP : Testicular germ cell specific antigen101 (194-217(24aa)) antigen.
Comment from the depositor
RCB4100
mTES101-RP(N6022B)
CommentCurrently not ready. Hybridoma against mTES101-RP : Testicular germ cell specific antigen101 (194-217(24aa)) antigen.
Comment from the depositor
RCB4101
mTES101-RP(N6035)
CommentCurrently not ready. Hybridoma against mTES101-RP : Testicular germ cell specific antigen101 (194-217(24aa)) antigen.
Comment from the depositor
RCB4102
mTES101-RP(N6038)
CommentCurrently not ready. Hybridoma against mTES101-RP : Testicular germ cell specific antigen101 (194-217(24aa)) antigen.
Comment from the depositor
RCB4103
TADA3(B0331A)
CommentCurrently not ready. Hybridoma against TADA3 (3-49 (61-160 (100aa)) antigen.
Comment from the depositor
RCB4104
WBP2(N2617)
CommentCurrently not ready. Hybridoma against WBP2 (3-49 (2-101(100aa)) antigen.
Comment from the depositor
RCB4105
WBP2(N2640)
CommentCurrently not ready. Hybridoma against WBP2 (3-49 (2-101(100aa)) antigen.
Comment from the depositor
RCB4106
WBP2(N2645)
CommentCurrently not ready. Hybridoma against WBP2 (3-49 (2-101(100aa)) antigen.
Comment from the depositor
RCB4107
AI-gp(Y3111)
CommentCurrently not ready. Hybridoma against AI-gp : AI (506-555(50aa)) antigen.
Comment from the depositor
RCB4108
AI-gp(Y3123)
CommentCurrently not ready. Hybridoma against AI-gp : AI (506-555(50aa)) antigen.
Comment from the depositor
RCB4109
AI-gp(Y3124)
CommentCurrently not ready. Hybridoma against AI-gp : AI (506-555(50aa)) antigen.
Comment from the depositor
RCB4110
AI-gp(Y3127)
CommentCurrently not ready. Hybridoma against AI-gp : AI (506-555(50aa)) antigen.
Comment from the depositor
RCB4111
AI-gp(Y3147)
CommentCurrently not ready. Hybridoma against AI-gp : AI (506-555(50aa)) antigen.
Comment from the depositor
RCB4112
AFP(B5925A)
CommentCurrently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
Comment from the depositor
RCB4113
AFP(B5937F)
CommentCurrently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
Comment from the depositor
RCB4114
AFP(B5939D)
CommentCurrently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
Comment from the depositor
RCB4115
AFP(B5944F)
CommentCurrently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
Comment from the depositor
RCB4116
AFP(B5955D)
CommentCurrently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
Comment from the depositor
RCB4117
AFP(B5963D)
CommentCurrently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
Comment from the depositor
RCB4118
AFP(B5980D)
CommentCurrently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
Comment from the depositor
RCB4119
CCR5 SP3(Y4108)
CommentCurrently not ready. Hybridoma against CCR5 SP3(Y sulfation) : Chemokine receptor 5 (11-19(9aa)) antigen.
Comment from the depositor
RCB4120
CCR5 SP3(Y4125)
CommentCurrently not ready. Hybridoma against CCR5 SP3(Y sulfation) : Chemokine receptor 5 (11-19(9aa)) antigen.
Comment from the depositor
RCB4121
CCR5 SP3(Y4126)
CommentCurrently not ready. Hybridoma against CCR5 SP3(Y sulfation) : Chemokine receptor 5 (11-19(9aa)) antigen.
Comment from the depositor
RCB4122
mNCoR-1(Y8110)
CommentCurrently not ready. Hybridoma against mNCoR-1 : Nuclear receptor corepressor 1 (1817-1879(63aa)) antigen.
Comment from the depositor
RCB4123
mNCoR-1(Y8111)
CommentCurrently not ready. Hybridoma against mNCoR-1 : Nuclear receptor corepressor 1 (1817-1879(63aa)) antigen.
Comment from the depositor
RCB4124
mNCoR-1(Y8129)
CommentCurrently not ready. Hybridoma against mNCoR-1 : Nuclear receptor corepressor 1 (1817-1879(63aa)) antigen.
Comment from the depositor
RCB4125
mNCoR-1(Y8131(A))
CommentCurrently not ready. Hybridoma against mNCoR-1 : Nuclear receptor corepressor 1 (1817-1879(63aa)) antigen.
Comment from the depositor
RCB4126
mSRC-1(Y8207)
CommentCurrently not ready. Hybridoma against mSRC-1 (626-668(43aa)) antigen.
Comment from the depositor
RCB4127
mSRC-1(Y8243)
CommentCurrently not ready. Hybridoma against mSRC-1 (626-668(43aa)) antigen.
Comment from the depositor
RCB4128
HSMRT(Y9017)
CommentCurrently not ready. Hybridoma against HSMRT (1922-2043(122aa)) antigen.
Comment from the depositor
RCB4129
HSMRT(Y9033)
CommentCurrently not ready. Hybridoma against HSMRT (1922-2043(122aa)) antigen.
Comment from the depositor
RCB4130
hRIP140(Y9140)
CommentCurrently not ready. Hybridoma against hRIP140 (733-847(115aa)) antigen.
Comment from the depositor
RCB4131
hTIF2(Y8917)
CommentCurrently not ready. Hybridoma against hTIF2 (733-847(753-804(52aa)) antigen.
Comment from the depositor
RCB4132
hTIF2(Y8918)
CommentCurrently not ready. Hybridoma against hTIF2 (733-847(753-804(52aa)) antigen.
Comment from the depositor
RCB4133
BAP37(Z1131B)
CommentCurrently not ready. Hybridoma against BAP37 : B-cell receptor-associated protein 37 (210-249(40aa)) antigen.
Comment from the depositor
RCB4134
SOX21 PepT3(Z3001)
CommentCurrently not ready. Hybridoma against SOX21 PepT3 : SRY (sex determining region Y)-box 21 (129-176(48aa)) antigen.
Comment from the depositor
RCB4135
Epc1AG(Z3703)
CommentCurrently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
Comment from the depositor
RCB4136
Epc1AG(Z3705)
CommentCurrently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
Comment from the depositor
RCB4137
Epc1AG(Z3710)
CommentCurrently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
Comment from the depositor
RCB4138
Epc1AG(Z3714)
CommentCurrently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
Comment from the depositor
RCB4139
Epc1AG(Z3715)
CommentCurrently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
Comment from the depositor
RCB4140
Epc1AG(Z3716)
CommentCurrently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
Comment from the depositor
RCB4141
Epc1AG(Z3725)
CommentCurrently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
Comment from the depositor
RCB4142
Epc1AG(Z3728)
CommentCurrently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
Comment from the depositor
RCB4143
Epc1AG(Z3733)
CommentCurrently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
Comment from the depositor
RCB4144
Epc1AG(Z3741)
CommentCurrently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
Comment from the depositor
RCB4145
Epc1AG(Z3742)
CommentCurrently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
Comment from the depositor
RCB4146
Epc2AG(Z3901)
CommentCurrently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
Comment from the depositor
RCB4147
Epc2AG(Z3906)
CommentCurrently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
Comment from the depositor
RCB4148
Epc2AG(Z3908)
CommentCurrently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
Comment from the depositor
RCB4149
Epc2AG(Z3911)
CommentCurrently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
Comment from the depositor
RCB4150
Epc2AG(Z3921)
CommentCurrently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
Comment from the depositor
RCB4151
Epc2AG(Z3922)
CommentCurrently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
Comment from the depositor
RCB4152
Epc2AG(Z3925)
CommentCurrently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
Comment from the depositor
RCB4153
Epc2AG(Z3931)
CommentCurrently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
Comment from the depositor
RCB4154
Epc2AG(Z3934)
CommentCurrently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
Comment from the depositor
RCB4155
Epc2AG(Z3940)
CommentCurrently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
Comment from the depositor
RCB4156
STK3(Z2801)
CommentCurrently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(55aa)) antigen.
Comment from the depositor
RCB4157
STK3(Z2804)
CommentCurrently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(55aa)) antigen.
Comment from the depositor
RCB4158
STK3(Z2814)
CommentCurrently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(55aa)) antigen.
Comment from the depositor
RCB4159
STK3(Z2816)
CommentCurrently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(55aa)) antigen.
Comment from the depositor
RCB4160
STK3(Z2822)
CommentCurrently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(55aa)) antigen.
Comment from the depositor
RCB4161
STK3(Z2828)
CommentCurrently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(55aa)) antigen.
Comment from the depositor
RCB4162
STK3(Z2829)
CommentCurrently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(55aa)) antigen.
Comment from the depositor
RCB4163
mDAI-3S(Z4401)
CommentCurrently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
Comment from the depositor
RCB4164
mDAI-3S(Z4410)
CommentCurrently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
Comment from the depositor
RCB4165
mDAI-3S(Z4415)
CommentCurrently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
Comment from the depositor
RCB4166
mDAI-3S(Z4420)
CommentCurrently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
Comment from the depositor
RCB4167
mDAI-3S(Z4424)
CommentCurrently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
Comment from the depositor
RCB4168
mDAI-3S(Z4429)
CommentCurrently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
Comment from the depositor
RCB4169
mDAI-3S(Z4402)
CommentCurrently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
Comment from the depositor
RCB4170
mDAI-3S(Z4418)
CommentCurrently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
Comment from the depositor
RCB4171
JHDM2A-3C(Z5507)
CommentCurrently not ready. Hybridoma against JHDM2A-3C : Jumonji domain containing gene family of histone demethylase 2A (1151-1224(74aa)) antigen.
Comment from the depositor
RCB4172
JHDM2A-4C(Z6316)
CommentCurrently not ready. Hybridoma against JHDM2A-4C : Jumonji domain containing gene family of histone demethylase 2A (1089-1138(50aa)) antigen.
Comment from the depositor
RCB4173
HIF1(Z6413)
CommentCurrently not ready. Hybridoma against HIF1 : Hypoxia-inducible transcription factor 1 (361-405(45aa)) antigen.
Comment from the depositor
RCB4174
HIF1(Z6414)
CommentCurrently not ready. Hybridoma against HIF1 : Hypoxia-inducible transcription factor 1 (361-405(45aa)) antigen.
Comment from the depositor
RCB4175
HIF1(Z6417)
CommentCurrently not ready. Hybridoma against HIF1 : Hypoxia-inducible transcription factor 1 (361-405(45aa)) antigen.
Comment from the depositor
RCB4176
HIF1(Z6437)
CommentCurrently not ready. Hybridoma against HIF1 : Hypoxia-inducible transcription factor 1 (361-405(45aa)) antigen.
Comment from the depositor
RCB4177
HIF2(Z6502)
CommentCurrently not ready. Hybridoma against HIF2 : Hypoxia-inducible transcription factor 2 (603-652(50aa)) antigen.
Comment from the depositor
RCB4178
HIF2(Z6526)
CommentCurrently not ready. Hybridoma against HIF2 : Hypoxia-inducible transcription factor 2 (603-652(50aa)) antigen.
Comment from the depositor
RCB4179
p65-12(Z6635)
CommentCurrently not ready. Hybridoma against p65-12 : p65 (116-168(53aa)) antigen.
Comment from the depositor
RCB4180
Mrf2-2(Z7411)
CommentCurrently not ready. Hybridoma against Mrf2-2 : Modulator recognition factor 2 (1140-1189(50aa)) antigen.
Comment from the depositor
RCB4181
Mrf2-2(Z7437)
CommentCurrently not ready. Hybridoma against Mrf2-2 : Modulator recognition factor 2 (1140-1189(50aa)) antigen.
Comment from the depositor
RCB4182
THRAP3(Z6803)
CommentCurrently not ready. Hybridoma against THRAP3 : Thyroid hormone receptor associated protein 3 (457-513(57aa)) antigen.
Comment from the depositor
RCB4183
THRAP3(Z6824)
CommentCurrently not ready. Hybridoma against THRAP3 : Thyroid hormone receptor associated protein 3 (457-513(57aa)) antigen.
Comment from the depositor
RCB4184
THRAP3(Z6832)
CommentCurrently not ready. Hybridoma against THRAP3 : Thyroid hormone receptor associated protein 3 (457-513(57aa)) antigen.
Comment from the depositor
RCB4185
THRAP3(Z6840)
CommentCurrently not ready. Hybridoma against THRAP3 : Thyroid hormone receptor associated protein 3 (457-513(57aa)) antigen.
Comment from the depositor
RCB4186
KLF4(Z6902)
CommentCurrently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(65aa)) antigen.
Comment from the depositor
RCB4187
KLF4(Z6913)
CommentCurrently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(65aa)) antigen.
Comment from the depositor
RCB4188
KLF4(Z6919)
CommentCurrently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(65aa)) antigen.
Comment from the depositor
RCB4189
KLF4(Z6928)
CommentCurrently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(65aa)) antigen.
Comment from the depositor
RCB4190
KLF4(Z6929)
CommentCurrently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(65aa)) antigen.
Comment from the depositor
RCB4191
KLF4(Z6943)
CommentCurrently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(65aa)) antigen.
Comment from the depositor
RCB4192
KLF4(Z6944)
CommentCurrently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(65aa)) antigen.
Comment from the depositor
RCB4193
CCR4aN(Y6206)
CommentHybridoma against CCR4aN : CCR4-NOT transcription complex, subunit 6 (141-190(50aa)) antigen.
Comment from the depositorCCR4aN : CCR4-NOT transcription complex, subunit 6 (141-190(50aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4194
CCR4bC(Y5601)
CommentCurrently not ready. Hybridoma against CCR4bC : CCR4-NOT transcription complex, subunit 6-like (501-555(55aa)) antigen.
Comment from the depositor
RCB4195
CCR4bC(Y5606)
CommentCurrently not ready. Hybridoma against CCR4bC : CCR4-NOT transcription complex, subunit 6-like (501-555(55aa)) antigen.
Comment from the depositor
RCB4196
CCR4bC(Y5657)
CommentCurrently not ready. Hybridoma against CCR4bC : CCR4-NOT transcription complex, subunit 6-like (501-555(55aa)) antigen.
Comment from the depositor
RCB4197
SETD3(Y2501)
CommentCurrently not ready. Hybridoma against SETD3 : SET domain containing 3 (2-139(138aa)) antigen.
Comment from the depositor
RCB4198
SETD3(Y2537)
CommentCurrently not ready. Hybridoma against SETD3 : SET domain containing 3 (2-139(138aa)) antigen.
Comment from the depositor
RCB4199
mSETDB2-1(Y7221)
CommentCurrently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
Comment from the depositor
RCB4200
mSETDB2-1(Y7227)
CommentCurrently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
Comment from the depositor
RCB4201
mSETDB2-1(Y7228)
CommentCurrently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
Comment from the depositor
RCB4202
mSETDB2-1(Y7232)
CommentCurrently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
Comment from the depositor
RCB4203
mSETDB2-1(Y7241)
CommentCurrently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
Comment from the depositor
RCB4204
mSETDB2-1(Y7246)
CommentCurrently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
Comment from the depositor
RCB4205
mSETDB2-1(Y7247)
CommentCurrently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
Comment from the depositor
RCB4206
Prdm6-2(Y7126)
CommentCurrently not ready. Hybridoma against Prdm6-2 : PR domain containing 6 (294-392(99aa)) antigen.
Comment from the depositor
RCB4207
Prdm16-1(Z0311)
CommentCurrently not ready. Hybridoma against Prdm16-1 : PR domain containing 16 (4-103(100aa)) antigen.
Comment from the depositor
RCB4208
Prdm16-1(Z0315)
CommentCurrently not ready. Hybridoma against Prdm16-1 : PR domain containing 16 (4-103(100aa)) antigen.
Comment from the depositor
RCB4209
Prdm16-1(Z0324)
CommentCurrently not ready. Hybridoma against Prdm16-1 : PR domain containing 16 (4-103(100aa)) antigen.
Comment from the depositor
RCB4210
Prdm16-1(Z0327)
CommentCurrently not ready. Hybridoma against Prdm16-1 : PR domain containing 16 (4-103(100aa)) antigen.
Comment from the depositor
RCB4211
Prdm16-1(Z0346)
CommentCurrently not ready. Hybridoma against Prdm16-1 : PR domain containing 16 (4-103(100aa)) antigen.
Comment from the depositor
RCB4212
Prdm16-2(Z1301)
CommentCurrently not ready. Hybridoma against Prdm16-2 : PR domain containing 16 (467-566(100aa)) antigen.
Comment from the depositor
RCB4213
Prdm16-2(Z1312)
CommentCurrently not ready. Hybridoma against Prdm16-2 : PR domain containing 16 (467-566(100aa)) antigen.
Comment from the depositor
RCB4214
Prdm16-2(Z1322)
CommentCurrently not ready. Hybridoma against Prdm16-2 : PR domain containing 16 (467-566(100aa)) antigen.
Comment from the depositor
RCB4215
Prdm2-2(Z0601)
CommentCurrently not ready. Hybridoma against Prdm2-2 : PR domain containing 2 (210-309(100aa)) antigen.
Comment from the depositor
RCB4216
Prdm2-2(Z0605)
CommentCurrently not ready. Hybridoma against Prdm2-2 : PR domain containing 2 (210-309(100aa)) antigen.
Comment from the depositor
RCB4217
Prdm2-2(Z0626)
CommentCurrently not ready. Hybridoma against Prdm2-2 : PR domain containing 2 (210-309(100aa)) antigen.
Comment from the depositor
RCB4218
Prdm2-2(Z0631)
CommentCurrently not ready. Hybridoma against Prdm2-2 : PR domain containing 2 (210-309(100aa)) antigen.
Comment from the depositor
RCB4219
Prdm2-2(Z0654)
CommentCurrently not ready. Hybridoma against Prdm2-2 : PR domain containing 2 (210-309(100aa)) antigen.
Comment from the depositor
RCB4220
Prdm4-1(Y8328)
CommentCurrently not ready. Hybridoma against Prdm4-1 : PR domain containing 4 (161-260(100aa)) antigen.
Comment from the depositor
RCB4221
Prdm4-1(Y8341)
CommentCurrently not ready. Hybridoma against Prdm4-1 : PR domain containing 4 (161-260(100aa)) antigen.
Comment from the depositor
RCB4222
COUP TFII-2(Z0504)
CommentCurrently not ready. Hybridoma against COUP TFII-2 : Chicken Ovalbumin Upstream Promoter-Transcription Factor II (1-50(50aa)) antigen.
Comment from the depositor
RCB4223
COUP TFII-2(Z0523)
CommentCurrently not ready. Hybridoma against COUP TFII-2 : Chicken Ovalbumin Upstream Promoter-Transcription Factor II (1-50(50aa)) antigen.
Comment from the depositor
RCB4224
COUP TFII-2(Z0533)
CommentCurrently not ready. Hybridoma against COUP TFII-2 : Chicken Ovalbumin Upstream Promoter-Transcription Factor II (1-50(50aa)) antigen.
Comment from the depositor
RCB4225
methylated budded baculovirus(C4914-2)
CommentCurrently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
Comment from the depositor
RCB4226
methylated budded baculovirus(C4930-101)
CommentCurrently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
Comment from the depositor
RCB4227
methylated budded baculovirus(C5006-9)
CommentCurrently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
Comment from the depositor
RCB4228
methylated budded baculovirus(C5009-33)
CommentCurrently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
Comment from the depositor
RCB4229
methylated budded baculovirus(C5032-60)
CommentCurrently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
Comment from the depositor
RCB4230
methylated budded baculovirus(C5123-70)
CommentCurrently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
Comment from the depositor
RCB4231
ATIP-CT(N4204)
CommentCurrently not ready. Hybridoma against ATIP-CT : Angiotensin II receptor type 2-interacting proteins (327-426(100aa)) antigen.
Comment from the depositor
RCB4232
ATIP-CT(N4207)
CommentCurrently not ready. Hybridoma against ATIP-CT : Angiotensin II receptor type 2-interacting proteins (327-426(100aa)) antigen.
Comment from the depositor
RCB4233
ATIP-CT(N4235)
CommentCurrently not ready. Hybridoma against ATIP-CT : Angiotensin II receptor type 2-interacting proteins (327-426(100aa)) antigen.
Comment from the depositor
RCB4234
ROBO1 Ag1(Y4314)
CommentCurrently not ready. Hybridoma against ROBO1 Ag1 : Roundabout 1 (946-1034(89aa)) antigen.
Comment from the depositor
RCB4235
ROBO1 Ag2(Y7002)
CommentCurrently not ready. Hybridoma against ROBO1 Ag2 : Roundabout 1 (1062-1148(87aa)) antigen.
Comment from the depositor
RCB4236
ROBO1 Ag6(Y8411)
CommentCurrently not ready. Hybridoma against ROBO1 Ag6 : Roundabout 1 (1458-1555(98aa)) antigen.
Comment from the depositor
RCB4237
APE-C(Y1202)
CommentCurrently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
Comment from the depositor
RCB4238
APE-C(Y1209)
CommentCurrently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
Comment from the depositor
RCB4239
APE-C(Y1215)
CommentCurrently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
Comment from the depositor
RCB4240
APE-C(Y1220)
CommentCurrently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
Comment from the depositor
RCB4241
APE-C(Y1221)
CommentCurrently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
Comment from the depositor
RCB4242
APE-C(Y1244)
CommentCurrently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
Comment from the depositor
RCB4243
APE-N1(N9406)
CommentCurrently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
Comment from the depositor
RCB4244
APE-N1(N9407)
CommentCurrently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
Comment from the depositor
RCB4245
APE-N1(N9426)
CommentCurrently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
Comment from the depositor
RCB4246
APE-N1(N9436A)
CommentCurrently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
Comment from the depositor
RCB4247
APE-N1(N9436B)
CommentCurrently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
Comment from the depositor
RCB4248
APE-N1(N9442)
CommentCurrently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
Comment from the depositor
RCB4249
APE-N3(Y0013)
CommentCurrently not ready. Hybridoma against APE-N3 : Akt-phosphorylation enhancer (551-601(51aa)) antigen.
Comment from the depositor
RCB4250
APE-N3(Y0026)
CommentCurrently not ready. Hybridoma against APE-N3 : Akt-phosphorylation enhancer (551-601(51aa)) antigen.
Comment from the depositor
RCB4251
APE-N3(Y0028)
CommentCurrently not ready. Hybridoma against APE-N3 : Akt-phosphorylation enhancer (551-601(51aa)) antigen.
Comment from the depositor
RCB4252
APE-N3(Y0038)
CommentCurrently not ready. Hybridoma against APE-N3 : Akt-phosphorylation enhancer (551-601(51aa)) antigen.
Comment from the depositor
RCB4253
hTobC(Y5432)
CommentHybridoma against hTobC : Transducer of ERBB2, 1 (263-345(83aa)) antigen.
Comment from the depositorhTobC : Transducer of ERBB2, 1 (263-345(83aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4254
hTobC(Y5443)
CommentHybridoma against hTobC : Transducer of ERBB2, 1 (263-345(83aa)) antigen.
Comment from the depositorhTobC : Transducer of ERBB2, 1 (263-345(83aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4255
hTobC(Y5444)
CommentHybridoma against hTobC : Transducer of ERBB2, 1 (263-345(83aa)) antigen.
Comment from the depositorhTobC : Transducer of ERBB2, 1 (263-345(83aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4256
hTobC(Y5452)
CommentHybridoma against hTobC : Transducer of ERBB2, 1 (263-345(83aa)) antigen.
Comment from the depositorhTobC : Transducer of ERBB2, 1 (263-345(83aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4257
hTobM(Y5807)
CommentCurrently not ready. Hybridoma against hTobM : Transducer of ERBB2, 1 (136-236(101aa)) antigen.
Comment from the depositor
RCB4258
hTobM(Y5815)
CommentCurrently not ready. Hybridoma against hTobM : Transducer of ERBB2, 1 (136-236(101aa)) antigen.
Comment from the depositor
RCB4259
p115-C(Y0902)
CommentCurrently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
Comment from the depositor
RCB4260
p115-C(Y0912)
CommentCurrently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
Comment from the depositor
RCB4261
p115-C(Y0915)
CommentCurrently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
Comment from the depositor
RCB4262
p115-C(Y0920)
CommentCurrently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
Comment from the depositor
RCB4263
p115-C(Y0921)
CommentCurrently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
Comment from the depositor
RCB4264
p115-C(Y0924)
CommentCurrently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
Comment from the depositor
RCB4265
p115-C(Y0931)
CommentCurrently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
Comment from the depositor
RCB4266
p115-C(Y0945)
CommentCurrently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
Comment from the depositor
RCB4267
LARG-C term(Y9601)
CommentCurrently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
Comment from the depositor
RCB4268
LARG-C term(Y9614)
CommentCurrently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
Comment from the depositor
RCB4269
LARG-C term(Y9618)
CommentCurrently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
Comment from the depositor
RCB4270
LARG-C term(Y9619)
CommentCurrently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
Comment from the depositor
RCB4271
LARG-C term(Y9625)
CommentCurrently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
Comment from the depositor
RCB4272
LARG-C term(Y9626)
CommentCurrently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
Comment from the depositor
RCB4273
LARG-C term(Y9627)
CommentCurrently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
Comment from the depositor
RCB4274
LARG-C term(Y9637)
CommentCurrently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
Comment from the depositor
RCB4276
ATIP-CT(C1708-1)
CommentCurrently not ready. Hybridoma against ATIP-CT : Angiotensin II receptor type 2-interacting proteins (327-426 (100aa)) antigen.
Comment from the depositor
RCB4277
ATIP-CT(C1717-5)
CommentCurrently not ready. Hybridoma against ATIP-CT : Angiotensin II receptor type 2-interacting proteins (327-426 (100aa)) antigen.
Comment from the depositor
RCB4278
NM6(Y0620)
CommentCurrently not ready. Hybridoma against NM6 : Myotubularin related protein 6 (1-100(100aa)) antigen.
Comment from the depositor
RCB4279
NM6s(Y67002)
CommentCurrently not ready. Hybridoma against NM6s : Myotubularin related protein 6 (1-100(100aa)) antigen.
Comment from the depositor
RCB4280
NM6s(Y67003)
CommentCurrently not ready. Hybridoma against NM6s : Myotubularin related protein 6 (1-100(100aa)) antigen.
Comment from the depositor
RCB4281
NM6s(Y67057)
CommentCurrently not ready. Hybridoma against NM6s : Myotubularin related protein 6 (1-100(100aa)) antigen.
Comment from the depositor
RCB4282
NM6s(Y67081)
CommentCurrently not ready. Hybridoma against NM6s : Myotubularin related protein 6 (1-100(100aa)) antigen.
Comment from the depositor
RCB4283
NM6s(Y67109)
CommentCurrently not ready. Hybridoma against NM6s : Myotubularin related protein 6 (1-100(100aa)) antigen.
Comment from the depositor
RCB4284
CM1s(Z1001)
CommentCurrently not ready. Hybridoma against CM1s : Myotubular myopathy 1 (555-604(50aa)) antigen.
Comment from the depositor
RCB4285
CM1s(Z1002)
CommentCurrently not ready. Hybridoma against CM1s : Myotubular myopathy 1 (555-604(50aa)) antigen.
Comment from the depositor
RCB4286
CM1s(Z1014)
CommentCurrently not ready. Hybridoma against CM1s : Myotubular myopathy 1 (555-604(50aa)) antigen.
Comment from the depositor
RCB4287
CM1s(Z1016)
CommentCurrently not ready. Hybridoma against CM1s : Myotubular myopathy 1 (555-604(50aa)) antigen.
Comment from the depositor
RCB4288
CM1s(Z1057)
CommentCurrently not ready. Hybridoma against CM1s : Myotubular myopathy 1 (555-604(50aa)) antigen.
Comment from the depositor
RCB4289
CM6(Y9506)
CommentCurrently not ready. Hybridoma against CM6 : Myotubularin related protein 6 (519-618(100aa)) antigen.
Comment from the depositor
RCB4290
CM6(Y9512)
CommentCurrently not ready. Hybridoma against CM6 : Myotubularin related protein 6 (519-618(100aa)) antigen.
Comment from the depositor
RCB4291
CM6(Y9515)
CommentCurrently not ready. Hybridoma against CM6 : Myotubularin related protein 6 (519-618(100aa)) antigen.
Comment from the depositor
RCB4292
CM6(Y9517)
CommentCurrently not ready. Hybridoma against CM6 : Myotubularin related protein 6 (519-618(100aa)) antigen.
Comment from the depositor
RCB4293
hVir-2(Y1503)
CommentCurrently not ready. Hybridoma against hVir-2 : Virilizer (561-611(51aa)) antigen.
Comment from the depositor
RCB4294
hVir-2(Y1513)
CommentCurrently not ready. Hybridoma against hVir-2 : Virilizer (561-611(51aa)) antigen.
Comment from the depositor
RCB4295
hVir-2(Y1523)
CommentCurrently not ready. Hybridoma against hVir-2 : Virilizer (561-611(51aa)) antigen.
Comment from the depositor
RCB4296
hVir-3(Y1613)
CommentCurrently not ready. Hybridoma against hVir-3 : Virilizer (1421-1480(60aa)) antigen.
Comment from the depositor
RCB4297
hVir-3(Y1625(4C3))
CommentCurrently not ready. Hybridoma against hVir-3 : Virilizer (1421-1480(60aa)) antigen.
Comment from the depositor
RCB4298
hVir-3(Y1639)
CommentCurrently not ready. Hybridoma against hVir-3 : Virilizer (1421-1480(60aa)) antigen.
Comment from the depositor
RCB4299
WTAP(Y6809)
CommentCurrently not ready. Hybridoma against WTAP : Wilms tumor 1 associated protein (6-76(71aa)) antigen.
Comment from the depositor
RCB4300
WTAP(Y6828)
CommentCurrently not ready. Hybridoma against WTAP : Wilms tumor 1 associated protein (6-76(71aa)) antigen.
Comment from the depositor
RCB4301
hFRS2β1(Y7610)
CommentCurrently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
Comment from the depositor
RCB4302
hFRS2β1(Y7612)
CommentCurrently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
Comment from the depositor
RCB4303
hFRS2β1(Y7624)
CommentCurrently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
Comment from the depositor
RCB4304
hFRS2β1(Y7632)
CommentCurrently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
Comment from the depositor
RCB4305
hFRS2β1(Y7641)
CommentCurrently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
Comment from the depositor
RCB4306
hFRS2β1(Y7642)
CommentCurrently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
Comment from the depositor
RCB4307
hFRS2β1(Y7643)
CommentCurrently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
Comment from the depositor
RCB4308
mNFATC-N(Y7402)
CommentCurrently not ready. Hybridoma against mNFATC-N : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (43-143(101aa)) antigen.
Comment from the depositor
RCB4309
mNFATC-N(Y7405)
CommentCurrently not ready. Hybridoma against mNFATC-N : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (43-143(101aa)) antigen.
Comment from the depositor
RCB4310
mNFATC-N(Y7428)
CommentCurrently not ready. Hybridoma against mNFATC-N : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (43-143(101aa)) antigen.
Comment from the depositor
RCB4311
mNFATC-N(Y7445)
CommentCurrently not ready. Hybridoma against mNFATC-N : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (43-143(101aa)) antigen.
Comment from the depositor
RCB4312
hEgr1(N8605)
CommentCurrently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
Comment from the depositor
RCB4313
hEgr1(N8611)
CommentCurrently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
Comment from the depositor
RCB4314
hEgr1(N8614)
CommentCurrently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
Comment from the depositor
RCB4315
hEgr1(N8616)
CommentCurrently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
Comment from the depositor
RCB4316
hEgr1(N8637)
CommentCurrently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
Comment from the depositor
RCB4317
hEgr1(N8640)
CommentCurrently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
Comment from the depositor
RCB4318
hEgr3(N8701)
CommentCurrently not ready. Hybridoma against hEgr3 : Early growth response 3 (27-82(56aa)) antigen.
Comment from the depositor
RCB4319
hEgr3(N8730)
CommentCurrently not ready. Hybridoma against hEgr3 : Early growth response 3 (27-82(56aa)) antigen.
Comment from the depositor
RCB4320
Prdm8-2(N8501)
CommentCurrently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
Comment from the depositor
RCB4321
Prdm8-2(N8506)
CommentCurrently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
Comment from the depositor
RCB4322
Prdm8-2(N8508)
CommentCurrently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
Comment from the depositor
RCB4323
Prdm8-2(N8513)
CommentCurrently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
Comment from the depositor
RCB4324
Prdm8-2(N8520)
CommentCurrently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
Comment from the depositor
RCB4325
Prdm8-2(N8526)
CommentCurrently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
Comment from the depositor
RCB4326
Prdm8-2(N8533)
CommentCurrently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
Comment from the depositor
RCB4327
Aggrecan-1(Y3416)
CommentCurrently not ready. Hybridoma against Aggrecan-1 : Aggrecan (2168-2223(56aa)) antigen.
Comment from the depositor
RCB4328
Aggrecan-1(Y3428)
CommentCurrently not ready. Hybridoma against Aggrecan-1 : Aggrecan (2168-2223(56aa)) antigen.
Comment from the depositor
RCB4329
Aggrecan-1(Y3431)
CommentCurrently not ready. Hybridoma against Aggrecan-1 : Aggrecan (2168-2223(56aa)) antigen.
Comment from the depositor
RCB4330
Aggrecan-1(Y3441)
CommentCurrently not ready. Hybridoma against Aggrecan-1 : Aggrecan (2168-2223(56aa)) antigen.
Comment from the depositor
RCB4331
Aggrecan-1(Y3446)
CommentCurrently not ready. Hybridoma against Aggrecan-1 : Aggrecan (2168-2223(56aa)) antigen.
Comment from the depositor
RCB4332
PTX3N46(Z3805(421))
CommentCurrently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
Comment from the depositor
RCB4333
PTX3N46(Z3818-1-19)
CommentCurrently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
Comment from the depositor
RCB4334
PTX3N46(Z3821(100))
CommentCurrently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
Comment from the depositor
RCB4335
PTX3N46(Z3825(125))
CommentCurrently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
Comment from the depositor
RCB4336
PTX3N46(Z3829-156)
CommentCurrently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
Comment from the depositor
RCB4337
PTX3N46(Z3835-467)
CommentCurrently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
Comment from the depositor
RCB4338
PTX3N46(Z3839-590)
CommentCurrently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
Comment from the depositor
RCB4339
CBLL1-2(Y6018)
CommentCurrently not ready. Hybridoma against CBLL1-2 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (430-491(62aa)) antigen.
Comment from the depositor
RCB4340
CBLL1-2(Y6026)
CommentCurrently not ready. Hybridoma against CBLL1-2 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (430-491(62aa)) antigen.
Comment from the depositor
RCB4341
CBLL1-2(Y6037)
CommentCurrently not ready. Hybridoma against CBLL1-2 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (430-491(62aa)) antigen.
Comment from the depositor
RCB4342
CBLL1-2(Y6047)
CommentCurrently not ready. Hybridoma against CBLL1-2 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (430-491(62aa)) antigen.
Comment from the depositor
RCB4343
CBLL1-2(Y6048)
CommentCurrently not ready. Hybridoma against CBLL1-2 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (430-491(62aa)) antigen.
Comment from the depositor
RCB4344
CBLL1-1(Y6610)
CommentCurrently not ready. Hybridoma against CBLL1-1 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (5-70(66aa)) antigen.
Comment from the depositor
RCB4345
CBLL1-1(Y6621)
CommentCurrently not ready. Hybridoma against CBLL1-1 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (5-70(66aa)) antigen.
Comment from the depositor
RCB4346
CBLL1-1(Y6641)
CommentCurrently not ready. Hybridoma against CBLL1-1 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (5-70(66aa)) antigen.
Comment from the depositor
RCB4347
PDZ-CS(Y7501)
CommentCurrently not ready. Hybridoma against PDZ-CS : Rho guanine nucleotide exchange factor (GEF) 11 (1423-1522(100aa)) antigen.
Comment from the depositor
RCB4348
PDZ-CS(Y7504)
CommentCurrently not ready. Hybridoma against PDZ-CS : Rho guanine nucleotide exchange factor (GEF) 11 (1423-1522(100aa)) antigen.
Comment from the depositor
RCB4349
PDZ-CS(Y7505)
CommentCurrently not ready. Hybridoma against PDZ-CS : Rho guanine nucleotide exchange factor (GEF) 11 (1423-1522(100aa)) antigen.
Comment from the depositor
RCB4350
PDZ-CS(Y7534)
CommentCurrently not ready. Hybridoma against PDZ-CS : Rho guanine nucleotide exchange factor (GEF) 11 (1423-1522(100aa)) antigen.
Comment from the depositor
RCB4351
PDZ-CS(Y7537)
CommentCurrently not ready. Hybridoma against PDZ-CS : Rho guanine nucleotide exchange factor (GEF) 11 (1423-1522(100aa)) antigen.
Comment from the depositor
RCB4352
Ets-1 Mid(Y8012)
CommentCurrently not ready. Hybridoma against Ets-1 Mid : v-ets erythroblastosis virus E26 oncogene homolog 1 (220-304(85aa)) antigen.
Comment from the depositor
RCB4353
Ets-1 Mid(Y8020)
CommentCurrently not ready. Hybridoma against Ets-1 Mid : v-ets erythroblastosis virus E26 oncogene homolog 1 (220-304(85aa)) antigen.
Comment from the depositor
RCB4354
Ets-1 Mid(Y8029)
CommentCurrently not ready. Hybridoma against Ets-1 Mid : v-ets erythroblastosis virus E26 oncogene homolog 1 (220-304(85aa)) antigen.
Comment from the depositor
RCB4355
prdm 5(C2518A)
CommentCurrently not ready. Hybridoma against gp64 fusion prdm 5 : PR domain containing 5 (10-110(101aa)) antigen expressed by baculovirus.
Comment from the depositor
RCB4356
RGS3T(C6501-4)
CommentCurrently not ready. Hybridoma against RGS3T : regular of G protein signaling 3 (full length) antigen.
Comment from the depositor
RCB4357
Gq(C6604-5)
CommentCurrently not ready. Hybridoma against Gq : GNAQ (full length) antigen.
Comment from the depositor
RCB4358
Gq(C6611A-11-A2)
CommentCurrently not ready. Hybridoma against Gq : GNAQ (full length) antigen.
Comment from the depositor
RCB4359
Gq(C6611B-35-18)
CommentCurrently not ready. Hybridoma against Gq : GNAQ (full length) antigen.
Comment from the depositor
RCB4360
Gq(C6618-81)
CommentCurrently not ready. Hybridoma against Gq : GNAQ (full length) antigen.
Comment from the depositor
RCB4361
Gq(C6623-18)
CommentCurrently not ready. Hybridoma against Gq : GNAQ (full length) antigen.
Comment from the depositor
RCB4362
Gα13(C9101-F5-1)
CommentCurrently not ready. Hybridoma against Gα13 : GNA12 (full length) antigen.
Comment from the depositor
RCB4363
Gα13(C9201-B5-4)
CommentCurrently not ready. Hybridoma against Gα13 : GNA13 (full length) antigen.
Comment from the depositor
RCB4364
Gα13(C9202-F9-1)
CommentCurrently not ready. Hybridoma against Gα13 : GNA13 (full length) antigen.
Comment from the depositor
RCB4365
Gα13(C9204-D4-1)
CommentCurrently not ready. Hybridoma against Gα13 : GNA13 (full length) antigen.
Comment from the depositor
RCB4366
Gα13(C9205-F6-4)
CommentCurrently not ready. Hybridoma against Gα13 : GNA13 (full length) antigen.
Comment from the depositor
RCB4367
Gα12(D0901-A1-E11)
CommentCurrently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
Comment from the depositor
RCB4368
Gα12(D0902-B12-G11)
CommentCurrently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
Comment from the depositor
RCB4369
Gα12(D0904-A6-H2)
CommentCurrently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
Comment from the depositor
RCB4370
Gα12(D0906-B10-D6)
CommentCurrently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
Comment from the depositor
RCB4371
Gα12(D0907-E2-E8)
CommentCurrently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
Comment from the depositor
RCB4372
Gα12(D0908-G5-A6)
CommentCurrently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
Comment from the depositor
RCB4373
Gα12(D0910-G5-D10)
CommentCurrently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
Comment from the depositor
RCB4374
Gα12(D0911-E6-G1)
CommentCurrently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
Comment from the depositor
RCB4375
Gα12(D0912-B5-C9)
CommentCurrently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
Comment from the depositor
RCB4376
Gα12(D0914-D5-D4)
CommentCurrently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
Comment from the depositor
RCB4377
NFATC-3(Z2705)
CommentCurrently not ready. Hybridoma against NFATC-3 : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (35-107(73aa)) antigen.
Comment from the depositor
RCB4378
mOSR-2(Z2914)
CommentCurrently not ready. Hybridoma against mOSR-2 : Odd-skipped related 2 (59-157(99aa) antigen.
Comment from the depositor
RCB4379
ATOX1(Z3101)
CommentCurrently not ready. Hybridoma against ATOX1 : ATX1 antioxidant protein 1 homolog (68AA) antigen.
Comment from the depositor
RCB4380
ATOX1(Z3112)
CommentCurrently not ready. Hybridoma against ATOX1 : ATX1 antioxidant protein 1 homolog (68AA) antigen.
Comment from the depositor
RCB4381
ATOX1(Z3138)
CommentCurrently not ready. Hybridoma against ATOX1 : ATX1 antioxidant protein 1 homolog (68AA) antigen.
Comment from the depositor
RCB4382
ATOX1(Z3140)
CommentCurrently not ready. Hybridoma against ATOX1 : ATX1 antioxidant protein 1 homolog (68AA) antigen.
Comment from the depositor
RCB4383
ATOX1(Z3144)
CommentCurrently not ready. Hybridoma against ATOX1 : ATX1 antioxidant protein 1 homolog (68AA) antigen.
Comment from the depositor
RCB4384
MAN-1(Z4201)
CommentCurrently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
Comment from the depositor
RCB4385
MAN-1(Z4202)
CommentCurrently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
Comment from the depositor
RCB4386
MAN-1(Z4205)
CommentCurrently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
Comment from the depositor
RCB4387
MAN-1(Z4209)
CommentCurrently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
Comment from the depositor
RCB4388
MAN-1(Z4221)
CommentCurrently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
Comment from the depositor
RCB4389
MAN-1(Z4222)
CommentCurrently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
Comment from the depositor
RCB4390
MAN-1(Z4223)
CommentCurrently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
Comment from the depositor
RCB4391
MAN-1(Z4237)
CommentCurrently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
Comment from the depositor
RCB4392
SETDB-1(Z4601)
CommentCurrently not ready. Hybridoma against SETDB-1 : SET domain, bifurcated 1 (1025-1080(56aa)) antigen.
Comment from the depositor
RCB4393
SETDB-1(Z4606)
CommentCurrently not ready. Hybridoma against SETDB-1 : SET domain, bifurcated 1 (1025-1080(56aa)) antigen.
Comment from the depositor
RCB4394
SETDB-1(Z4613)
CommentCurrently not ready. Hybridoma against SETDB-1 : SET domain, bifurcated 1 (1025-1080(56aa)) antigen.
Comment from the depositor
RCB4395
SETDB-1(Z4630)
CommentCurrently not ready. Hybridoma against SETDB-1 : SET domain, bifurcated 1 (1025-1080(56aa)) antigen.
Comment from the depositor
RCB4396
mp250GAP(Z4906)
CommentCurrently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
Comment from the depositor
RCB4397
mp250GAP(Z4932)
CommentCurrently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
Comment from the depositor
RCB4398
mp250GAP(Z4937)
CommentCurrently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
Comment from the depositor
RCB4399
mp250GAP(Z4942)
CommentCurrently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
Comment from the depositor
RCB4400
mp250GAP(Z4946)
CommentCurrently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
Comment from the depositor
RCB4401
mp250GAP(Z4947)
CommentCurrently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
Comment from the depositor
RCB4402
SETD5-1(Z5235-36)
CommentCurrently not ready. Hybridoma against SETD5-1 : SET domain containing 5 (43-93(51aa)) antigen.
Comment from the depositor
RCB4403
SETD5-1(Z5235-42)
CommentCurrently not ready. Hybridoma against SETD5-1 : SET domain containing 5 (43-93(51aa)) antigen.
Comment from the depositor
RCB4404
NFATC1-2(Z5302)
CommentCurrently not ready. Hybridoma against NFATC1-2 : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (134-223(90aa)) antigen.
Comment from the depositor
RCB4405
NFATC1-2(Z5321)
CommentCurrently not ready. Hybridoma against NFATC1-2 : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (134-223(90aa)) antigen.
Comment from the depositor
RCB4406
GluR1-1(Z6114)
CommentCurrently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
Comment from the depositor
RCB4407
GluR1-1(Z6119)
CommentCurrently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
Comment from the depositor
RCB4408
GluR1-1(Z6123)
CommentCurrently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
Comment from the depositor
RCB4409
GluR1-1(Z6135)
CommentCurrently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
Comment from the depositor
RCB4410
GluR1-1(Z6141)
CommentCurrently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
Comment from the depositor
RCB4411
GluR1-1(Z6143)
CommentCurrently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
Comment from the depositor
RCB4412
SETD5-4(Z5702-3)
CommentCurrently not ready. Hybridoma against SETD5-4 : SET domain containing 5 (1241-1291(51aa)) antigen.
Comment from the depositor
RCB4413
SETD5-4(Z5704-209)
CommentCurrently not ready. Hybridoma against SETD5-4 : SET domain containing 5 (1241-1291(51aa)) antigen.
Comment from the depositor
RCB4414
SETD5-4(Z5708-71)
CommentCurrently not ready. Hybridoma against SETD5-4 : SET domain containing 5 (1241-1291(51aa)) antigen.
Comment from the depositor
RCB4415
SETD5-4(Z5714-114)
CommentCurrently not ready. Hybridoma against SETD5-4 : SET domain containing 5 (1241-1291(51aa)) antigen.
Comment from the depositor
RCB4416
SETD5-4(Z5721-234)
CommentCurrently not ready. Hybridoma against SETD5-4 : SET domain containing 5 (1241-1291(51aa)) antigen.
Comment from the depositor
RCB4417
PRMT1-N(Z5017)
CommentCurrently not ready. Hybridoma against PRMT1-N : Protein arginine methyltransferase 1 (7-56(50aa)) antigen.
Comment from the depositor
RCB4418
PRMT1-N(Z5018)
CommentCurrently not ready. Hybridoma against PRMT1-N : Protein arginine methyltransferase 1 (7-56(50aa)) antigen.
Comment from the depositor
RCB4419
PRMT1-N(Z5026)
CommentCurrently not ready. Hybridoma against PRMT1-N : Protein arginine methyltransferase 1 (7-56(50aa)) antigen.
Comment from the depositor
RCB4420
NM1S/Tg(Z7332)
CommentCurrently not ready. Hybridoma against NM1S/Tg : Myotubular myopathy 1 (1-50(50aa)) antigen.
Comment from the depositor
RCB4421
NM1S/Tg(Z7342)
CommentCurrently not ready. Hybridoma against NM1S/Tg : Myotubular myopathy 1 (1-50(50aa)) antigen.
Comment from the depositor
RCB4422
CM3(Z7511)
CommentCurrently not ready. Hybridoma against CM3 : Myotubularin related protein 3 (1111-1161(51aa)) antigen.
Comment from the depositor
RCB4423
CM3(Z7528)
CommentCurrently not ready. Hybridoma against CM3 : Myotubularin related protein 3 (1111-1161(51aa)) antigen.
Comment from the depositor
RCB4424
CM3(Z7536)
CommentCurrently not ready. Hybridoma against CM3 : Myotubularin related protein 3 (1111-1161(51aa)) antigen.
Comment from the depositor
RCB4425
NM3(Z8021)
CommentCurrently not ready. Hybridoma against NM3 : Myotubularin related protein 3 (1-50(50aa)) antigen.
Comment from the depositor
RCB4426
CM4/Tg(Z8214)
CommentCurrently not ready. Hybridoma against CM4/Tg : Myotubularin related protein 4 (909-959(51aa)) antigen.
Comment from the depositor
RCB4427
CM4/Tg(Z8217)
CommentCurrently not ready. Hybridoma against CM4/Tg : Myotubularin related protein 4 (909-959(51aa)) antigen.
Comment from the depositor
RCB4428
CM4/Tg(Z8245B)
CommentCurrently not ready. Hybridoma against CM4/Tg : Myotubularin related protein 4 (909-959(51aa)) antigen.
Comment from the depositor
RCB4429
Fbxl 10-N(Z8310)
CommentCurrently not ready. Hybridoma against Fbxl 10-N : F-box and leucine-rich repeat protein 10 (45-92(48aa)) antigen.
Comment from the depositor
RCB4430
Fbxl 10-N(Z8312)
CommentCurrently not ready. Hybridoma against Fbxl 10-N : F-box and leucine-rich repeat protein 10 (45-92(48aa)) antigen.
Comment from the depositor
RCB4431
Fbxl 10-N(Z8320)
CommentCurrently not ready. Hybridoma against Fbxl 10-N : F-box and leucine-rich repeat protein 10 (45-92(48aa)) antigen.
Comment from the depositor
RCB4432
Fbxl 10-N(Z8327)
CommentCurrently not ready. Hybridoma against Fbxl 10-N : F-box and leucine-rich repeat protein 10 (45-92(48aa)) antigen.
Comment from the depositor
RCB4433
Fbxl 10-N(Z8345)
CommentCurrently not ready. Hybridoma against Fbxl 10-N : F-box and leucine-rich repeat protein 10 (45-92(48aa)) antigen.
Comment from the depositor
RCB4434
LARG-C term(D4004-4E2-6)
CommentCurrently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
Comment from the depositor
RCB4435
LARG-C term(D4005-6A6-29)
CommentCurrently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
Comment from the depositor
RCB4436
LARG-C term(D4101-2G11-41)
CommentCurrently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
Comment from the depositor
RCB4437
LARG-C term(D4106-5G1-67)
CommentCurrently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
Comment from the depositor
RCB4438
LARG-C term(D4107-5H2-110)
CommentCurrently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
Comment from the depositor
RCB4439
LARG-C term(D4202-2E6-130)
CommentCurrently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
Comment from the depositor
RCB4440
LARG-C term(D4204-1A10-163)
CommentCurrently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
Comment from the depositor
RCB4441
LARG-C term(D4205-2A9-213)
CommentCurrently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
Comment from the depositor
RCB4442
LARG-C term(D4206-2B8-221)
CommentCurrently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
Comment from the depositor
RCB4443
LARG-C term(D4207-2D10-262)
CommentCurrently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
Comment from the depositor
RCB4444
Emerin Ab-3(D2702-12)
CommentCurrently not ready. Hybridoma against Emerin Ab-3 : Emerin (48-110(63aa)) antigen.
Comment from the depositor
RCB4445
Emerin Ab-3(D2703-2)
CommentCurrently not ready. Hybridoma against Emerin Ab-3 : Emerin (48-110(63aa)) antigen.
Comment from the depositor
RCB4446
Emerin Ab-3(D2704-5)
CommentCurrently not ready. Hybridoma against Emerin Ab-3 : Emerin (48-110(63aa)) antigen.
Comment from the depositor
RCB4447
Emerin Ab-3(D2705-2)
CommentCurrently not ready. Hybridoma against Emerin Ab-3 : Emerin (48-110(63aa)) antigen.
Comment from the depositor
RCB4448
Emerin Ab-3(D2738-2)
CommentCurrently not ready. Hybridoma against Emerin Ab-3 : Emerin (48-110(63aa)) antigen.
Comment from the depositor
RCB4451
UPS-1
CommentSub-line of CHO-K1 which is defective in the non-endocytic uptake of fluorescent analogs of phosphatidylserine (C6-NBD-PS).
Comment from the depositor
RCB4452
FL-YB
CommentMouse follicular dendritic cell line
Comment from the depositor
RCB4455
PC-9
CommentHuman cell line derived from lung adenocarcinoma cells. Differentiated type. Previous name:PC-14(RCB0446)
Comment from the depositor
RCB4467
TIG-1
CommentHuman lung-derived adherent cells. The origin is not cancer.
Comment from the depositor
RCB4468
TIG-3
CommentHuman lung-derived adherent cells. The origin is not cancer.
Comment from the depositor
RCB4469
TIG-7
CommentHuman lung-derived adherent cells. The origin is not cancer.
Comment from the depositor
RCB4472
IN-IC
CommentRat cell line derived from kidney.
Comment from the depositor
RCB4474
Ba/F3-CL1
CommentMouse pro-B cell line derived from C3H strain. IL-3 dependent. After cloning (RCB0805 Ba/F3). Information
Comment from the depositor
RCB4476
Ba/F3
CommentMouse pro-B cell line derived from C3H strain. IL-3 dependent. Information
Comment from the depositor
RCB4477
ACK2
CommentHybridoma cell line producing anti-mouse c-kit (CD117) antibody.
Comment from the depositor
RCB4478
ACK4
CommentHybridoma cell line producing anti-mouse c-kit (CD117) antibody.
Comment from the depositor
RCB4479
ACK30
CommentHybridoma cell line producing anti-mouse c-kit (CD117) antibody.
Comment from the depositor
RCB4480
ACK45
CommentHybridoma cell line producing anti-mouse c-kit (CD117) antibody.
Comment from the depositor
RCB4481
A7R34
CommentHybridoma cell line producing anti-mouse IL-7 Receptor alpha (CD127) antibody.
Comment from the depositor
RCB4482
APA5
CommentHybridoma cell line producing anti-mouse PDGF Receptor alpha (CD140a) antibody.
Comment from the depositor
RCB4483
APB5
CommentHybridoma cell line producing anti-mouse PDGF Receptor beta (CD140b) antibody.
Comment from the depositor
RCB4484
Avas12
CommentHybridoma cell line producing anti-mouse Flk-1/VEGF-Receptor 2 (CD309) antibody.
Comment from the depositor
RCB4485
A2F10
CommentHybridoma cell line producing anti-mouse Flk-2/Flt-3 (CD135) antibody.
Comment from the depositor
RCB4486
AFS98
CommentHybridoma cell line producing anti-mouse c-fms (CD115) antibody.
Comment from the depositor
RCB4487
ACD1
CommentHybridoma cell line producing anti-mouse CDK4 antibody.
Comment from the depositor
RCB4488
AFL4
CommentHybridoma cell line producing anti-mouse VEGF-Receptor 3 antibody.Application consideration
Comment from the depositor
RCB4489
MB86
CommentHybridoma cell line producing anti-mouse IgM(b)/Igh6b antibody.
Comment from the depositor
RCB4495
BL2-5-8
Comment
Comment from the depositorA reporter cell line derived from a mouse hematopoietic cell line, Ba/F3, for identification of proteins that are translocated into or out of the nucleus in response to an extracellular stimulus and other changes in cell status using the inducible translocation trap (ITT) technology. The cell line can also be used for screening of compounds affecting inducible nuclear translocation and nuclear export by ITT. The human CD2 (hCD2) gene is used as reporter gene.
RCB4496
BLG-139-3
Comment
Comment from the depositorA reporter cell line derived from a mouse hematopoietic cell line, Ba/F3, for identification of proteins that are translocated into or out of the nucleus in response to an extracellular stimulus and other changes in cell status using the inducible translocation trap (ITT) technology. The cell line can also be used for screening of compounds affecting inducible nuclear translocation and nuclear export by ITT. The green fluorescent protein (GFP) gene is used as reporter gene.
RCB4497
BBLG-50-1
Comment
Comment from the depositorA reporter cell line derived from the BB13 cell line for identification of proteins that are translocated into or out of the nucleus in response to an extracellular stimulus and other changes in cell status using the inducible translocation trap (ITT) technology. The cell line can also be used for screening of compounds affecting inducible nuclear translocation and nuclear export by ITT. BB13 is derived from a mouse hematopoietic cell line, Ba/F3, and ectopically expresses epidermal growth factor receptor (EGFR) and the anti-apoptotic Bcl-2 protein. BB13 can survive in the absence of IL-3 if EGF is present. The green fluorescent protein (GFP) gene is used as reporter gene.
RCB4498
NP 2
CommentHuman cell line derived from anaplastic glioma.
Comment from the depositor
RCB4499
Onda 10
CommentHuman cell line derived from anaplastic glioma.
Comment from the depositor
RCB4500
Onda 11
CommentHuman cell line derived from glioblastoma.
Comment from the depositor
RCB4504
NP 3
CommentHuman cell line derived from anaplastic glioma.
Comment from the depositor
RCB4505
NP 5
CommentHuman cell line derived from anaplastic glioma.
Comment from the depositor
RCB4516
STIM2^(-/-)DT40
CommentA subline of avian cell line, DT40, lacking STIM2 gene.
Comment from the depositor
RCB4517
STIM1^(-/-)STIM2^(-/-)DT40
CommentA subline of avian cell line, DT40, lacking both STIM1 and STIM2 genes.
Comment from the depositor
RCB4518
Orai1^(-/-)DT40
CommentA subline of avian cell line, DT40, lacking Orai1 gene.
Comment from the depositor
RCB4519
Orai2^(-/-)DT40
CommentA subline of avian cell line, DT40, lacking Orai2 gene.
Comment from the depositor
RCB4548
PT-r
CommentRat cell line derived from parathyroid gland.
Comment from the depositor
RCB4554
HiDEP-1
CommentHuman erythroid progenitor cell line derived from iPS cells. Expressing fetal type hemoglobin.
Comment from the depositor
RCB4555
HiDEP-2
CommentHuman erythroid progenitor cell line derived from iPS cells. Expressing fetal type hemoglobin.
Comment from the depositor
RCB4556
HUDEP-1
CommentHuman erythroid progenitor cell line derived from umbilical cord blood cells. Expressing fetal type hemoglobin.
Comment from the depositor
RCB4557
HUDEP-2
CommentHuman erythroid progenitor cell line derived from umbilical cord blood cells. Expressing adult type hemoglobin.
Comment from the depositor
RCB4561
MOLT-17
CommentHuman cell line derived from T cell leukemia (T-ALL). Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to DSMZ no.: ACC 36 prior to order.
Comment from the depositor
RCB4562
HUDEP-3
CommentHuman erythroid progenitor cell line derived from umbilical cord blood cells. Expressing fetal type hemoglobin.
Comment from the depositor
RCB4563
TSt-4/N-DLL4
CommentOriginal murine mesenchymal cell line was derived from fetal thymus tissue. A line Expressing DLL4 gene.
Comment from the depositor
RCB4566
TEC1C8
CommentCulture of Thymic Epithelial Cell Lines., Protocol (pdf:120KB)
Comment from the depositorA mouse thymic cortical epithelial cell. It does not have the ability to present soluble antigen to its antigen specific helper T cells. This cell line is available to analyze the functions of cortical epithelial cells and medullary epithelial cells that control the differentiation and selection of intrathymic T cells. It is also useful for attempts such as thymus reconstruction using these cell lines, aiming at such functional recovery.
RCB4568
TEC2-3
CommentCulture of Thymic Epithelial Cell Lines., Protocol (pdf:120KB)
Comment from the depositorA mouse thymic medullary epithelial cell line. It has the ability to present soluble antigen to its antigen specific helper T cells. This cell line is available to analyze the functions of cortical epithelial cells and medullary epithelial cells that control the differentiation and selection of intrathymic T cells. It is also useful for attempts such as thymus reconstruction using these cell lines, aiming at such functional recovery.
RCB4569
TEC3-10
CommentCulture of Thymic Epithelial Cell Lines., Protocol (pdf:120KB)
Comment from the depositorA mouse thymic medullary epithelial cell line. It has the ability to present soluble antigen to its antigen specific helper T cells. This cell line is available to analyze the functions of cortical epithelial cells and medullary epithelial cells that control the differentiation and selection of intrathymic T cells. It is also useful for attempts such as thymus reconstruction using these cell lines, aiming at such functional recovery.
RCB4592
r/mHM-SFME-1
Comment
Comment from the depositorIn 1987, D.Loo et al at D.Barnes lab established a pre-glial cell line SFME from Balb/c mouse embryo in serum free condition. C.Rawson et al established a tumorigenic but non-metastatic transformed cell line, ras/mycSFME, by introducing active human cH-ras and mouse c-myc into SFME cells in 1992. T.Nomura et al introduced pSV2neo into ras/mycSFME cells and discovered metastatic cells in syngeneic host lungs. Obtained mtastatic cells no longer showed neomycin resistancy. The r/mHM-SFME-1 cell line, an experimental tumor cell line carrying metastatic ability in immuno-competent Balb/c mouse, was established from the mtastasized lung in 1993 by cloning from soft agar colony,.
RCB4593
CALM WT MEF
CommentCALM non-deficient MEF cells. Tranformed with SV40 large T antigen gene.
Comment from the depositor
RCB4594
CALM KO MEF
CommentCALM deficient MEF cells. Tranformed with SV40 large T antigen gene.
Comment from the depositor
RCB4623
Ba/ER
CommentBa/ER was created by stable transfection of murine pro-B Ba/F3 cells with a murine erythropoietin receptor gene. Ba/ER proliferates dependent on erythropoietin or interleukin-3.
Comment from the depositor
RCB4627
KUP5
Comment
Comment from the depositorAn immortalized mouse Kupffer cell line established from C57BL/6 strain. The Kupffer cells were proliferated in the mixed primary culture of C57BL/6 adult mouse liver cells, then infected with a replication-deficient retroviral vector containing the human c-myc oncogene and neomycin resistance gene, isolated and selected with G418 (cloned by a limited dilution). No significant production of infectious viral particles from KUP5 cells was confirmed by bioassay using SC-1 cells.
RCB4635
#16-15
CommentHybridoma cell line producing anti-human BEND3 antibody (rat IgM).
Comment from the depositor
RCB4661
Hepa/8F5
CommentCurrently not ready.
Comment from the depositorHepa/8F5 derived from mouse hepatoma Hepa1-6 [RCB1638] cells was established by introducing doxycycline (Dox)-inducible eight liver-enriched transcription factor (LETF) genes. Upon overexpression of LETF genes by Dox addition, cell proliferation ceases and the cells change the morphology expressing high liver functions.
RCB4662
HCT116 CMV-OsTIR1
Commentcf.: Kanemaki’s Auxin Inducible Degron (AID) System
Comment from the depositorThis is an HCT116 cell line in which CMV-OsTIR1 (pMK232, PURO) was introduced at the both alleles of the AAVS1 locus by using CRISPR/Cas.This parental cell line consitutively express OsTIR1 and can be used for generation of AID mutants.
RCB4664
d5P
Comment
Comment from the depositorRenal cell carcinoma cell line d5P has established from renal tubule cells of Crlj:WI rat. Moreover this cell line is able to do transplantation for wild type Crlj:WI rat.
RCB4665
d5krm7
Comment
Comment from the depositord5krm7 cell line has established from d5P cell line. Moreover this cell line has highly metastatic activity to lung by intracapsular transplantation.
RCB4666
d5krm3
Comment
Comment from the depositord5krm3 cell line has established from d5P cell line. Moreover this cell line has highly metastatic activity to lung by intracapsular transplantation.
RCB4667
id5P
Comment
Comment from the depositorRenal cell carcinoma cell line d5P has established from renal tubule cells of Crli:WI rat. Moreover this cell line is able to do transplantation for wild type CrlJ:WI rat.
RCB4668
id5krm7
Comment
Comment from the depositorid5krm7 cell line has established from d5P cell line. Moreover this cell line has highly metastatic activity to lung by intracapsular transplantation.
RCB4669
id5krm3
Comment
Comment from the depositorid5krm3 cell line has established from d5P cell line. Moreover this cell line has highly metastatic activity to lung by intracapsular transplantation.
RCB4670
KN7
Comment
Comment from the depositorKN7 is an anti-idiyotypic antibody for TCRVα5Vβ11 on CD4 T celIs wihich recognize Peptide-25 of A285B from Mycobacterium tuberculosis.
RCB4676
HeLa/Fucci(CA)2
CommentImportant notice regarding nomenclature of Fucci.
Comment from the depositorA subline of the HeLa cell line expressing Fucci(CA)2, a cell cycle marker.
RCB4679
HepG2-NIAS
CommentA subline of Hep G2 cells that can not only rapidly activate hepatic functions such as albumin secretion, urea synthesis and CYP3A4 activity but also induce the formation of bile canaliculus-like structures by utilizing a collagen vitrigel membrane as a culture substratum.
Comment from the depositorHep G2 cells (RCB1648) described as a backup of ECA2870 derived from ECACC were conditioned in culture using a DMEM containing 10% heat-inactivated FBS, 20mM HEPES 100U/ml penicillin and 100μg/ml streptomycin. By the use of collagen vitrigel membrane as a culture substratum, hepatic functions such as albumin secretion, urea synthesis and CYP3A4 activity were rapidly activated, and also the formation of bile canaliculus-like structures were induced.
RCB4680
MS-5
CommentMouse stromal cell line which supports hematopoietic cells.
Comment from the depositor
RCB4681
MS-K
CommentMurine cell line derived from sarcoma.
Comment from the depositor
RCB4683
6330403Rik
Comment
Comment from the depositorAnti-6330403k07Rik antibody production hybridoma cell
RCB4684
celf3
Comment
Comment from the depositorAnti-Celf3 antibody production hybridoma cell
RCB4685
Dgcr14
Comment
Comment from the depositorAnti-Dgcr14 antibody production hybridoma cell
RCB4687
HEK-Dsup
Comment
Comment from the depositorA subline of the HEK293(RCB1637) cells. Stably expressing Damage suppressor (Dsup). Radio-resistance. Dsup is a tardigrade-unique DNA protection protein.
RCB4688
HEK-DsupKD
Comment
Comment from the depositorA subline of the HEK293(RCB1637) cells. Expressing shRNA against Dsup in HEK-Dsup celIs. Dsup is a tardigrade-unique DNA protection protein.
RCB4689
HEK-DsupΔC
Comment
Comment from the depositorA subline of the HEK293(RCB1637) cells. Stably expressing Damage suppressor (Dsup) mutant lacking the C-terminal region. Dsup is a tardigrade-unique DNA protection protein.
RCB4692
HCT116-vim
CommentCurrently not ready.
Comment from the depositorTransenlchumance nederlvedfromcooncancer Thiscell lnelssultableto Observeepitheliahnesenchymal transfOrmation.
RCB4693
ChR2-C2C12
CommentA subline of the murine C2C12 cell line (RCB0987) which stably expresses channelrhodopsin 2-Venus (ChR2-Venus), one of light-gated cation channels derived from a green alga Chlamydomonas reinhardtii, tagged with a fluorescent protein, Venus.
Comment from the depositor
RCB4695
GFP-LC3-RFP-LC3ΔG HeLa
Comment
Comment from the depositorThis cell line stablly expresses EGFP-LC3-mRFP-LC3Δ, an autophagic flux probe. Cellular autophagic flux can be evaluated by calculating the ratio of GFP against RFP fluorescent intensity.
RCB4696
GFP-LC3-RFP-LC3ΔG MEF
Comment
Comment from the depositorThis cell line stablly expresses EGFP-LC3-mRFP-LC3Δ, an autophagic flux probe. Cellular autophagic flux can be evaluated by calculating the ratio of GFP against RFP fluorescent intensity.
RCB4699
S-TFE